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Abstract 
Hairless mice have been widely used in basic research and clinical trials. Two 
new mouse mutants with hair loss arose spontaneously in the breeding colony of Oak 
Ridge National Laboratory. The first homozygotes mutant, called near naked hairless 
(Hrn), never develops a normal coat, while heterozygotes display a sparse coat and 
become completely nude as they age. The Hrn/Hrn mutant mice are significantly smaller 
in body size and have very short, curly, and few vibrissae. Histological analysis revealed 
premature keratinization in the precortical region of hair follicles, formation of 
mineralized dermal cysts, and loss of hair follicles. Adult heterozygotes display pili 
multigemini (i.e. more than one hair from one piliary canal) after the first hair cycle, 
suggesting abnormal regulation of hair shaft formation by the mutation. A mutation was 
not identified in the coding region of Hr nor in candidate genes around Hr, suggesting a 
possible regulatory mutation of Hr. Microarray analysis was used to survey the gene 
expression profile and to identify the molecular mechanisms altered by the Hrn mutation. 
Several pathways including Wnt/β-catenin, TGF-β, and apoptosis are significantly altered 
in Hrn mutants, indicating the involvement of Hrn in these pathways. Hrn mutant mice are 
also suggested to be a research model for human MUHH (Marie Unna Hereditary 
Hypotrichosis). 
The second mouse mutant, called rhino-like (HrrhR), displays progressive and 
random hair loss and wrinkling skin, leading to a rhinocerotic appearance. Histological 
analysis revealed the formation of utricles at as early as 10 days of age, the formation of 
dermal cysts, and the destruction of hair follicles. Since the phenotype in the homozygous 
mutants is very close to that in Hrrh mutant mice, the genomic DNA of Hr gene was 
directly sequenced. A nonsense mutation was identified in the exon 12, leading to 
significantly reduced Hr expression, probably due to nonsense-mediated decay. The 
allele was named as rhino in Oak Ridge with the symbol HrrhR (R for Oak Ridge). 
Microarray analysis of skin from mice at 7, 10, and 35 days was applied to identify the 
downstream events of the HrrhR mutation. Several genes including Krt1-10, Krt2-1, IL-
17, and Itgb4, were identified as the potential targets of HrrhR. Wnt/β-catenin, apoptosis, 
and ERK/MAPK signaling pathways were altered in HrrhR/HrrhR mutant mice, suggesting 
v 
a possible role of Hr to regulate these pathways. Microarray analysis also shows many 
immune-related genes with differential expression, indicating the possible involvement of 
Hr in immune response. Identification of this new Hr allele and its related research 
allows further understanding about the function of Hr and the mechanisms of alopecia, 
i.e. hair loss. 
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Chapter 1 Introduction  
The hair follicle represents a very complex biological system with growth and 
cycling throughout the whole life.  Hair follicle is widely used as a model to study 
epithelial-mesenchymal interactions during animal and human development.  Hair 
follicles are also used as a source of pluripotent stem cells from adult skin. Hair loss in 
mice can be used to model many different human diseases with hair loss. Mouse models 
can be treated as preclinical models to test new treatments for human alopecia, i.e. hair 
loss.  In industry, hair follicle is also the scientific foundation for a multi-billion dollar 
industry. Therefore it is critical to study the mechanisms involved with hair growth and 
cycle in both mouse and human. 
In this dissertation research, two mouse mutants, each with a hair loss phenotype, 
were used to study the mechanisms of hair loss. Both of the mutants arose spontaneously 
in Oak Ridge National Laboratory (ORNL) mouse colony. The first one, called near 
naked hairless (Hrn), arose spontaneously in the 1980s. Homozygous Hrn/Hrn mice never 
grow a normal coat of hair and are virtually hairless. The phenotype of heterozygous 
mice is less severe. They develop a sparse coat early in life, but become completely nude 
with age. Homozygous mutants also exhibit reduced body growth, and the homozygous 
females have difficulties in caring for their offspring. Allelism testing with the known 
hairless mice (Hrhr) (Stelzner, 1983) suggested that the mutation might be an allele of the 
hairless gene (Hr) with 95% confidence. However, no mutation was found by sequencing 
the entire Hr gene, including introns, exons, 3’UTR and 5’-UTR region. Although a 
mutation was not identified in the Hrn mutants, the Hrn mutant mice were characterized 
systematically by using histological study, scanning electron microscopy, 
immunohistochemistry, microarray analysis, sequencing, and other molecular biological 
techniques. A group of differentially expressed genes and related signal pathways were 
identified in the mutant mice through microarray analysis, which suggests the possible 
functions of the mutated gene. Hrn mice are potential models for Marie Unna Hereditary 
Hypotrichosis (MUHH), a hair loss syndrome in humans for which the genetic cause is 
not yet known.  
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The second mutant is named as Rhino-like (registered as Oak Ridge rhino allele 
of Hr (HrrhR) in MGI (Mouse Genome Informatics)). It arose spontaneously downstream 
from a translocation experiment in ORNL, but the mutation is not due to a translocation 
in the genome. Homozygous mutant mice have a normal coat of hair until 2-3 weeks after 
birth, the time at which the first hair cycle initiates. Mutant mice fail to initiate the first 
hair cycle and begin to lose their hair. By 5-weeks of age the mice are hairless and their 
skin is wrinkled. The phenotype of this mutant is very similar to the known rhino (Hrrh) 
mice. The mutation was identified in exon 12 of Hr as a nonsense mutation leading to a 
premature stop codon, by genomic sequencing. Formation of utricles was identified as the 
earliest phenotypic changes that started at day 10 after birth, through histological analysis. 
Microarray experiments were used to characterize the downstream events caused by the 
mutation with the mice at 7, 10, and 35 days after birth. Groups of differentially 
expressed genes were identified as well as their related signal pathways, which suggest 
possible roles of Hr protein in hair follicle cycling. 
Altogether, the research related with these two mouse mutants will promote the 
understanding of hair growth and cycle. It will help to understand how the hair growth 
and cycles in mouse are regulated, and eventually help to cure the hair loss in human 
patient or remove hair from patients. 
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Chapter 2 The mammalian hair follicle and alterations that lead to hair loss 
Reasons to study hair loss in mice 
 Hair follicles in mammalian skin produce hair shafts for many functions including 
decoration, thermoregulation, collecting sensory information, protection against trauma 
and insect penetration, social communication, and mimicry (Stenn and Paus, 2001). Hair 
loss, i.e. alopecia, is a chronic dermatological disorder. There are a variety of different 
causes for hair loss, including but not limited to hormones (Schmidt, 1994),  
chemotherapy (Rosman, 2004), radiotherapy (Rosman, 2004), genetic mutations 
(O'Shaughnessy and Christiano, 2004), stress (Brajac et al., 2003), smoking (Trueb, 
2003), cancer (Pierard-Franchimont and Pierard, 2004) and systemic diseases (Spencer 
and Callen, 1987). Hair loss itself is neither life threatening nor very painful. However, 
the aesthetic effects can induce a strong stress and anxiety, especially for women patients 
with complete hair loss (Cash et al., 1993; Hadshiew et al., 2004; Hunt and McHale, 
2005). 
The hair follicle is unique with its cycling characteristic of regression and 
regeneration during the entire life span in mammals as it completely regenerates itself 
with each hair follicle cycle due to the presence of a stem cell population in the region 
known as the bulge (Christiano, 2004). It represents a stem cell-rich, prototypic 
neuroectodermal-mesodermal interaction system and a classical model for the study of 
epithelial-mesenchymal interactions during development (Rendl et al., 2005; Reynolds 
and Jahoda, 2004). Mouse hair loss mutants are potential models for human alopecia 
(Irvine and Christiano, 2001; O'Shaughnessy and Christiano, 2004; Porter, 2003), and 
they offer two distinct advantages for hair loss research: one is the synchronized cycles 
that occur during the first two hair cycles in mouse, while the other is the short time of 
mouse hair cycles, only 28 days compared to several years in human (Porter, 2003). 
Study of hair follicle cycle is also potentially important to promote further understanding 
of skin tumors, as many types of skin cancer are thought to originate from cells within the 
hair follicle (Paus et al., 1999a; Paus and Cotsarelis, 1999; Stenn and Paus, 2001). 
Altogether, research with hair follicle will be critical to further our understanding about 
development and growth control of keratinocytes and stem cells. 
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Structure of the hair follicle 
 The size and shape of hair follicles varies with their locations (Paus and Cotsarelis, 
1999). However, they all have the same basic structure, shown in figure 2-1. The hair 
shaft is produced from the hair matrix as the end product of hair follicle proliferation and 
differentiation. Hair matrix contains rapidly proliferating keratinocytes and melanocytes. 
The hair shaft is divided into the hair cuticle on the outside, the cortex, and the medulla in 
the center. Hair shaft cuticle consists of overlapping cells that are arranged like shingles 
pointing outward and upward. Hair shaft cortex, the bulk of the hair shaft, is composed of 
hair-specific keratin filaments and keratin-associated proteins with melanin produced by 
melanocytes in the matrix region (Paus and Cotsarelis, 1999). Hair shaft medulla, the 
central part of the hair shaft, is composed of large, loosely connected keratinized cells 
with large intercellular air spaces. The hair shaft is surrounded by the inner and outer root 
sheath (IRS and ORS). The inner root sheath contains three concentric layers including 
Henle’s layer, Huxley’s layer, and the cuticles (Muller-Rover et al., 2001). The bulge is a 
portion of the outer root sheath, located at the region of the insertion of the arrector pili 
muscle. It contains epithelial stem cells responsible for regenerating the follicle during 
early anagen (Fuchs, 1998; Gho et al., 2004; Morris et al., 2004). The outer root sheath 
also contains melanocytes, Langerhan’s cells (dendritic antigen-presenting cells), and 
Merkel cells, which are specialized neurosecretory cells. The dermal papilla at the base of 
hair follicles is a cluster of mesenchymal cells and is thought to control the number of 
matrix cells and thus the size of hair (Hardy, 1992; Paus and Cotsarelis, 1999). Hair 
follicles have a very complex immunologic profile that includes perifollicular 
macrophages, mast cells and other immunocytes.  
Hair follicle morphogenesis 
Normal development of hair follicles requires interactions between the epithelium 
and underlying mesenchyme in utero. Different types of hair follicles have different time-
courses of induction during morphogenesis. In murine dorsal skin, hair follicle 
morphogenesis is induced at E14.5 and development is complete at postnatal day 6 to 8. 
The induction of vibrissae hair follicle morphogenesis starts at E12.5, earlier than dorsal 
skin hair follicles. Hair follicles for the secondary shorter and thinner hair develop from 
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Figure 2-1 Schematic illustration of the structure of hair follicle (Botchkarev and Paus, 
2003; Fuchs, 1998) and hair shafts (Adapted from www.regentpharmacy.co.uk). 
Abbreviations: SG: sebaceous gland; APM: arrector pili muscle; ORS: outer root sheath; 
IRS: inner root sheath; HS: hair shaft; mel: melanocytes; HM: hair matrix; DP: dermal 
papilla.  
 
DP 
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E16.5 to postnatal day 0.5. There are eight consecutive stages in hair follicle 
morphogenesis as shown in figure 2-2 (Botchkarev and Paus, 2003).  
In stage 1, hair germ or hair placode forms in the basal layer of epidermis. The 
source of the first dermal message to form a hair placode is not known. The keratinocytes 
in hair placodes are distinguished from other keratinocytes by the expression of growth 
factors (Wnt-10b, Eda, BMP-2), growth factor receptors (Edar, TGFβRII, BMPR-1A) and 
transcriptional regulators (Lef1, β-catenin and Msx2) (Botchkarev and Kishimoto, 2003; 
Schmidt-Ullrich and Paus, 2005). Accordingly, at least three signaling pathways 
including Wnt/β-catenin/Lef-1, Eda/Edar, and TGFβ2/TGFβ-RII, are involved in the 
positive regulation of hair placode formation (Fuchs, 1998). There are two signaling 
pathways inhibiting hair follicle induction, including BMP-2/4 and EGF (epidermal 
growth factor) signaling (Botchkarev and Paus, 2003). The balance between these 
inhibitors and stimulators tightly controls the initiation stage of hair follicle development.  
Hair placode grows down into the dermis and forms hair peg in stage 2 and 3. The 
keratinocytes in hair peg highly express sonic hedgehog (Shh) and its receptor Ptc1, 
platelet-derived growth factor A (PDGF-A), neurotrophins, TGFβ-RII, and neural-cell 
adhesion molecule (N-CAM) (Rogers, 2004). The mesenchymal cells express Wnt-5a and 
downstream effectors Lef1, Ptc1, Gli1, PDGF-Rα, Noggin, and alkaline phosphatase 
(Botchkarev and Kishimoto, 2003; Fuchs, 1998). All these molecules are essential to 
promote the morphogenesis of dermal papilla (Botchkarev and Kishimoto, 2003). 
In stage 4, the dermal papilla is formed and is incorporated into the epithelial hair 
bulb. The keratinocytes in hair bulb proliferate and differentiate into the inner root sheath 
and hair shaft cells (Paus and Cotsarelis, 1999). At stage 5, sebocytes are visible in the 
distal parts of the hair follicle and melanin granules and hair shaft are above the dermal 
papilla (Schmidt-Ullrich and Paus, 2005). The hair shaft reaches the level of sebaceous 
gland and the hair canal becomes visible in skin during stage 6-7. In stage 8, the hair 
follicle elongates to the maximal length and hair bulb is visible; sebaceous gland and 
arrector pili muscle are present in the dermis and the hair shaft finally emerges through  
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Figure 2-2 Schematic diagram of hair follicle morphogenesis and its molecular regulation 
(adapted from (Botchkarev and Paus, 2003))
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the epidermis (Rogers, 2004; Schmidt-Ullrich and Paus, 2005). It is found that Foxn1, 
Cutl1, EGF receptor or its ligand TGF-β, keratin 1-10 and keratin 2-1, trichohyalin, 
and the components of the cornified envelope including transglutaminases, loricrin, and 
involucrin affect the differentiation of inner root sheath (Botchkarev and Paus, 2003; 
Fuchs, 1998). Hair shaft differentiation is controlled by multiple signaling pathways 
including Wnt/β-catenin/Lef-1, Hoxc13, BMP/Msx-2/Foxn1, Notch, and desmoglein 4 
(Dsg4) (Botchkarev and Paus, 2003; Fuchs, 1998). Interestingly, BMP signaling is 
involved in controlling the expression and function of Lef1, Hoxc13, and Foxn1 
transcription factors in differentiating hair shaft precursor cells. 
Hair follicle cycling 
Hair follicles show periodic changes in their activity during hair cycles. The most 
unique feature of a hair follicle is its ability to regress and regrow in a regulated manner 
throughout life. The length of the hair cycle, i.e. the period between catagens in two 
continuous hair cycles, varies widely across species. In human it is about 10 years, while 
in mice it is about 28 days. Many species, like humans, exhibit asynchronous cycles, in 
which adjacent hair follicles can be in completely different stages of the hair follicle 
cycle. In mice, at least in the first few cycles, follicles are synchronized and proceed in a 
head to tail manner. Hair follicle cycle includes three stages: intensive growth and hair 
production in anagen, apoptosis-driven regression in catagen, and resting stage in telogen 
(Stenn and Paus, 2001) as shown in figure 2-3. Hair follicle cycling represents repetitive 
tissue regeneration and involution. The first hair cycle in mice begins with hair follicle 
development and anagen prenatally and ends with the first catagen, about 14 days after 
birth. Catagen is induced by regulated apoptosis, leading to retraction of the epithelial 
strand and its disconnection from the dermal papilla. In telogen, the hair fiber becomes 
loosened and falls out. A new cycle initiates, the follicle regrows, and the next anagen 
proceeds. The cycling of hair follicles begins with catagen instead of anagen shortly after 
the hair follicle morphogenesis with the first coat. Therefore, the chronology of hair 
follicle cycling is from catagen to telogen, to anagen, and back to catagen. The hair 
follicle alters its normal cycling behavior in response to damage, such as by 
chemotherapy so that hair follicle cycling continues later (Paus and Foitzik, 2004). 
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Figure 2-3 Schematic illustration of the hair follicle cycle.  
 
 Catagen 
 Late anagen 
 Early anagen  Telogen 
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Pigmented hair shafts are actively produced and the follicle reaches it maximal length 
and volume during anagen. All new hair shaft production and pigmentation is ceased as 
the club hair is formed during catagen. The club hair rest loosely in the hair canal and is 
actively shed during telogen (Paus and Foitzik, 2004). 
It is known that a large number of cytokines, growth factors, transcription factors, 
enzymes, and adhesion molecules, including members of the epidermal, fibroblast, and 
transforming growth factor families, are implicated in the hair growth cycle (Reviewed in 
(Nakamura et al., 2001; Paus and Foitzik, 2004)).  For instance, insulin-like growth factor 
1, fibroblast growth factor 5 and 7, play very important roles in hair follicle development 
and cycling, especially in the anagen stage (Paus, 1998; Paus and Cotsarelis, 1999; Paus 
and Foitzik, 2004; Paus et al., 1999b).  The genes that are important in the hair follicle 
cycle are summarized in table 2-1.  
General mechanisms of hair growth disorders 
Hair follicle morphogenesis and hair cycle are the scientific foundations of the 
vast majority of human patients with hair growth disorders. For the genes involved in hair 
follicle morphogenesis or the hair cycle, mutations in these genes leading to reduced 
expression or overexpression could destroy the balance required for hair follicle 
morphogenesis and hair follicle cycles, thus leading to disorders of hair growth, including 
hair loss. Telogen effluvium is an extremely common form of alopecia, i.e. hair loss with 
excessive shedding of hair. Normally, most of the hair follicles are in the anagen stage 
while a rather small portion of hair follicles are in telogen. A larger portion of hair 
follicles stays in telogen leading to hair shedding when telogen effluvium occurs. The 
causes for telogen effluvium include pregnancy, medications including minoxidil, change 
of exposure to sunlight, psychological stress, and high fever (Cotsarelis and Millar, 2001). 
The hair follicles in telogen effluvium are still intact and able to generate new hairs later. 
Androgenetic alopecia is due to the progressive shortening of successive anagen cycles 
and is commonly manifested as telogen effluvium. The hair loss in male is patterned as 
frontal recession and thinning at the vertex and that in female is as loss of hair over the 
crown with sparsing of the frontal hair line. Androgenetic alopecia results in a decrease 
in hair follicle size as well as a decrease in the duration of anagen and an increase in the 
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Table 2-1. The genes involved in mammalian hair cycles  
Interfaces List of genes involved in the process 
 
Anagen-catagen 
transition 
FGF-5, FGFR1, TGFβ-1 and 2, Neurotrophins (BDNF, NT-3, 
NT-4) and their receptors (TrkB, TrkC), SCF, VEGF, HGF, IGF-
1, KGF, Endothelin-1 (ET-1), IL-1α/β, IGF-BP3/4/5, vitamin D 
receptor, prolactin, RXRα,  glucocorticoid receptors, 
neuropeptide substance P, BMP-2, follistatin, PTHrp, calcitriols, 
retinoids, estrogens, activin, GDNF, INF-γ 
Cell death and 
survival during 
catagen 
TNF receptor, Fas/CD95, p75 kD neurotrophin receptor, 
Caspase-1, 3, 4, 7, P53, Bax, Bcl-2, Bcl-XL, desmoglein-3 and 
cathepsin L  
 
Telogen-anagen 
transition 
BMP-4, BMPR-IA, noggin, STAT3, FGF7, WNTs, desmoglein-3, 
cathepsin L, neuropeptide substance P, estrogen receptor, Ssh, 
HGF, IGF-1, TGF-α, KGF, ACTH, SP, β-catenin, desmoglein 1/3, 
Msx2 
 
Abbreviations: FGF: fibroblast growth factor; TGF: transforming growth factor; BDNF: 
brain-derived neurotrophin factor; NT: neurotrophins; SCF: stem cell factor: VEGF: 
vascular endothelial growth factor; HGF: hepatocyte growth factor; IGF: Insulin-like 
growth factor; KGF: Keratinocyte growth factor; IGF-BP: Insulin-like growth factor 
binding protein; RXR: retinoid X receptor; BMP: bone morphogenic protein; PTHrp: 
parathyroid-related peptide; GDNF: glial cell line-derived neurotrophic factor; IL: 
interleukin; TNF: Tumor necrosis factor; STAT: Signal Transducer and Activators of 
Transcription; ACTH: adrenocorticotrophin; INF: interferon; SP: substance P. 
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percentage of hair follicles in telogen (Cotsarelis and Millar, 2001). Testosterone is 
required for androgenetic alopecia to develop in men, but not determined in women.  
Hypertrichosis is excessive hair growth beyond that considered normal according 
to age, race, sex, and skin region. Hirsutism is excessive hair growth in androgen-
dependent areas in women. Both hypertrichosis and hirsutism result from a prolonged 
anagen with an abnormal enlargement of hair follicles. Small vellus hairs turn into large, 
terminal hairs. In mice, a mutation in FGF5 causes the striking angora mouse phenotype 
with 50% longer hair growth due to 50% longer anagen phase and delay of the catagen 
phase. Overexpression of either Bcl-XL or Bcl-2 in the outer root sheath decreases the 
duration of anagen and causes alopecia. It has been known that a large number of 
different genes contribute to the switches for the transformations from one hair cycle 
stage to the next as shown in table 2-1. There are still a lot of unknowns about hair 
follicle cycle. There are no exact numbers on the times that a given hair follicle subtype 
in a given location could cycle during life time of a mammalian organism. The autonomy 
and spontaneity of hair follicle, the non-linkage to known perennial, seasonal, circadian 
or diurnal rhythms, disparate length of individual hair cycle phases, the micro- and 
macro-environment around hair follicles during hair cycles, are formidable challenge for 
dermatological research with hair follicle even if cycling of a single hair follicle is very-
well known. However, many molecular players in hair cycle control have been identified 
in murine hair follicle cycle, including Wnt family members, TGFβ/BMP family 
members and their antagonists, the Shh-patched-Gli pathway, notch signaling, HGF, 
neurotrophins, and FGFs (reviewed in (Paus and Foitzik, 2004). Mutations in these genes 
contribute to abnormal hair growth and hair follicle cycling. Hairless is one of the key 
catagen controllers (Panteleyev et al., 1999) and mutations in hairless cause alopecia in 
both mouse and human (Panteleyev et al., 1998b). Below, two genes closely related with 
hair shaft differentiation and hair growth are described in detail. 
Foxn1 
 Foxn1 gene, formerly called Whn and Hfh11, is the second gene to be defined to 
affect hair growth after Hr. Mutations in this gene, which are autosomal recessive, cause 
the “nude” phenotype first reported in 1966 by Flanagan SP in Edinburgh, UK (Flanagan, 
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1966). It was noticed that nude mice have normal hair follicle at birth, but that by 6 days 
of age the hair shaft starts to twist and coil with the follicular infundibulum, failing to 
penetrate the epidermis (Flanagan, 1966). Nude mice also suffer from agenesis of the 
thymus and are severely immunocompromised (Pantelouris, 1968; Pantelouris and Hair, 
1970). This suggests the pleiotropic effects of Foxn1 in different tissues (Flanagan, 1966). 
Foxn1 gene encodes a highly conserved transcription factor of the winged helix domain 
family containing a C-terminal transcriptional activation domain and a DNA binding 
domain (Mecklenburg et al., 2005). Loss of function of either one is thought to cause the 
lack of fur development and thymic agenesis. The mutation of Foxn1 in nude mice is 
caused by a single base pair deletion in exon 3, which leads to a frameshift and a 
premature stop codon and a protein lacking the DNA binding domain (Nehls et al., 1994). 
There are totally six spontaneously arisen mutations in Foxn1 gene as well as two 
targeted mutations (Blake et al., 2003). Both the skin and the thymic phenotype of nude 
mice were able to be rescued by an engineered 110kb transgene containing Foxn1, but 
not by a cosmid-derived 26kb transgene containing Foxn1 (Cunliffe et al., 2002). 
Mutations in Foxn1 gene have been described in rats and in humans (Frank et al., 1999; 
Fuchs, 1998; Nehls et al., 1994) 
Nude mice are actually not hairless at all. They have a normal number of hair 
follicles and normally cycling hair follicles despite the marked defects within the hair 
shafts (Mecklenburg et al., 2005). However, the keratinization in the hair follicles is 
severely impaired. A decreased sulfur concentration in nude mice was found in hair fibers 
(Kopf-Maier et al., 1990; Mecklenburg et al., 2005). The IRS cuticle and the cuticle of 
the hair shaft are fragmented into globular amorphous structures (Kopf-Maier et al., 
1990) due to the lack of keratin mHa3. The cortex of hair shaft is composed by abnormal 
globular aggregates (Kopf-Maier et al., 1990). The epidermis shows only few and thin 
bundles of tonofilaments in the basal, spinous and granular layers and bizarrely formed 
and irregularly arranged lamellae of corneocytes in the stratum corneum (Kopf-Maier et 
al., 1990). The medulla of hair shaft in nude mice is less septulated than in heterozygous 
or wild type animals probably due to the reduced expression of desmocollin-2 (Johns et 
al., 2005). The nails of nude mice are severely malformed showing an onychodystrophy 
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associated with a basophilic stippling of the dorsal nail plate and a significantly reduced 
sulfur concentration (Flanagan, 1966; Mecklenburg et al., 2005).  
Foxn1 is not expressed in the formation of the hair bud, but in the pre-cortical 
matrix of developing hair follicles as well as in the hair matrix keratinocytes, precortical 
hair matrix cells, trichocytes of the hair cortex, and the outer root sheath keratinocytes in 
cycling hair follicles (Mecklenburg et al., 2005). Foxn1 is very important for maintaining 
the balance between keratinocyte growth and differentiation in differentiating 
keratinocytes. Overexpression of Foxn1 under the control of involucrin promoter in 
differentiating keratinocytes inhibited markers of late differentiation including 
profilaggrin, involucrin, and loricrin while the keratinocytes from nude mice express 
higher levels of profilaggrin and loricrin than those from wild type mice after stimulation 
with calcium (Mecklenburg et al., 2005). Foxn1 is suggested to be involved in the control 
of the expression of certain keratins, such as mHa1, mHa3, and mHa4, which are 
downregulated in nude mice and upregulated with over-expression of Foxn1 in HeLa 
cells (Mecklenburg et al., 2005; Schlake et al., 2000; Schorpp et al., 2000). Foxn1 is also 
suggested to be a negative regulator of protein kinase C (PKC) activity, which is known 
to regulate keratinocyte proliferation and differentiation, and to inhibit hair growth 
(Harmon et al., 1995; Harmon et al., 1997; Xiong and Harmon, 1997). Foxn1 might 
stimulate the expression of protein kinase B (Akt kinase) triggering the completion of the 
differentiation and formation of the granular and cornified epidermal layer despite of the 
lack of knowledge with the nude mice (Janes et al., 2004). The regulation of Foxn1 is 
inhibited by the activation of MAP kinases and promoted by the overexpression of Wnt4 
or Wnt5b (Mecklenburg et al., 2005) or under the stimulation of bone morphogenic 
protein receptor 1a (BMPr1a) (Ma et al., 2003).  
Hoxc13 
Hoxc13 is the first hox gene shown to play a universal role in hair follicle 
development as both Hoxc13-deficient and over-expressing mice exhibit severe hair 
growth and patterning defects (Godwin and Capecchi, 1998; Tkatchenko et al., 2001). 
Hoxc13 is expressed in the vibrissae and hair follicles, mainly in the matrix of the hair 
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bulb and the precortical region of the hair shaft as well as in the filiform papillae of the 
tongue (Awgulewitsch, 2003; Godwin and Capecchi, 1998).  
Hoxc13 mutant mice lack vibrissae, all pelage hair types, peri-anal hairs, 
eyelashes due to the brittleness of the hair fibers although the mice develop 
morphologically normal hair follicles (Godwin and Capecchi, 1998). Most homozygotes 
die between postnatal day 7 and 14 with progressive weight loss and weakness relative to 
the littermates (Godwin and Capecchi, 1998). The lack of external hair in Hoxc13 mutant 
mice suggests that Hoxc13 plays important roles in hair shaft differentiation by either 
regulating the expression of hair specific keratin or controlling the differentiation of 
precursor cells in hair follicle, which are supported by the following evidence.  
The GC13 mice, which overexpress murine Hoxc13 in differentiating 
keratinocytes of hair follicles, showed short tails, taut skin, kinky whiskers, and smaller 
stuture, progressive alopecia with age with epidermal thickening and follicular 
enlargement due to thickened outer root sheath and keratinaceous materials filled cysts 
(Tkatchenko et al., 2001). The expression of a cluster of keratin-associated proteins 
complex 16 (krtap16) was downregulated due to in GC13 mice, suggesting the possible 
role of Hoxc13 in the regulation of keratin expression.  
It was also found that Hoxc13 was involved in the regulation of human hair 
keratin gene expression via binding to the recognition motif TT(A/T)ATNPuPu (Jave-
Suarez et al., 2002). The reduced expression of bone morphogenic protein 4 (BMP-4) in 
hair follicles, which had the similar expression pattern with Hoxc13 in hair follicles, 
caused down-regulation of Hoxc13 and impaired hair shaft differentiation and distal 
expansion of proliferating keratinocytes normally restricted in the proximal matrix region 
(Kulessa et al., 2000). It suggests that Hoxc13 might be involved in the control of 
precursor cell differentiation in hair follicles. Hoxc13 might help to maintain the balance 
of hair keratin expression and of the controls for keratinocytes differentiation through a 
negative autoregulatory feedback control of Hoxc13 expression level (Awgulewitsch, 
2003; Tkatchenko et al., 2001). 
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Hairless and hair loss 
History of hairless mice 
In the search of genes responsible for hair loss, hairless (Hr) gene was the first 
one found to cause alopecia. The hairless mouse was first captured in an aviary in 1924 
in North London, UK (Brooke, 1926). It was pink with smooth skin. The first description 
of rhino mice was reported by Gaskoin in 1856 (Gaskoin, 1856) as “rhinoceros” with hair 
loss and wrinkled skin. Later, it was shown that rhino and hairless are alleles of the same 
gene, Hr (Howard, 1940). Rhino alleles (Hrrh) have a more severe phenotype than alleles 
designated as hairless (Hrhr). It should also be noted that the skin from different Hr 
alleles differ in subtle details, which may be due to strain differences or the mutations 
themselves (Panteleyev et al., 1998c; Sundberg, 1994). The hairless (Hrhr) mice, widely 
used in dermatological research today, arose spontaneously in 1939 at McGill University 
in Montreal, Canada (Sundberg, 1994). 
Both hairless (Hrhr/Hrhr) and rhino (Hrrh/Hrrh) mutants are born with normal hair 
coat but lose their hair around the age of 3 - 4 weeks, and are more sensitive to UV and 
chemical carcinogens (Panteleyev et al., 1998b).  Both have been extensively used for 
many cutaneous studies due to the absence of hair, including ultraviolet and chemical 
induced carcinogenesis, topical application of compounds, wound healing, and 
microcirculation (Sundberg, 1994).  Homologs of murine hairless have been identified in 
human, rat, monkey, sheep, and pig (Ahmad et al., 1998a; Ahmad et al., 2002; Fernandez 
et al., 2003; Finocchiaro et al., 2003; Thompson, 1996).  
Features of Hr gene 
There are 19 exons in both human and murine Hr (Ahmad et al., 1998a; Cachon-
Gonzalez et al., 1994; Cichon et al., 1998). Hr is mainly expressed in brain and the 
epidermis and hair follicle in the skin, with lower expression in cartilage, developing 
tooth, inner ear, retina, testis, colon, stomach, pituitary gland, small intestine, appendix, 
liver, kidney, pancreas, spleen, and thymus (Ahmad et al., 1998a; Cachon-Gonzalez et 
al., 1999; Cichon et al., 1998). It was found that Hr in rat is expressed at high levels in 
cerebellum shortly after birth, reaching a peak between postnatal days 14 and 21 (Potter 
et al., 2001).  It was first cloned in rat as part of a screen for thyroid hormone-responsive 
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genes in the brain (Thompson and Bottcher, 1997). Three different isoforms of Hr have 
been described in human: isoform 1 (full length), and isoform 2 (short without exon 17) 
(Cichon et al., 1998), and isoform 3, which is not experimentally confirmed (Strausberg 
et al., 2002).  Isoform 2 is exclusively expressed at high levels in the human skin (Cichon 
et al., 1998).  No alternative transcripts have been reported in murine Hr thus far. 
Hairless protein (HR) is highly conserved in human, mouse, and rat (Cichon et 
al., 1998) with approximately 85% identity between human and rodent HR (Panteleyev et 
al., 1998b). The hairless protein (HR) in human, rat, and monkey have similar length to 
murine HR (Ahmad et al., 2002).  The identified sheep HR is similar to the fragment of 
1-715 amino acids in murine HR (Finocchiaro et al., 2003).  The identified pig HR is 
similar to the fragment of 818-1153 amino acids in murine HR (Fernandez et al., 2003).  
All of them share at least 70% similarity in protein sequence. Interestingly, no homologs 
of HR have been identified outside of mammals. 
HR contains a single zinc finger domain, which is a conserved 4-cysteine motif 
(C-X2-C-X18-C-X2-C) and is predicted to bind with DNA (Cachon-Gonzalez et al., 1994).  
It shares structural homology to the GATA family and to TSGA, a protein mainly 
expressed in rat testis (Cachon-Gonzalez et al., 1994). The homologs of murine hairless 
in sheep and monkey also contain the putative zinc finger domain by multiple sequence 
alignment (Ahmad et al., 2002; Finocchiaro et al., 2003).  Although most GATA family 
members contain two zinc finger domains, it is indicated that a single zinc finger domain 
found in GATA family members is sufficient for DNA binding (Pedone et al., 1997).  In 
addition to the putative zinc finger domain, HR is translocated into the nucleus via a 
novel bipartite nuclear localization signal (NLS) of the form KRA(X13)PKR (amino acid 
412-430), and is associated with components of the nuclear matrix, which may play roles 
in DNA organization, replication, gene transcription, RNA processing, potentially intra-
nuclear signaling for the regulation of gene transcription (Djabali et al., 2001; Djabali and 
Christiano, 2004). Mutation of the third cysteine residue in the conserved zinc finger 
domain to a glycine residue in human (C622G) is shown to be associated with APL (Aita 
et al., 2000). However, a residue change between the second and the third cysteines 
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(R620Q) does not cause APL or AUC in human (Hillmer et al., 2001; Hillmer et al., 
2002).  It suggests that the putative zinc finger domain is critical for the function of HR.   
It has been shown that HR has three LXXLL motifs within two separate α-helical regions 
(Djabali et al., 2001).  This LXXLL motif is conserved in many transcriptional 
coactivators, including TRIPs (Thyroid hormone Receptor Interacting Proteins) (Voegel 
et al., 1998) and DRIPs (vitamin D Receptor Interacting Proteins) (Rachez and Freedman, 
2000), and is required for interaction with nuclear receptors.   
Interestingly, HR has been shown to directly and specifically interact with thyroid 
hormone receptor (TR) and histone deacetylases (HDACs) in rat brain (Potter et al., 2001; 
Potter et al., 2002) and with vitamin D receptors (VDR) in vitro (Hsieh et al., 2003).  HR 
expression is directly regulated by thyroid hormone through TR, and then HR will bind 
with TR and facilitate the transcriptional repression by unliganded TR through the 
interaction with HDACs (Histone Deacetylases) (Potter et al., 2001; Thompson, 1996; 
Thompson and Bottcher, 1997).  A thyroid hormone responsive element was identified in 
the rat Hr promoter (Thompson, 1996). However, the Hr promoter was transactivated by 
T3 in neuroblastoma cells but not in keratinocytes (Engelhard and Christiano, 2004), 
suggesting that HR interacts with TR signaling in brain but not skin. The interaction of 
HR and TR is further found not to be involved in the pathogenesis of atrichia with 
popular lesions in human (Djabali et al., 2004).  
VDR is a nuclear receptor that functions as a ligand-activated transcription factor 
(Haussler et al., 1998).  Co-expression of HR with VDR inhibits VDR-mediated 
transactivation (Hsieh et al., 2003). VDR knockout mice (Li et al., 1997) also develop 
alopecia in skin, and are a phenocopy of Hrhr/Hrhr mutants (Miller et al., 2001).  Targeted 
expression of VDR in the skin promotes initiation of the postnatal hair follicle cycle and 
rescues the alopecia in VDR null mice (Kong et al., 2002a).  Both HR (Djabali et al., 
2001) and VDR (Haussler et al., 1998) are translocated into the nucleus via bipartite 
nuclear localization signals.  Expression of both HR and VDR are localized to normal 
murine epidermis and hair follicles (Gurlek et al., 2002), and are also differentially 
regulated during different hair cycle stages (Panteleyev et al., 2000; Reichrath et al., 
1994).  Mutations in human Hr cause atrichia with papular lesions, while mutations in 
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human VDR cause vitamin D-dependent rickets type IIA (VDDRIIA; OMIM 277440) 
along with atrichia with papular lesions in patients. A detailed clinical and histological 
comparison was done between these two genetically distinct forms of atrichia with 
papules (Zlotogorski et al., 2003). The similarity between these two distinct forms of 
APL suggests a functional relationship between HR and VDR. It was found recently that 
induction of vitamin D responsive genes including involucrin, transglutaminase, 24-
hydroxylase, was potentiated by inhibition of HR expression in the presence of vitamin 
D3, and vice versa (Xie et al., 2005). This suggests that HR functions as a co-repressor of 
VDR to block vitamin D3 action on keratinocytes.  
HR also contains a domain called Jumonji C (jmjC) (amino acids 999-1133) 
(Letunic et al., 2002).  Human homozygous missense mutations in this domain (D1012N 
and V1056M) (Klein et al., 2002; Zlotogorski et al., 2002a) cause AUC or APL, 
suggesting that this domain is critical for the normal function of HR in hair follicle 
cycles. One of the interaction domains of HR with thyroid hormone receptor (TR) is 
amino acids 1024-1040 (Potter et al., 2001), which is part of the JmjC domain.  The exact 
function of this domain still remains unknown. There are over 370 proteins containing the 
jmjC domain, ranging from Saccharomyces cerevisiae, C. elegans, Drosophila, and 
Arabidopsis, to mouse and human (Letunic et al., 2002).  Most of these proteins are 
hypothetical or putative proteins, which may represent a large family of proteins with 
unknown functions. It is also found that many transcription factors contain jmjC domains 
suggesting the possible single functional unit within the folded proteins (Balciunas and 
Ronne, 2000). The jmjC domain is a part of the cupin metalloenzyme superfamily and is 
described as “probable enzymes, but of unknown functions, that regulate chromatin 
reorganization processes” (Letunic et al., 2002). The function of jmjC domain was 
recently linked to the modulation of heterochromatization in fission yeast by showing that 
Epe1, a nuclear protein with jmjC domain, counteracts transcriptional silencing by 
negatively affecting heterochromatin stability (Ayoub et al., 2003). In addition, the jmjC 
domain is essential for the normal function of Epe1 in yeast (Ayoub et al., 2003). This 
suggests that HR might act through chromosome remodeling to regulate the expression of 
downstream genes.  
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Mutations in mice and phenotypes 
A large variety of mutations of Hr have been identified in mouse and human, all 
of which display autosomal recessive inheritance. Many different Hr alleles have been 
cloned in mice and are summarized in table 2-2. There are two general classes of 
phenotypes that result from the mutations in murine hairless. The less severe mutants are 
designated as hairless, while the more severe mutants are known as rhino. The phenotype 
of Hrba is intermediate between hairless and rhino(Garber, 1952). The mutations Hrba, 
Hrrh-2J, Hrrh-9J are now extinct (Panteleyev et al., 1998b). Hr was originally cloned in 
HRS/J mice as an insertion of a polytrophic provirus in the intron 6, which results in the 
aberrant splicing of Hr transcript therefore significantly reduced expression as low as 5-
10% of that in +/+ mice (Cachon-Gonzalez et al., 1994; Jones et al., 1993).  Most of the 
mutations identified in rhino mice are nonsense mutations in different exons of hairless 
(Brancaz et al., 2004; Panteleyev et al., 1998b; Zhang et al., 2005), leading to nonsense-
mediated decay of Hr transcripts (Maquat, 2005; Panteleyev et al., 1998b). The 
phenotype of different rhino alleles varies in terms of the severity of the wrinkling, 
possibly due to the genetic backgrounds. The skin phenotype in both Hrhr and Hrrh 
mutants has been linked to massive and premature apoptosis that leaves the dermal 
papilla stranded and unable to reinitiate induction of the epithelial strand into follicle 
formation (Panteleyev et al., 1998b). Utricles and dermal cysts filled with keratins form 
in the skin of rhino mutant mice and expand with age. The dermis becomes filled with 
cysts, causing the severe skin wrinkling (Mann, 1971; Panteleyev et al., 1998b; 
Sundberg, 1994; Sundberg and Boggess, 1998). All confirmed alleles of Hr are autosomal 
recessive and most of them have been genetically characterized.  The near naked (Hrn) is 
a semi-dominant allele at the Hr locus (Stelzner, 1983).  The homozygous Hrn/Hrn mice 
never grow their hair. Homozygotes are recognizable at 5 days of age with their thin, 
slick skin and short, curly vibrissae.  Heterozygous adults undergo repeated hair loss and 
regrowth in contrast to heterozygous hairless and rhino mice with normal hair and 
permanent fur coat. The vibrissae of Hrn/+ mice are very short, their skin is very thin, and 
wrinkles extensively with age. Both sexes are fertile, but females are poor mothers for 
breeding. The expression of all the alleles of murine Hr except Hrn is downregulated at 
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Table 2-2 Genetic mutations and phenotypes in murine hairless gene 
Alleles Mutation Location Phenotype Inheritance Reference 
Hrhr 
MLV 
insertion Intron 6 Hairless Recessive (Stoye et al., 1988) 
Hrrh R597X Exon 6 Rhino Recessive 
(Cachon-Gonzalez et al., 1999; 
Howard, 1940) 
Hrrh-J E534del Exon 5 Rhino Recessive (Cachon-Gonzalez et al., 1999) 
Hrrh-7J W292X Exon3 Rhino Recessive (Sundberg, 1994) 
Hrrh-8J K512X Exon 4 Rhino Recessive (Ahmad et al., 1998d) 
HrrhChr R467X Exon 4 Rhino Recessive (Ahmad et al., 1998c) 
HrrhY 
13 bp 
insertion Exon 16 Rhino Recessive (Panteleyev et al., 1998a) 
Hrrhbmh 
296 bp 
deletion 
Exon 19 & 
3’-UTR 
Rhino-
Bald Recessive (Brancaz et al., 2004) 
Hrrhsl W911X Exon 12 Rhino Recessive (Zhang et al., 2005) 
HrrhR R814X Exon12 Rhino Recessive Liu unpublished 
Hrba N/A N/A Bald Recessive (Garber, 1952) 
Hrrh-2J N/A N/A Rhino Recessive (Bailey and Bunker, 1973) 
Hrrh-9J N/A N/A Rhino Recessive (Sundberg and Boggess, 1998) 
HrN N/A N/A 
Near 
naked 
Semi-
Dominant (Stelzner, 1983) 
HrTg5053Mm 
Transgene 
insertion 
Intron 5 – 
Exon 8 Rhino Recessive (Jones et al., 1993) 
Hrtm1Cct Transgene Exon 8-10 Rhino Recessive (Zarach et al., 2004) 
N/A: not available 
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least 10-fold in homozygous mutant mice compared to the wild type regardless of age 
(Cachon-Gonzalez et al., 1994; Cachon-Gonzalez et al., 1999; Panteleyev et al., 1998b; 
Panteleyev et al., 1998c). 
Both Hrhr/Hrhr and Hrrh/Hrrh mutants have very low levels of Hr expression and 
start to lose their hair around 2-3 weeks age due to the disruption of the integrity of key 
functional tissue units in the hair follicle (Panteleyev et al., 2000).  This suggests that 
normal levels of Hr protein are important for hair follicle to initiate the first hair cycle 
(Panteleyev et al., 1998c) and that Hr may be involved in the control of the first hair 
follicle cycling (Panteleyev et al., 2000).  More specifically, the absence of Hr in hairless 
mice may cause dysregulation of normal, catagen-associated apoptosis and an 
impairment of cell adhesion (Panteleyev et al., 2000). 
Hr mutant mice are also found to be dramatically more susceptible to dioxin than 
the wild type mice (Sundberg, 1994).  The aryl hydrocarbon receptor (AhR), a ligand-
activated transcription factor, is shown to mediate most of the toxic effects of dioxin 
(Whitlock, 1990). This suggests that Hr may be protective against aryl hydrocarbon (Ah) 
receptor-mediated dioxin toxicity in mouse skin (Knutson and Poland, 1982).  Ornithine 
decarboxylase (ODC) is an important enzyme in the polyamine biosynthetic pathway, 
which plays an essential role in epithelial tumorogenesis (Weeks et al., 1982). 
Overexpression of ODC in the epidermis of transgenic mice causes a phenotype similar 
to hairless mutant mice (Soler et al., 1996).  The transgenic mice have a normal first hair 
cycle, but lose the hair around 2-3 weeks old (Soler et al., 1996).  The overexpression of 
ODC in the transgenic mice is first detected at day 12 (Soler et al 1996).  Interestingly, it 
is found that dioxin is able to modulate ODC activity in skin of ODC transgenic mice 
(Raunio and Pelkonen, 1983) while hairless mutant mice are more susceptible to dioxin 
in the skin. This suggests that ODC plays an important role in hair follicle cycling and 
that there might be a direct interaction between HR and AhR.  
It is also found that there might be Hr mutation-associated impairment of 
mammary gland function (Panteleyev et al., 1998b) since HR is expressed in mammary 
gland.  However, the details still remain unknown. Hr mutants also show some 
neurological phenotypes, such as altered neuronal morphology, inner ear defects, and 
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abnormal retinal cytoarchitecture (Cachon-Gonzalez et al., 1999; Garcia-Atares et al., 
1998). Hr mutants demonstrate a tendency toward skin ulceration upon minor epidermal 
trauma, suggesting a potential role for HR in the regulation of wound healing (Sundberg, 
1994). All together these findings indicate that HR is pleiotropic and plays wide roles in 
development. 
Mutations in human and related diseases 
It is shown that mutations of Hr homolog in human are related with two 
autosomal recessive diseases, including congenital alopecia universalis (AUC, OMIM 
203655) and atrichia with popular lesions (APL, OMIM 209500). Atrichia with popular 
lesions (APL, OMIM 209500) in human patients is the counterpart of the Hrhr/Hrhr in 
mice. The features of APL include papillary lesions over most of the body and almost 
complete absence of hair. Patients are born with hair that falls out shortly after birth and 
is not replaced. Malformations of the hair follicles are shown in histological studies. In 
addition to hair loss, other symptoms including concomitant mental retardation (Aita et 
al., 2000; del Castillo et al., 1974) and retardation of bone age (Kruse et al., 1999) are 
also reported in some cases. 
The mutation in human Hr was first identified as causing APL by Christiano’s 
group in 1998 (Ahmad et al., 1998a), although the missense mutation first reported was 
proved to be a single nucleotide polymorphism (Hillmer et al., 2002). A number of 
mutations in Hr responsible for causing APL have been found since 1998 (Ahmad et al., 
1998a; Ashoor et al., 2005; Bergman et al., 2005; Djabali et al., 2004; Henn et al., 2002; 
Hillmer et al., 2001; Indelman et al., 2003; John et al., 2005; Masse et al., 2005b; Paradisi 
et al., 2003; Paradisi et al., 2005; Sprecher et al., 1999a; Sprecher et al., 1998; Sprecher et 
al., 2000; Yang et al., 2005; Zlotogorski et al., 2003; Zlotogorski et al., 2002a). There are 
four different types of mutations, including nonsense mutations, missense mutations, 
deletions/insertions, and splice site mutations, in human Hr that cause APL (Ashoor et 
al., 2005) as shown in table 2-3. In addition, the APL phenotype has been shown to result 
from compound heterozygosity in Hr (Ashoor et al., 2005). Interestingly, two originally 
reported mutations were shown to be just polymorphisms by examining a larger 
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Table 2-3 Genetic mutations and phenotypes of human hairless gene.  
Mutation Location OMIM Reference 
Nonsense mutations    
R33X Exon 2 APL (Zlotogorski et al., 2002a) 
R154X Exon 2 APL (Ashoor et al., 2005) 
Q260X Exon 3 APL (Masse et al., 2005a) 
Q478X Exon 4 APL (Sprecher et al., 1999b) 
Q515X Exon 4 APL (Ashoor et al., 2005) 
R613X Exon 6 APL (Ahmad et al., 1999a) 
W699X Exon 8 APL (Masse et al., 2005a) 
Q1176X Exon 19 APL (Henn et al., 2002) 
Missense mutations    
E583V Exon 5 APL (Paradisi et al., 2003) 
C622G Exon 6 APL (Aita et al., 2000) 
N970S Exon 14 APL (Kruse et al., 1999) 
D1012N Exon 15 ALUNC (Djabali et al., 2004) 
T1022A Exon 15 APL (Ahmad et al., 1998a) 
V1056M Exon 16 APL (Zlotogorski et al., 2002b) 
V1136D Exon 18 ALUNC (Cichon et al., 1998) 
Deletions/insertions    
177del11 Exon 2 APL (Zlotogorski et al., 2003) 
189-199del Exon 2 APL (Indelman et al., 2003) 
1256delC; 1261del21 Exon 3 ALUNC (Ahmad et al., 1999d) 
2001delCCAG Exon 7 APL (Kruse et al., 1999) 
2147delC Exon 9 APL (Zlotogorski et al., 1998) 
2847-2delAG Exon 14 APL (Henn et al., 2002) 
3434delC Exon 18 APL (Sprecher et al., 1999a) 
Splice site mutations    
1557-1 G to T Intron 4 APL (Paller et al., 2003) 
IVS8+2 T to G Intron 8 APL (Paradisi et al., 2005) 
2776+1 G to A Intron 12 APL (Cichon et al., 1998) 
2776+2 insT Intron 12 APL (Paller et al., 2003) 
2847-3 C to G Intron 13 APL (Paller et al., 2003) 
APL: atrichia with papular lesions; ALUNC: alopecia universalis congenital; 
X: nonsense mutation; del: deletion; ins: insertion 
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population (Ahmad et al., 1998a; Ahmad et al., 1998b; Hillmer et al., 2001; Hillmer et 
al., 2002).  Totally 17 different Hr genetic variants in human have been reported (Hillmer 
et al., 2002; Zhang et al., 2005), including nine amino acid substitutions, one amino acid 
deletion, four silent changes, and three variants in exon-flanking intronic sequences.  
About this dissertation 
 The objective of this dissertation is to study the molecular and physiological 
mechanisms underlying hair loss in two mouse models: near naked hairless (Hrn) and 
Oak Ridge rhino-like (HrrhR) mutant mice. Several major approaches were applied in the 
dissertation, including microarray analysis, histological analysis, and electron 
microscopy, to systematically characterize these two mutants. There are two different 
primary platforms of microarray: cDNA or long oligo arrays (also referred to as spotted 
or two-color arrays) and Affymetrix arrays, which consist of short oligos synthesized in 
situ (also known as single-color arrays). The Affymetrix platform has much greater probe 
density and can be used to profile expression across the entire genome. Two-color arrays 
are printed with either long oligonucleotides (~65mers) or cDNA, and are used to detect 
the relative expression changes. Oligonucleotide microarrays representing either 15,000 
or 21,000 mouse genes are used in this dissertation. Histological analysis is a basic tool 
used in dermatological research and is widely used in this dissertation to detect 
morphological changes in hair follicles of skin due to the mutations. Scanning electron 
microscope is used to examine in fine detail the external defects in hair structure of the 
mutant mice.  
 This dissertation begins with the introduction of our research in chapter 1, 
followed by chapter 2, the background and significance of our research in the effort to 
search mutations underlying hair loss in mice models. In chapter 2, the basic information 
about hair follicle development and cycles is discussed, followed by a summary of the 
recent research with hairless gene (Hr). Chapter 3 summarizes all the materials and 
techniques used in this dissertation. Chapter 4 presents the effort in search for the genetic 
mutation in Hrn mice, while chapter 5 shows the early molecular and physiological 
alterations in Hrn mice. Chapter 6 displays the genetic basis for HrrhR mutation and the 
effort in search of the initial downstream event due to the mutation. Conclusion and 
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future works for elucidating the roles of HR are presented in Chapter 7 with a hypothesis 
about the possible roles of HR in both Hrn and HrrhR mutants.  
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Chapter 3   Experimental methods and materials used in this study 
Animals and tissue collection 
Hrn mice (Stelzner, 1983) were maintained in the ORNL mouse facility on a 
congenic BalbC/Rl background by crossing Hrn/+ males (identified phenotypically) with 
wild type BalbC/Rl females (Stelzner, 1983).  Because intercross matings of Hrn/+ 
animals on the BalbC/Rl genetic background failed to reliably yield homozygous 
offspring, Hrn/Hrn animals were produced by first outcrossing Hrn/+ males to FVB/N 
females and then intercrossing F1 Hrn/+ mice to produce the three genotypes (+/+, Hrn/+, 
and Hrn/Hrn).  Hrn/+ and Hrn/Hrn mice were identifiable by phenotype at approximately 6 
days of age by the presence of sparse or absent pelage, respectively.  
HrrhR mice arose several generations downstream of a translocation experiment.  
The male parent was a treated JH male and the female parent was an SB female.  SB 
refers to the F1 hybrid made from SEC/E x C57BL/E. The mutant was outcrossed to 
BLH F1's for stock maintenance. BLH refers to C3Hf x C57BL10a. It was maintained in 
the ORNL mouse facility by mating HrrhR/HrrhR male with HrrhR/+ female with a mixed 
strain background. HrrhR/HrrhR mice are distinguishable as early as 2 weeks of age due to 
hair loss. HrrhR/+ mice were normal and do not have hair loss compared to +/+ mice.  
At various ages, animals were euthanized by cervical dislocation, and dorsal skin 
was harvested from littermate animals of each genotype for RNA isolation and various 
histological analyses.  Dorsal skin collected for RNA extraction was harvested into 
RNALater (Ambion, Texas), refrigerated at 4°C overnight, and then stored at -80°C until 
RNA extraction was performed.  Skin harvested for histological analysis and 
immunohistochemistry was fixed in 10% neutral buffered formalin for 24-48 hours and 
then stored at room temperature in 70% ethanol.  Liver and spleen samples used for 
genomic DNA isolation were collected into liquid nitrogen and stored at -80°C. Tails and 
ear snips used for genomic DNA isolation were collected into a 1.5 ml microtube and 
stored at -20°C. 
PCR reactions and DNA sequencing of Hr 
For Hrn mutation, direct sequencing was performed with the PCR products 
amplified from both cDNA and genomic DNA templates. The full length Hr cDNA was 
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sequenced using cDNA templates prepared from skin RNA extracted from Hrn/Hrn 
animals on the BalbC/Rl / FVB/N mixed background and from C3H/HeJ and 101/Rl 
strains, the two potential strains on which the original Hrn mutation arose. cDNA was 
synthesized in reverse transcription reactions using total skin RNA reverse transcription 
reactions were performed using SuperScript II reverse transcriptase, oligo d(T) primer, 
and 2 µg of DNase I-treated total RNA according to the manufacturer’s protocol 
(Invitrogen.com).  Primers to produce overlapping amplicons for both genomic DNA and 
cDNA templates were designed using the Primer3 database (Rozen and Skaletsky, 2000).  
Primers to amplify the entire Hr cDNA were designed according to the full-length 
mRNA sequence (GenBank accession number Z32675) originally reported by Cachon-
Gonzalez, et al (1994). Melting temperature and MgCl2 concentration were optimized for 
each primer pair, and products were verified by electrophoresis in 1% agarose gels to 
confirm amplicon size and check for nonspecific products.  After optimization, PCR 
products were electrophoresed in 1% agarose gels and the specific bands were isolated 
and purified across columns (GFX PCR DNA and Gel Band Purification Kit, Amersham 
Biosciences).  Purified amplicons were sequenced bidirectionally using BigDye Version 
3.1 dye terminator kit (ABI, Foster City, CA) and analyzed on an ABI 3100 Genetic 
Analyzer. Genomic DNA from Hrn/Hrn mice was extracted from liver and spleen using a 
standard protocol (Bultman SJ, 1992). The entire Hr gene, including introns and exons, 
was sequenced from genomic DNA of Hrn/Hrn and +/+ animals, by sequencing the PCR 
products to cover the whole region. The primers for genomic DNA sequencing were 
listed in table 3-1. DNA corresponding to the genomic region between coordinates 
62324459-62349944 on mouse chromosome 14 (based on UCSC May 2004 mouse draft 
genome), including the Hr gene and 8 kb upstream of the first exon, was sequenced.  
For HrrhR, the sequencing was performed by sequencing the entire genomic region 
of Hr. Genomic DNA of HrrhR was extracted based on the method called HotSHOT 
(Truett et al., 2000). Briefly, tissue samples (ear punches, 0.2-cm tail snips) were 
collected into a 1.5 ml eppendorf microtube. The samples were lysed with 75 µl of 
alkaline lysis buffer (25mM NaOH, 0.2 mM Disodium EDTA, pH 12.0) at 95°C for 1 
hour. After heating, samples were cooled to 4°C.  Each sample was added with 75 µl  
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Table 3-1  List of primers used for Hr genomic sequencing (sequences from 5’ to 3’ end) 
Primer 
Pairs 
Sequence of Forward primers Sequence of Reverse Primers Size of 
Product 
F2/R2 ATGGCGATCAGAGGTCCTG CAAGCGAGGGAAAATTGAAC 872 
F3/R3 CGACCCACCCTAGTCTGAAA TTCAGGAAGCTGGGCATACT 871 
F4/R4 ATGAGGGCAGGAGAGTGATG AAACAGACCACGAGGACGAC 866 
F5/R5 AAAGATGGGCATGAGAGTGC GCCAGGTCTTTTTCAGCTTG 855 
F6/R6 ATCACTGACCCGTGAGAACC GTTCTCCCGCTTTCTGCTC 920 
F7/R7 CAGGGGAATCCAGTGAAGAA CGATGTACCCAAAAGGCTGT 912 
F8/R8 AGCCTTTTGGGTACATCGTG GAGTGCTGCTGGCTCTGACT 860 
F9/R9 GCTCCAGGAGTCCAGACTTG ACTAGGGGCTTCCCTCTCTG 910 
F10/R10 GCAATGGTGTGAACTTCGTG AGCCACCCTCTTAGGGACAT 953 
F11/R11 TGTCCCTAAGAGGGTGGCTA CCTCCTGTTTGCTTGGTCAT 910 
F12/R12 TGATGACCAAGCAAACAGGA TCAGCAAGCCACAAAACAAG 938 
F13/R13 TTACATGCGCACAAGTTTCC CTGCCAGGTGCCTGAGATAC 855 
F14/R14 ACCTGGCAGGCACTTAACAT GGAGAGGGAGAGAGGGAAAA 915 
F15/R15 GCATTTTGACTTTCCCCAAT ATTGTTTTGCTTGCCACCTC 924 
F16/R16 GAGGTGGCAAGCAAAACAAT AGTGTTGGGAAGGGAGAGGT 873 
F17/R17 ACCTCTCCCTTCCCAACACT TGAGACCCATCAGAGCTTCC 887 
F18/R18 GGAAGCTCTGATGGGTCTCA GGGAGCACATACAGGGACAT 757 
F19/R19 CTGTGATGTCCCTGTATGTGCT ACTCCCCTGCTAGACTCTCCTT 1016 
F20/R20 GCTAGATCCAGGTGCAGAGG TTTGGTGGTGGTGGTAGTCA 799 
F21/R21 TGACTACCACCACCACCAAA TCCCTTCAGCTAGGACCTCA 789 
F22/R22 ATGGCTGAGGTCCTAGCTGA ACCAGGTAAGCACCTGATGG 920 
F23/R23 GAGAAGAGTGGGGTGTGAGC CGGACCACACCGTCTAAGTT 950 
F24/R24 ACTGGGGAACTTAGACGGTGT TTCCGTAATCTCCACAGGTTG 804 
F25/R25 AAAGAAGGCGAATGCAGAAA TGTTCCATCACACCCAGCTA 758 
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neutralizing buffer (40 mM Tris-HCl, pH 5.0). Five to ten microliters of the final 
preparation are used per 50-µl PCR volume. The genomic region of Hr in mouse was 
sequenced with the primers designed to cover Hr DNA (listed in Table 3-1). The PCR 
reactions were performed to amplify all the fragments covering the Hr genomic DNA. 
The PCR products were then sequenced as described earlier.  
The sequences from both Hrn and HrrhR were analyzed by using a trial version of 
Chromas software provided by Technelysium Pty Ltd (Queensland, Australia) and 
compared to the public Hr sequence using two-sequence alignment in BLAST (NCBI). If 
a nucleotide change was seen in both sequences from forward and reverse primers of 
sequencing, the nucleotide change was considered as true. The sequences from either Hrn 
or HrrhR were compared with those from wild type animals to identify any nucleotide 
change. If the change was also seen in either of the founder strains C3H/HeJ or 101/Rl, 
the change was considered as a SNP and not a true change. A base pair change in the 
exon 12 was identified as a nonsense mutation in HrrhR mutant mice. However, there was 
no base pair change found for Hrn mutation in Hr gene.  
Genotyping of HrrhR mice 
After the mutation of Hr in exon 12 was identified, a pair of specific primers 
covering the DNA containing the mutation was used for genotyping of the mice. The 
sequence of the forward primer (GRHF) is 5′- CCAAGAACCTGAGGACCAGA-3′. The 
sequence of the reverse primer (GRHR) is 5′ GCCAGTGTTCCTGGAAGAGA -3′. PCR 
was performed using Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA) with 
standard protocols in an Eppendorf Mastercycler thermal cycler (Eppendorf, Westbury, 
NY).  The PCR products were isolated through electrophoresis in a 1% agarose gel with 
1X TAE buffer. The DNA was purified using GFX PCR DNA and Gel Band Purification 
kit (Amersham Biosciences Corp, Piscataway, NJ) and sequenced on both strands. The 
sequences were analyzed with Chromas software (Technelysium Pty Ltd, Queensland, 
Australia) and blasted to NCBI database directly. 
Total RNA isolation 
RNA was isolated from dorsal skin using the QIAGEN RNeasy mini RNA 
isolation system (Qiagen) according to a protocol modified for fibrous tissue supplied by 
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the manufacturer and including an optional DNase I treatment step to eliminate 
contaminating genomic DNA.  RNA quality was assessed by visualization in denaturing 
agarose gel electrophoresis and spectrophotometrically by the 260 nm/280 nm ratio of 
absorbance.  Samples were quantified spectrophotometrically based on the absorbance at 
260 nm.  Only RNA samples of high quality were used for further analysis. 
Microarray construction, labeling, hybridization and data analysis  
Two array platforms were used in these studies. Focused cDNA microarrays were 
designed and fabricated to represent genes of interest in skin and hair biology.  Plasmid 
clones for selected cDNAs were purchased from Research Genetics and amplified and 
purified according to standard protocols (Sambrook et al., 1989). cDNA inserts contained 
in plasmid DNA were verified by bi-directional sequencing using universal M13 primers 
(TIGR).  Sequences were analyzed using BLAST (NCBI).  Clones with confirmed 
identity were amplified by PCR, lyophilized, resuspended in 3X SSC, and spotted in 
triplicate onto Corning UltraGAPS slides using an SDDC-2 arrayer (Virtek).  After 
printing, slides were air-dried and the cDNAs irreversibly immobilized by UV-
crosslinking.  Spot quality was assessed by hybridization with fluorescently-labeled 
panomers according to manufacturer’s protocols (Molecular Probes). 
CompuGen Mouse OligolibraryTM 2.0 representing about 21000 mouse genes was 
purchased from CompuGen (www.compugen.com). The oligonucleotides were printed 
on Corning Ultra Gap slides by the Center for Applied Genomics (Newark, NJ).  After 
printing, slides were air-dried and the oligonucleotides were irreversibly immobilized by 
UV-crosslinking.  
Total RNA (10 µg) from dorsal skin was fluorescently labeled with either 
cyanine-3 (Cy3) or cyanine 5 (Cy5) using an indirect dye incorporation protocol (TIGR).  
Briefly, RNA was reverse transcribed using 2.0 µg of anchored oligo(dT) (T20-V-N) 
primer and SuperScriptTM II reverse transcriptase in the presence of 5-(3-aminoallyl)-
2’deoxyuridine-5’-triphosphate (AA-dUTP).  The resulting cDNA was purified using 
QIAquick PCR columns (Qiagen) with a modification to eliminate Tris from the column 
washing buffers (TIGR) and the reaction efficacy confirmed by measuring cDNA yield 
spectrophotometrically.  Purified, aminoallyl-labeled cDNA was coupled to either Cy3 or 
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Cy5 (Amersham) by incubation in the dark in a basic (pH 9.5) phosphate buffer.  
Unbound dyes were removed from cDNAs by column purification using QIAquick 
columns (Qiagen).  Dye incorporation and labeled cDNA yield were measured by 
scanning spectrophotometry and calculated from the absorbance values at 260 nm (cDNA) 
and at either 550 nm (Cy3) or 650 nm (Cy5). 
Each hybridization consisted of a pair of RNA samples from littermates. For Hrn, 
either homozygous or heterozygous mice were compared to wild type; for HrrhR, 
HrrhR/HrrhR mice were compared to HrrhR/+ mice. For each pair of animals a dye swap 
was performed to control for dye-specific bias in labeling and to provide a replicate 
hybridization for each pair of samples.  Cy3 and Cy5 labeled samples were combined in 
hybridization buffer (50% formamide, 5X SSC ad 0.1% SDS) containing 10 µg each 
mouse Cot-1 DNA and poly(dA) DNA (Invitrogen), applied to slides, coverslipped and 
hybridized to arrays overnight in a humidified chamber at 42oC according to established 
protocols (TIGR). After washing to remove nonspecifically bound probe, slides were 
scanned for Cy3 and Cy5 fluorescence using a ScanArray 4000 confocal laser scanner 
(Perkin Elmer), and fluorescent intensities were represented as TIFF images. Images 
were analyzed and median pixel fluorescence intensities collected using ImaGene 
(Biodiscovery). Data were normalized using Lowess after removing spots of poor quality 
or low expression and subtracting local background. Replicate values for each gene were 
combined and median expression values analyzed for differential expression using the 
Confidence Analyzer function available in GeneSight and a 95% confidence interval.   
The differentially expressed genes from microarray analysis were uploaded to 
DAVID 2.1 (Database for Annotation, Visualization and Integrated Discovery, 
http://david.abcc.ncifcrf.gov/main.htm) for functional annotation including gene ontology 
(GO) analysis. The differentially expressed genes with their expression alterations were 
uploaded to Ingenuity (http://www.ingenuity.com/) for pathway and network analysis, 
suggesting potential signaling pathways altered due to the mutations. 
Quantitative real time RT-PCR 
cDNA was generated from 1-5 µg of total RNA using SuperScript II reverse 
transcriptase (Invitrogen, Carlsbad, CA) and oligo(dT) primer.  All qRT-PCR reactions 
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were performed using a SmartCycler thermal cycler (Cepheid, Sunnyvale, CA), and 
software supplied by the manufacturer was used to identify threshold cycle (Ct) values.  
Expression levels of many genes were assayed using Assays-on-DemandTM pre-designed 
gene-specific primer/TaqMan probe sets and TaqMan Universal Master Mix (Applied 
Biosystems), following the manufacturer’s protocol.  Expression levels of most of the 
genes were quantified using SYBR green I detection chemistry and custom primers 
designed using the Primer3 website (Rozen S, et al., 2000).  Primers were designed to 
span at least two exons if possible and to produce amplicons 75-150 bp in size.  SYBR 
green assays were done with Hotstart ExTaq DNA polymerase (TaKaRa Mirus Bio, 
Madison, WI) with the standard protocol supplied by TaKaRa. Annealing temperatures 
and MgCl2 concentrations were optimized for each primer pair prior to quantitation, and 
products was verified by electrophoresis in ethidium bromide-stained 2% agarose gels. 
Each sample for both TaqMan and SYBR green detection systems was assayed in 
duplicate.  A standard curve was generated for each primer pair using log dilutions (1:5) 
of a pool of skin cDNA samples.   
Northern blot 
Twenty micrograms of total RNA with a volume of 15 µl were mixed with 3 µl of 
6X loading buffer (Formamide 720 µl, Formaldehyde 260 µl, 10X MOPS 160 µl, 80% 
Glycerol 100 µl, RNase-free water 80 µl). 10X MOPS buffer contains 200 mM MOPS, 
50 mM EDTA, 21 mM NaOAC, and was adjusted to pH 7.0.  Samples were denatured at 
65°C for 10 minutes, chilled on ice, and loaded onto a RNA gel (1% agarose, 1X MOPS, 
2.7% Formaldehyde, 0.5 ng/ml Ethidium Bromide). The running buffer is 1X TAE buffer 
(40 mM Tris, 1 mM EDTA, 20 mM acetic acid) containing 1X MOPS. The gel was 
electrophoresed at 4-5 Volts/cm for 5-6 hours. Gel was photographed under UV light. 
Positively charged nylon membrane (Roche Diagnostics GmbH, Mannheim, Germany) 
and transfer filter papers were equilibrated in 20X SSC buffer (3M NaCl, 0.3 M Na3-
citrate). The gel was then transferred to the nylon membrane overnight (Sambrook et al., 
1989). The membrane was then crosslinked in Stratalinker.  
The cDNA probes of Hr were generated from mouse skin total RNA by RT-PCR 
using two pair of primers covering different portions of Hr. One pair of primers is called 
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HrMF/HrMR to cover the exon 12 in Hr gene. Their sequences are HrMF: 5’-
GATTCACATGGCCTTTGCTC-3’; HrMR: 5’- CCCCACAGGCTAAGTCTCAA-3’. 
The second pair of primers is called HrF5/HrR5 to cover the sequences of Hr mRNA 
from 1728-2567 base pairs in NM_021877. The sequences of these primers are Hr-F5: 
5’-CAACGGATCCATATAGGAAGCAAGGCGGAG-3’; Hr-R5: 5’-CGCCGAATTCC- 
TCTTCTTTGATGTCCTTGGTC-3’. The blot was washed for 30 minutes in 1X SSC, 
0.1% SDS (Sodium Dodecyl Sulfate) at 65°C.  The blot was then incubated with 
hybridization buffer (0.1% SDS, 50% formamide, 5X SSC, 50 mM NaPO4, pH 6.8, 0.1% 
sodium Pyrophosphate, 5X Denhardt’s solution, 50 µg/ml sheared herring sperm DNA) 
without the probe for at least 2 hours at 42°C. 5X Denhardt’s solution contains 0.1% 
Ficoll (type 400), 0.1% polyvinylpyrrolidone, and 0.1% bovine serum albumin. The 
blotted membrane was then hybridized with [α-32P]-CTP-labeled cDNA probe in 
hybridization buffer at 42°C overnight. The membrane was washed with fresh 
hybridization buffer for 30 minutes, 2X SSC containing 0.1% SDS for 30 minutes twice, 
1X SSC containing 0.1% SDS for 30 minutes at room temperature. After the final wash 
with 0.2X SSC containing 0.1% SDS for 45 minutes at 55°C, the membrane was exposed 
to X-ray film with intensifying screens at -80°C.  
Histological analysis  
Hematoxylin and Eosin (HE) staining was done according to standard protocols 
(Prophet et al., 1992).  Von Kossa staining was used to assess mineralization of dermal 
cysts.  Sections were dewaxed, rinsed in alcohol and distilled water, and treated with 5% 
silver nitrate placed directly in front of a bright lamp for one hour.  After rinsed in 
distilled water, the sections were rinsed in 5% sodium thiosulfate for 2 minutes and 
counterstained with nuclear fast red for 1 minute.  Finally the sections were rinsed in 
distilled water, dehydrated, and mounted.  
Actively replicating cells were selectively highlighted within tissue samples by 
immunostaining with an antibody to the Ki67 antigen.  Five-micron sections were placed 
on charged slides and dehydrated.  Endogenous peroxidases were neutralized with 0.03% 
hydrogen peroxide followed by a casein-based protein block (DakoCytomation) for 
nonspecific staining blocking.  The sections were incubated with rabbit anti-human Ki-67 
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(NovaCastra Laboratories Ltd.) diluted 1:1500 for 60 minutes.  Sections without primary 
antibody served as negative controls. The Dako Envision+ HRP/DAB System 
(DakoCytomation) was used to produce localized, visible staining.  The slides were 
lightly counterstained with Mayer’s hematoxylin, dehydrated and coverslipped.  
Scanning electron microscopy 
The samples were dehydrated in a graded ethanol series, then dried in CO2 using a 
LADD Research critical point dryer. After drying the samples were mounted on sample 
supports using silver paint, and then lightly coated with gold in an SPI sputter coater.  
Samples were examined and photographed in a LEO 1525 scanning electron microscope 
(Zeiss, New York, USA) operating at 3KV.   
In situ hybridization   
A standard protocol for paraffin embedding was used and sections were cut 6 
micron in thickness using Lecia RM2135 microtome (Deerfield, IL). The transcribed 
region of mouse RefSeq NM_021877 was used for in vitro transcription reactions 
according to protocols supplied by the manufacture (Ambion, Texas). Antisense probe 
was labeled with a biotin RNA labeling mix (Roche, Germany). The in situ hybridization 
experiments were carried out according to a standard protocol with minimum 
modifications. The probe was detected by Tetramethyl-rhodamine Tyramide Signal 
Amplification System (PerkinElmer). DAPI was used for counter stain and then 
examined using Olympus BX61 microscope, and pictures were taken using a CC12 CCD 
camera (Melville, NY). 
Hematology analysis 
 Mice from 9, 13, 15, and 35 days of age were anesthetized with isoflurane in a 
drop jar. Blood was collected from retro-orbital sinus with a microhematocrit blood tube 
filled with EDTA. The collected blood sample was released into a special tube in which 
the blood sample was loaded to Cell-Dyn 3500 automated hematology analyzer (Abbott 
Laboratories, Abbott Park, IL). The analyzer measures the complete blood count, 
different parameters of red blood cells and platelets. 
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Chapter 4 The near naked hairless (Hrn) mutation disrupts hair formation  
but is not due to a mutation in the hairless gene 
Part of the results presented in Chapter 4 and 5 are being combined into a single 
manuscript (with the same title as given to this chapter), which will be submitted to 
Physiological Genomics. 
Introduction 
The mammalian hair follicle is a unique structure due to its cyclical ability to 
regress and regrow throughout the life of the animal.  The hair cycle consists of anagen, a 
growth stage, followed by orchestrated regression (catagen) and a resting phase (telogen) 
(Chase, 1954).  Catagen is demarcated by cessation of proliferation and onset of 
apoptosis in the lower portion of the hair follicle, separating the hair bulb from the dermal 
papilla (Lindner et al., 1997).  The lower follicle retracts toward the epithelial surface, 
where it remains quiescently in telogen until receiving a cue to proliferate, grow down 
towards the dermal papilla, and re-enter anagen (Stenn and Paus, 2001).  The cascade of 
signals triggering onset of anagen are poorly defined (Stenn and Paus, 1999), but the 
delicate balance necessary to maintain normal cycling is evidenced by multiple mouse 
mutations that lead to hair loss by disrupting the hair cycle (Sundberg, 1994).  Of these, 
the mostly well-characterized are mutations at the hairless (Hr) locus.  Multiple allelic 
mutations have arisen in Hr, all of which manifest in mice as an inability to regrow a 
normal coat of hair after the initial catagen stage, resulting in a progressive loss of hair 
from head-to-tail beginning in the third week of life (Brooke, 1926; Howard, 1940).  
Mouse hairless mutants fall into two general categories, hairless (Hrhr) and rhino (Hrrh), 
based on phenotypic severity.  Both classes of mutants display dermal cysts and 
wrinkling of the skin (Mann, 1971; Sundberg, 1994), but rhino mutants are characterized 
by progressively thickened and loosened skin that develops due to expansion of horn-
filled cysts in the lower dermis (Sundberg et al., 1991).  A fundamental role for Hr in the 
mammalian hair follicle is reflected in the fact that Hr mutations in sheep (Finocchiaro et 
al., 2003) and rhesus macaques (Ahmad et al., 2002) also cause a strikingly similar hair 
loss phenotype.  Moreover, multiple mutations in the orthologous human gene underlie 
various forms of congenital atrichia, including those classified as atrichia with papular 
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lesions (APL; OMIM 290500) and alopecia universalis congenital (ALUNC; OMIM 
203655) (Klein et al., 2002). While the molecular bases differ for Hr mutations 
characterized to date, all display recessive inheritance.   
The underlying Hr gene was originally cloned in mouse by virtue of an 
endogenous murine leukemia provirus that inserted into intron 6, leading to defective Hr 
splicing and a significant reduction in Hr mRNA (~ 5% of wild type) in Hrhr/Hrhr 
animals (Cachon-Gonzalez et al., 1994; Stoye et al., 1988).  The phenotypic severity of 
Hr mutations was recently linked to the level of mRNA and protein that remain, with the 
least severe allele Hrhr (HRS/J) retaining some level of both mRNA and protein; Hrrh-J, a 
rhino allele, expressing only a minor 3 kb Hr transcript; and a completely null allele (Hr-/-) 
generated by gene targeting displaying no Hr expression and the most severe skin 
wrinkling (Zarach et al., 2004).  Hr is highly conserved between mouse, rat and human, 
but orthologous genes in non-mammalian species have yet to be identified.  It encodes a 
relatively novel protein of 127 kDa that includes a single zinc finger and a jumomji C 
domain (Cachon-Gonzalez et al., 1994), a metalloenzyme-like domain implicated in 
chromatin remodeling (Balciunas and Ronne, 2000).  Its predicted role in control of gene 
expression is borne out by its demonstrated ability to function as a transcriptional 
corepressor by heterodimerization with the thyroid hormone receptor (TR) (Thompson 
and Bottcher, 1997), vitamin D receptor (VDR) (Hsieh et al., 2003) and retinoic acid-like 
orphan receptor α (ROR-α) (Moraitis et al., 2002), possibly mediated through association 
with histone deacetylases (Potter et al., 2002).  Hr is expressed in multiple tissues, with 
highest levels in developing brain and skin (Cachon-Gonzalez et al., 1994). The skin 
phenotype in Hrhr and Hrrh mutants has been linked to massive and premature apoptosis 
that leaves the dermal papilla stranded and unable to reinitiate induction of the epithelial 
strand into follicle formation (Panteleyev et al., 1998b).   
The only mutation allelic with hairless but not displaying recessive inheritance 
was first described by Stelzner in 1983 and designated near naked (Hrn).  The mutation 
arose spontaneously in the mouse colony at Oak Ridge National Laboratory, and allelism 
testing with Hrhr suggested that the two mutations resided in the same or a closely linked 
locus (Stelzner, 1983) (figure 4-1). Hrn differs from classical Hr mutations in that it  
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Figure 4-1 Schematic illustration of allelism test between Hrn/+ and Hrhr/Hrhr 
(based on the report of (Stelzner, 1983). 
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exerts its effects in a semi-dominant rather than recessive manner.  Heterozygous animals  
display a very sparse coat that undergoes some level of cyclic loss and regrowth, while 
Hrn/Hrn animals are virtually hairless. The etiology of the phenotype in Hrn mutants also 
differs markedly from that of other Hr mutants in that mice never grow a normal coat of 
hair (Stelzner, 1983). We sought to identify the molecular basis for the Hrn mutation and 
to define the alterations in skin and hair morphology that underlie hair loss.  Because Hr 
encodes a transcriptional corepressor, we also investigated the changes in skin gene 
expression that result from the Hrn mutation. We report here that despite original allelism 
tests suggesting that Hrn is an allele of Hr (Stelzner, 1983), the phenotype of these 
animals is not due to a mutation in the Hr gene.  Based on our collective results, we 
propose that the phenotype of Hrn mice results from either an as yet unidentified 
regulatory mutation in Hr, or a mutation in a closely linked gene.   
Results 
Phenotype 
Both Hrn/+ and Hrn/Hrn are first distinguishable from their wild type littermates at 
approximately 5 days of age, when the hair coat begins to appear.  Heterozygous animals 
display a sparse but uniform coat while homozygous animals exhibit a skin slick in 
appearance and are virtually devoid of hair.  The sparseness of the coat in Hrn/+ animals 
increases in severity as mice age and progress through successive hair cycles, with few 
hairs present in aged animals (figure 4-2).  Vibrissae of Hrn/Hrn are extremely short and 
wavy, while those of Hrn/+ are intermediate between Hrn/Hrn and +/+ in both length and 
texture (figure 4-3).  The hairs in both Hrn/+ and Hrn/Hrn are thinner compared to those 
in +/+ mice under the dissecting microscope with the same magnification (figure 4-3).  
There are no significant differences found between the mutants and the wild type animals 
in ear or foot or nails. The Hrn mice also displayed impaired body growth.  Both body 
weight and body length were significantly reduced in Hrn/Hrn mice beginning at 7 days of 
age. Hrn/+ displayed a similar reduction in size that was significant at some but not all 
ages measured (figure 4-4).   
HE stained sections of dorsal skin were examined in order to further define the 
morphological changes in hair follicles accompanying the gross hair loss defect in Hrn  
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(A) 13-day old mice 
 
 
(B) adult mice 
 
Figure 4-2 Phenotypes of Hrn/Hrn, Hrn/+, and +/+ mice. (A) 13-day old mice; (B) 5-week 
old mice.  
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(A) 7-day 
 
(B) 3-week     +/+                             Hrn/+                     Hrn/Hrn 
 
 
 
Figure 4-3 Comparison of phenotypes between +/+, Hrn/+, and homozygous Hrn/Hrn 
mutant mice. (A) and (B): vibrissae of Hrn/Hrn, Hrn/+, and +/+ mice at 7-day (A) and 3-
week (B) old age; (C): hair from +/+; (D): hair from Hrn/+ mutant mice; (E): hair from 
Hrn/Hrn mutant mice; (F): ear from +/+; (G): ear from Hrn/Hrn mutant mice; (H): foot 
from +/+ mice; (I): foot from Hrn/Hrn mutant mice.  
 
 
 
 
(C) (D) (E)
(F) (G) (H) (I)
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Figure 4-4 The growth curve of Hrn/Hrn, Hrn/+, and +/+ mice based on body weight (top 
panel) and body length (bottom panel).  
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mutants. Morphological analysis began with mice at 7 days of age, the point at which the 
3 genotypes (+/+, Hrn/+ and Hrn/Hrn) are clearly phenotypically distinguishable from 
each other.  Hair follicles were regularly distributed in skin and that their abundance and 
stage of follicle cycling were similar between the three genotypes. The dermal papilla and 
the bulb region of the follicles appeared normal in terms of shape and size.  However, just 
distal to the bulb, striking changes in morphology were apparent.  At the first age 
examined (7 days), follicles of Hrn/Hrn mice appeared to undergo premature degeneration 
of the hair shaft medulla and cortex (figure 4-5).  In the majority of hair follicles, 
nucleated cells in the cortex and medulla were replaced with keratinized material.  The 
degenerative changes occurred early in the follicle, well below the bulge in the region of 
the precortex.  A mild degree of acanthosis and hyperkeratosis was also present. The 
outer root sheath appeared intact.  As expected from the gross appearance, hair follicles 
from Hrn/+ animals displayed a much more modest phenotype.  Follicles in heterozygous 
animals were intermediate between those of wild type and Hrn/Hrn. Disorganization of 
the hair follicles progressed rapidly with age. By 9 or 11 days (figure 4-6 A-D) the cortex 
and medullary regions of the hair shaft in Hrn/Hrn mice consisted almost completely of 
keratin, with loss of nucleated cells in the precortex.  By 13 or 15 days of age (figure 4-6 
E-F) the cortex, medullary, and matrix regions of hair follicle are full of cornified 
materials. Filling with keratinized materials became more severe with age. By 4 weeks of 
age (figure 4-6 G), hair shafts region were filled with keratin. The lower portion of hair 
follicle including matrix and dermal papilla were also full of keratin. By 5 weeks, keratin-
filled dermal cysts began to form from the follicle remnants (figure 4-6 H).  Cysts were 
numerous at 6 months of age and were similar to those described in Hrhr and Hrrh mice 
(Data not shown).  Staining with von Kossa indicated that some of the cysts contained 
mineralized deposits, consistent with those seen in other Hr mutants (figure 4-7). 
These histopathological changes indicated significant structural changes in the 
medullary region and inner root sheath of the hair follicle. Scanning electron microscopy 
was then used to further examine the structural changes in Hrn hair fibers and to 
determine if the cuticle was also disrupted. As expected, few hairs were present at the 
surface of Hrn/Hrn skin (figure 4-8).  Those that did emerge displayed an abnormal form,  
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Figure 4-5 Histology of 7-day old mice (Hrn/Hrn, Hrn/+, and +/+) with HE staining. (A) 
histology of 7-day +/+ mouse; (B) histology of 7-day Hrn/+ mouse; (C) histology of 7-
day Hrn/Hrn mouse.  
  
(A) (B) (C) 
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Figure 4-6 Histology of 9, 11, 13, 15, 28, and 35 -day old Hrn/Hrn, Hrn/+, +/+ mice with 
HE staining. (A) histology of 9-day old +/+ mouse; (B) histology of 9-day old Hrn/+ 
mouse; (C) histology of 9-day old Hrn/Hrn mouse; (D) Histology of 11-day Hrn/Hrn mice; 
(E) Histology of 13-day Hrn/Hrn mice; (F) Histology of 15-day Hrn/Hrn mice; (G) 
Histology of 28-day Hrn/Hrn mice; (H) Histology of 35-day Hrn/Hrn mice. 
(E) 
(B) (C) (D) 
(H) 
(A) 
(G)(F)
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Figure 4-7 Von Kossa staining of Hrn/Hrn, Hrn/+, +/+ mice skin. The dermal cysts in 
Hrn/Hrn are mineralized.
Hrn/Hrn 
Hrn/+ 
Hrn/Hrn 
+/+ 
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Figure 4-8 Hair structure from SEM (scanning electron microscope) with the hair from 
Hrn/Hrn, Hrn/+, and +/+ mice at different ages. A, 8-day +/+ mice; B, 8-day Hrn/+ mice; 
C, 8-day Hrn/Hrn mice; D, magnified view of hair shaft of 8-day Hrn/Hrn mice; E, 5-week 
Hrn/+ mice; F, magnified view of hair shaft of 5-week Hrn/+ mice; G, 5-month Hrn/+ 
mice; H, magnified view of hair shaft of 5-month Hrn/+ mice. 
A B C D
E F HG
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however, the cuticle appeared normal, with regular, overlapping scales. Hair fibers of 
both 8-day and 5 week-old Hrn/+ mice exhibited an irregular contour, with variations in 
thickness spanning the entire length of the hair. Distal ends of the hair fibers were often 
curled, in contrast to the uniform shape observed in wild type mice. In addition to 
alterations in morphology, numerous follicles in 5-week and 5-month Hrn/+ mice 
displayed pili multigemini with 2 or more hair fibers emerging from the same piliary 
canal on the surface of skin. Fibers emerging from the same canal did not appear to result 
from fiber splitting, as the cuticles were intact and the ends of the fibers relatively 
uniform.  Re-examination of the H&E stained sections of 5-week Hrn/+ mice found 
several examples of pili multigemini (figure 4-9). The additional fibers did not resemble 
club hairs that had not yet been lost during telogen; rather they were positioned at a depth 
in the follicle comparable to the primary hair fiber.  In some cases, 2 follicles at the same 
level of the skin appeared to merge into a single hair canal.   
The hair fibers observed in cross sections of both Hrn/+ and Hrn/Hrn skin 
appeared to be prematurely keratinized from the earliest age examined (7 days), 
suggesting that keratinocyte differentiation was initiated prematurely in the developing 
fiber. To determine if the Hrn mutation disrupted the normal transition from proliferation 
to differentiation in the precortex region, we stained skin sections from 7 day-old Hrn/Hrn  
and +/+ mice with the proliferation marker Ki67 (figure 4-10).  Wild type displayed the 
expected gradual transition from proliferation to differentiation in matrix cells.   
Proliferation in Hrn/Hrn hair follicles, however, appeared to be reduced and the transition 
into differentiation was premature and abrupt.  In this respect, hair fibers in Hrn mutants 
resemble those found in Lanceolate mice, in which the normal pattern of keratinocyte 
differentiation is altered by a mutation in the desmoglein 4 (Dsg4) gene that disrupts 
normal cellular adhesion (Kljuic et al., 2003).   
Sequencing the Hr locus 
The near naked allele arose spontaneously in the ORNL mouse colony and was 
not directly associated with mutagenesis experiments.  Northern blots indicated that the 
Hr transcript was of similar size between Hrn and wild type animals, indicating that the 
mutation was not due to a large deletion or insertion and did not cause production of a  
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Figure 4-9 Histology of 5-week Hrn/+ mice for pili multigemini.  
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Figure 4-10 Ki-67 staining of hair follicle from +/+ and Hrn/Hrn mice 
 
+/+ Hrn/Hrn
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truncated transcript (data not shown).  The entire Hr cDNA was sequenced from skin 
cDNA templates prepared from Hrn/Hrn mice (BalbC/Rl / FVB/N mixed genetic 
background) and from both C3H/HeJ and 101/Rl mice, the two potential parental strains 
in which the original mutation occurred, and comparing it to the published Hr sequence 
(GenBank accession number Z32675).  The Hrn sequence matched perfectly to the 
published Hr sequence, demonstrating that the Hrn mutation does not lie in the Hr coding 
region.  Based on these changes in Hr gene expression, we sequenced the entire Hr 
genomic region, including the introns, 8414 bp of the 3’-UTR, and 1483 bp upstream of 
the transcription start site from Hrn/Hrn animals and compared our sequence to the public 
sequence using BLAST analysis.  The sequence from Hrn/Hrn perfectly matched that 
contained in the public database, indicating that the Hrn mutation does not lie within the  
Hr gene and is not due to a regulatory mutation in the region immediately upstream of 
transcription.  
Other genes in the region close to Hr gene on chromosome 14 were selected for 
sequencing the cDNA based on their possible roles in skin and no mutations was found 
on these genes. These genes include Dok2, FGF17, Adam7, Adam28, RAI16, Gfra2, 
Pdlim2, TNFrsf10b, Loxl2, BB150350 and BC036718. There are also two RIKEN 
cDNAs 1700020M16, and 4930506C02 differentially expressed with hair follicle cycles 
suggested by large-scale gene expression survey (Lin et al., 2004; Morris et al., 2004). 
These RIKEN cDNAs were sequenced by PCR and no mutation was found. MicroRNAs 
have recently been suggested to play important roles in different diseases including 
leukemia (Calin et al., 2002; Calin et al., 2005; Calin et al., 2004). There are two 
microRNAs close to the locus of Hr gene on mouse chromosome 14, microRNA 124a 
and 130.  The pre-microRNAs of these two microRNAs were sequenced from genomic 
DNA and no mutation was identified. All of the sequencing primers were listed in table 
4-1. This suggests that the mutation might be due to another unknown gene mutation of a 
regulatory mutation in Hr.  
The Hr gene encodes a transcriptional regulator expressed in the developing hair 
follicle (Panteleyev et al., 2000), a site in which careful coordination of gene expression 
is necessary to produce and assemble the appropriate combinations of structural fibers  
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Table 4-1 Sequencing Primers genes and transcripts in the region close to Hr gene on 
mouse chromosome 14 (sequences from 5’ to 3’ end)  
 
Genes Primers Sequences Positions Size 
LF1 AGCTTTTCTTCTGGGCAACC 
LR1 AGACCACGTGGGAATTCTTG 
53-834 782 bp 
LF2 TGTCACTGACTGCAAGCACA 
LR2 CCTGTGATGGCCTCTTTAGC 
575-1276 702 bp 
LF3 AGCTGTGGTCAGTTGTGTGC 
LR3 CAGCATTAAGCACCAGGTCA 
1031-
1803 
773 bp 
LF4 CCTGGTACTGGCATGGAAAT 
LR4 CTCCTCACTGAAGGCTCCAC 
1618-
2405 
788 bp 
LF5 GGAGAACAAGGCATCACCAT 
 
 
 
 
Lysyl oxidase-like 2 
(Loxl2) (NM_033325.1) 
LR5 TGAGTTCATGCCTGCTGTGT 
2169-
2954 
786 bp 
P2F1 AGCAACTGAAGAGGCAGGAG 
P2R1 GCTGAACCTAGGGCTGGAG 
2-693 692 bp 
P2F2 GCTCACCACTTGACCTACCC 
 
PDZ and LIM domain 2 
(Pdlim2, NM_145978) 
P2R2 CCATACGCTTTCGTGTCAAA 
571-1390 820 bp 
FGF17F1 GTTGCCGCATCAAACCTG 
FGF17R1 TCTCCCCCTGTGTTTGACA 
16-592 577 bp 
FGF17F2 AATCGCCCCAAGAAGTCTCT 
FGF17R2 TACTGGCCTCCCTGACTACG 
488-1179 692 bp 
FGF17F3 CTTCATCAAGCGCCTCTACC 
 
 
Fibroblast growth factor 
17 (Fgf17, NM_008004) 
FGF17R3 TGGTTTTATTCTGGGGCTTG 
1032-
1680 
649 bp 
T10BF1 CTGGGAGTGAGGAAATCCAG 
T10BR1 CCAAGAGAGACGAATGCACA 
29-828 800 bp 
T10BF2 ACGGGGAAGAGGAACTGACT 
Tumor necrosis factor 
receptor superfamily, 
member 10b (Tnfrsf10b, 
NM_020275) T10BR2 CATCTTCGGGGCTCTCTACA 
589-1340 752 bp 
RAI16F1 CCTGGGGAGAGCAATCTTATC 
RAI16R1 GCAATGCTGATCTCGTCTGA 
21-655 635 bp 
RAI16F2 CATAGAGGACAGCCCCCATA 
RAI16R2 CACCCTGACAAGCACAGAGA 
578-1299 722 bp 
RAI16F3 AGCCGTACAGCCTGAACCTA 
RAI16R3 CTGCCGAGTCTTAGCAGCTT 
1153-
1967 
815 bp 
RAI16F4 AGCTAGAGGATGGCCAGTGA 
RAI16R4 GGCCTGTTGTGAGGTAATGC 
1737-
2556 
820 bp 
RAI16F5 AAGGTACAGCATGGGACAGG 
 
 
 
 
Retinoic acid induced 16 
(RAI16, AK090035) 
RAI16R5 CAAATGCCAAAGTGCATTGA 
2359-
3132 
774 bp 
Dok2F1 GCACACAGAGCAAGAAACCA 
Dok2R1 TTCCCACCTCCTCTCCTTTT 
N/A 817 bp 
Dok2F2 TTACCCAGCTGTGCTTACCC 
Dok2R2 ACAGGCAGATGGCCTGTATC 
N/A 770 bp 
Dok2F3 CTTCTCCCCTTTCATGACCA 
Dok2R3 CACCAAGAAGCCAGGAAGAG 
N/A 804 bp 
Dok2F4 CTCTTCCTGGCTTCTTGGTG 
Dok2R4 ACCTTCCTCCTCGATCCACT 
N/A 924 bp 
Dok2F5 AGTGGATCGAGGAGGAAGGT 
Dok2R5 GGATCCTCCTGAATGCTGTC 
N/A 781 bp 
Dok2F6 ACACGGCAATGAGATCTTCC 
 
 
 
 
 
Downstream of tyrosine 
kinase 2 
(Dok2) Genomic DNA 
 
Dok2R6 TCTGGGAGCTAGAGGGACAA 
N/A 937 bp 
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Table 4-1 Continued  
 
Genes Primers Sequences Positions Size 
GFRA2F1 AACGCCTTCTGCCTCTTCTT 
GFRA2R1 CAGTTGGGCTTCTCCTTGTC 
13-752 740 bp 
GFRA2F2 CCTGAACGACAACTGCAAGA 
GFRA2R2 CCAAGGTCACCATCAGGAGT 
507-1387 881 bp 
GFRA2F3 AGCATGGCTGACTAGGTTGG 
GFRA2R3 CCGTCATCCAGTTCATCCTC 
Covering 
Exon 2 
665 bp 
GFRA2F4 GGGTCGTTATCATTGCTTGG 
Glial cell line derived 
neurotrophic factor 2 
(GFRA2, NM_008115) 
GFRA2R4 TCCAGTGGGCGACTGAAC 
Covering 
exon 1 
215 bp 
BB15F CAAGCAAAGATGGGAACCTC BB150350 
BB15R TGTCCCAGACTTGCTTTTCC 
N/A 95 bp 
HydF CCTCCGATCCTGTGAGAGTT BC036718 
HydR CTGCAGGGAGGTACCATGTC 
N/A 140 bp 
ADAM7F1 TGTTTCCCACAGGTATATTTTT
GA 
ADAM7R1 AAATTGACCATCCCCCAAAT 
2-695 694 bp 
ADAM7F2 AATGTCAAGGCACCCTATGC 
ADAM7R2 CAGCACTCTCCTTCCACACA 
475-1340 866 bp 
ADAM7F3 GGAAGCATCCCTGCAATAAA 
ADAM7R3 CTTCCTCACACTGGCACTCA 
1084-
1957 
874 bp 
ADAM7F4 ACGTGACCATCAAATGCAGA 
ADAM7R4 ACGGAGGATTAGCCCAGTCT 
1748-
2375 
628 bp 
ADAM7F5 TGACCGATATCCATCCCCTA 
ADAM7R5 CACCCAGTGTGTCTCCCTTT 
2180-
2931 
752 bp 
ADAM7F6 AGGCTGAGGCAGTAGGATCA 
 
 
 
 
A disintegrin and 
metalloprotease domain 
7 (Adam 7, NM-007402) 
 
ADAM7R6 AGGATGGGGGAAAAATCATC 
2759-
3426 
668 bp 
ADAM28F GTTGGAGCAGAAGCAACCTC Adam28, NM_176991 
ADAM28R GTGCAAAGGGTTCTGACGAT 
65-714 650 bp 
170F1 CTCTTGGGGACCCTGAGC 
170R1 CGCATCCCATGACTCCTATT 
5-810 806 bp 
170F2 AAAAGGAACAAGGGGCTGAG 
 
RIKEN cDNA 
1700020M16 
170R2 CCATAGCAGCTCCAGTGAGG 
723-1632 910 bp 
493F GGGGAGAGGGCAGTCATATT RIKEN cDNA 
4930506C02 493R GCATTCAGCACACAGAAACA 
688-1252 565 bp 
M320F GGCGGAAGTGACATCAAGG microRNA-320 
M320R GAGGACCGCACCTCTACTCC 
N/A 215 bp 
MR124F TCCTCCCTCTCTTCCATCCT microRNA-124a1 
MR124R TGTGCTGGGTCGATCCTT 
N/A 238 bp 
N/A: not available
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required to form potent hair fibers (Botchkarev and Kishimoto, 2003).  It is possible, 
therefore, that alterations in the expression levels of a key transcription factor could  
disrupt hair follicle gene expression and cause dystrophic hairs as seen in Hrn/Hrn mice.  
Thus, a regulatory mutation outside the Hr coding region could underlie the near naked 
phenotype. Northern blots and quantitative RT-PCR (qPCR) were used to assay levels of 
Hr expression in Hrn mutants and wild type littermates.  For these assays 7 day-old mice 
were used to represent the visual onset of the phenotype and to dissociate results from the 
secondary phenotypic changes that ensure as the phenotype progresses. Northern blot 
hybridization to a probe spanning exons 5-12 indicated that the Hrn mutation did not alter 
Hr transcript size, but that expression levels were slightly but significantly increased 
relative to +/+. Quantitative RT-PCR was used to for further determination of Hr 
expression. Hr expression in 7-day animals was significantly increased in Hrn/+ (~ 2-fold 
over +/+) and further elevated in Hrn/Hrn (~ 3-fold over +/+). However, its expression in 
5-week mice was significantly decreased in Hrn/+ (~ 3-fold over +/+) and further down in 
Hrn/Hrn (~ 7-fold over +/+). This suggests that the Hrn phenotype might be due to altered 
Hr expression. The phenotype in skin of near naked mice is marked, and expression 
levels of numerous genes (not only Hr) are likely to be altered. However, to further 
explore the upregulation of Hr expression revealed by qRT-PCR, in situ hybridization 
was applied to determine if the elevation in Hr expression was ectopically detected. As 
shown in figure 4-11, wild type mice showed strong Hr expression in matrix cells and in 
the inner and outer root sheaths, as did Hrn/+ mice.  Hr expression appeared to be 
stronger in the outer and inner root sheath of Hrn/Hrn mice. A considerable proportion of 
fibroblasts in the cavernous sinus also appeared to express Hr, unlike those in wild type 
animals. Therefore, the elevated expression of Hr seen with qPCR appears to be due to 
both ectopic expression (in fibroblasts) and to elevated expression in normal locations 
(IRS and ORS). Consistent with HE staining, the numbers of matrix cells appeared to be 
significantly reduced in Hrn/Hrn. 
Microarray expression profiling 
As part of a larger emphasis on the study of skin and hair biology, focused arrays 
were developed and fabricated, representing genes important in skin and hair biology, as  
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Figure 4-11 In situ hybridization of 7-day old mice with Hr probe. 
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well as in skin cancer. Arrays consisted of approximately 300 sequence-verified genes 
with multiple functional assignments, including epithelial differentiation, hair structure, 
cell cycle, apoptosis, and DNA repair, and of uncharacterized clones sequenced from a 
skin cDNA library. These arrays were used to identify the set of genes with altered 
expression in skin of Hrn mutants at 5 weeks of age as a next step to understanding the 
basis for the near naked phenotype. We were only able to reliably produce homozygous 
animals by outcrossing to FVB/N and then intercrossing F1 animals, and we were 
concerned that the mixed genetic background from this strategy would confound 
interpretation of microarray results. Therefore we used a 2-step strategy for differential 
expression studies, first profiling expression with microarrays in wild type and Hrn/+ 
mice congenic on Balb/cRL and then screening mice of all 3 genotypes (but on the mixed 
background) to determine the range of expression changes altered by heterozygosity and 
homozygosity, and at 2 ages (7 days and 5 weeks).  A subset of genes highlighted by 
microarrays was validated first by qRT-PCR in the same RNA samples to verify the 
microarray results. Microarrays identified many genes that were significantly 
differentially expressed (p<0.05) across a panel of 3 pairs of wild type and Hrn/+ mice 
(Table 4-2). This set of genes includes several hair keratins and keratin-associated 
proteins (KRTAPs) and S100A3, a Ca2+ binding protein expressed specifically in 
postmitotic differentiated cells of the hair follicle (Kizawa and Ito, 2005), all of which 
were downregulated in Hrn/+ mice. In addition to keratins and KRTAPs, Rab27b, a Ras-
like monomeric GTPase involved in vesicular transport, and sequestosome 1, a scaffold 
protein involved in signaling through atypical protein kinases Cs (aPKCs), were also 
downregulated in Hrn mutants. Genes with increased expression included cytochrome b 
and sequestosome 1, a scaffolding protein that interacts with multiple signaling pathways.  
Aside from the common structural functions of keratins and krtaps, differentially 
expressed genes were enriched in the GO category of cellular proliferation (BP). 
We then screened the expression levels of these genes with qRT-PCR in wild type, 
Hrn/+ and Hrn/Hrn mice at 7 days of age to identify genes differentially expressed at the 
onset of the visible phenotype as shown in table 4-2. Most of the keratins and keratin-  
57 
Table 4-2 Genes with altered expressions in 5-week and 7-day old mice from microarray 
analysis and real time PCR experiments  
7 days  5 weeks  
Hrn/+ vs. +/+ Hrn/Hrn vs. +/+ Hrn/+ vs. +/+  Gene Name 
   RT-PCR RT-PCR Array RT-PCR 
KRT 1-C29 -1.5 -2.4 -2.9 -8.4 
KRT 1-2 0 0 -2.3 -3.2 
KRT 2-1 1.5 2.9 N/A 9.6 
KRT2-4 N/A -2.7 -1.9 0 
KRT 2-6 0 -3.6 N/A -4.4 
KRT1-13 1.4 2.1 -1.7 0 
KRTAP3-1 N/A N/A -1.7 N/A 
KRTAP 6-1 0 -2.6 N/A -13.8 
KRTAP 6-2 0 -3.3 N/A -8.4 
KRTAP 8-1 -15.8 -22.3 -2.7 -73 
KRTAP 8-2 -2.4 -8.4 N/A -14 
KRTAP 9-1 0 -2.7 N/A -5.5 
KRTAP16-5 -1.8 -6.3 -1.8 -2.7 
KRTAP 16-10 -3.1 -17 N/A -16.2 
Ccna2 0 0 N/A -1.7 
Cct7 0 0 -3.4 -2.1 
Stat1 0 0 N/A 1.8 
Rab27b 0 0 -2.1 -3 
S100A3 -1.6 -1.9 -1.9 -4.1 
SPRR1B N/A N/A N/A -1.7 
Cytochrome B N/A N/A N/A 1.6 
Sequestosome 0 1.6 N/A 1.8 
N/A: not available; “0” means fold change < 1.5 
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associated proteins except krt2-1 are significantly downregulated in 7-day and 5-week 
mutant mice.  
The majority of keratin-associated proteins in mouse reside in 2 large gene 
clusters on chromosomes 11 and 16, and the genes in this family display highly 
coordinated patterns of expression during hair formation (Awgulewitsch, 2003; Pruett et 
al., 2004).  Accordingly it has been proposed that keratin and krtap genes within a cluster 
are regulated by locus control regions, much like what has been reported for α-globin 
genes and homeobox genes (Awgulewitsch, 2003; Pruett et al., 2004).  Because all of the 
krtaps represented on our arrays were differentially expressed in Hrn skin, and because 
disruption of krtap expression could result in aberrant hair fibers as manifested in Hrn 
mutants, we used qRT-PCR to determine if additional krtaps also exhibited altered 
expression.  We assayed expression levels of 10 additional Krtap genes, all of which 
displayed significantly lower levels of expression in Hrn mutants than in wild type (Table 
4-2).  Therefore the Hrn mutation directly or indirectly disrupts the expression levels of a 
large group of genes critical for normal hair structure. 
Examination of hair shaft formation markers 
 Recently it was found that the genetic pathways containing BMP-2, BMP-4, 
Foxn1, Msx2, Notch, and Hoxc13, might regulate hair shaft differentiation (Ma and Cai, 
2005; Mecklenburg et al., 2005). Our histological analysis suggests that hair shaft 
differentiation was significantly altered in Hrn/Hrn mutants. We used quantitative real 
time PCR to examine the expression levels in Hrn/Hrn mutants vs. +/+ mice and the 
results are shown in figure 4-12. One of the Notch effectors, Hes1 (Hairy and enhancer of 
split 1), was also examined for its gene expression level. The expression of BMP-2, Dsg4, 
GATA3, Ntc, and Msx2 was not altered. The expression of BMP-4, Noggin, and β-catenin, 
was increased by 2 fold. However, the expression levels of Hoxc13, Foxn1, Hes1, and 
hair keratins were significantly decreased by at least 2 fold compared to +/+ mice.  The 
altered expression of these genes further supports that hair shaft differentiation in Hrn/Hrn 
mutants is altered and suggests that Hrn mutation might be in the upstream of BMP-4 in 
the hair follicle signaling.  
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Figure 4-12 Schematic illustration of checkpoints for hair shaft formation in  
7-day Hrn/Hrn mice with altered expressions. Red: increased expression;  
Blue: decreased expression; Green: no expression change 
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Discussion 
A novel spontaneous mouse mutation was characterized here. This mutation was 
originally mapped to the Hr locus but results in a phenotype markedly different from 
other Hr mutants (Stelzner, 1983).  The Hrn mutation displays semi-dominant inheritance  
and prevents the initial growth of a normal coat of hair.  In both respects, it differs not 
only from mutant alleles of Hr (Ahmad et al., 1999b; Ahmad et al., 1999c) but also from 
the majority of spontaneous mutations that have been shown to alter the pelage (Irvine 
and Christiano, 2001; Lane and McLean, 2004; Porter, 2003).  
Delayed body growth in Hrn mutants was observed in both Hrn/Hrn and Hrn/+ at 
most of the ages tested with less body weight and smaller body length. This retarded 
development was first documented at 7 days of age. Hair coat does not affect mouse 
development and growth; therefore, the delayed growth in Hrn mutant mice was due to 
the mutation, not due to the loss of hair coating. Hematology analysis was done at 9, 13, 
15, and 35 days of age to determine if there were any obvious abnormalities in red and 
white blood cells, and platelets. No abnormalities were found (data not shown). 
The structure of hair fiber in Hrn/Hrn mice is altered due to the mutation as shown 
under scanning electron microscope. Pili multigemini was observed in 5-week and 5-
month old Hrn/+ mice, but not in 8-day old Hrn/+ mice, indicating that pili multigemini 
might be related with hair cycles. Histological analysis with 5-week Hrn/+ mice suggests 
that either multiple hair follicles were associated together or multiple hair shafts were 
formed in one hair follicle during the early anagen of hair cycle. It has been reported that 
a kinetic dermal papilla changes its form from single-tipped to double-tipped producing 
two hair shafts that separately grow from the same piliary canal on the skin surface 
during anagen (Whiting, 1987). This would support the idea that multiple hair shafts were 
formed in one hair follicle during anagen.  
Pili multigemini is actually very useful for hair transplantation in clinics to 
produce more hairs with a limited number of hair follicles. It was found that the entire 
hair follicle is not necessary to generate hair growth (Gho et al., 2004). Even just the 
upper part of hair follicle is enough to grow a normal hair. It was found there are two 
different sites containing stem cells (Gho et al., 2004), either of which is able to induce 
Ma et a
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normal hair growth, suggesting that two hairs could grow from one hair follicle. 
Unpublished data from GHO clinic (http://www.ghoclinic.com/) found that two or more 
hair follicles could be developed from a single hair follicle, producing two or three 
normal hairs. It was also found that three or even five hairs were developed when one or 
two upper parts of hair follicles were implanted. These observations might help explain 
the pili multigemini in 5-week and 5-month Hrn/+ mice. It could be that the Hrn mutation 
alters hair follicle stem cell populations. Alternatively, pili multigemini might be 
triggered by the separation of the upper part of the follicle from the bulge during first 
catagen. 
Based on the initial allelism testing with Hr, we began by sequencing the Hr gene, 
including all introns and exons, 1483 bp of the 3’-UTR and 8414 bp upstream to the next 
gene.  Despite Hr as an obvious candidate for hair loss in this region of mouse 
chromosome 14, no mutation was identified in any portion of Hr. Therefore we are left to 
conclude that another gene near Hr on chromosome 14 underlies the Hrn mutant 
phenotype. It is also possible that the Hrn phenotype results from a regulatory mutation in 
Hr. Hr mRNA levels were increased in Hrn/Hrn animals at 7 days of age, although the 
effect was relatively modest (3-fold).  Hr encodes a transcriptional co-repressor(Potter et 
al., 2001; Zarach et al., 2004), and even small alterations in a transcription factor can 
have significant effects on its target genes.  In the hair follicle, a very tightly coordinated 
sequence of events controls the transition from proliferation to differentiation and the 
formation of concentric hair fiber layers from a pool of precursor keratinocytes 
(Botchkarev and Kishimoto, 2003).  It has been suggested that even subtle alterations in 
the transcription factors responsible for hair formation might dramatically impact the hair 
fiber phenotype (Fuchs, 1998; Jamora et al., 2003; Rendl et al., 2005). Therefore it is 
possible that an as yet unidentified mutation that increases expression of Hr is sufficient 
to disrupt the normal pattern of expression of its target genes and lead to a dysmorphic 
hair follicle. Consistent with this possibility, all of the hair keratin and keratin associated 
protein genes with altered expression in Hrn skin were downregulated, as might be 
predicted from increased expression of a transcriptional co-repressor. By contrast, the 
vast majority of genes differentially expressed in skin of Hr null mice were upregulated, 
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including keratin 10, loricrin, filaggrin, caspase 14, calmodulin 4, and keratinocyte 
differentiation-associated protein (Zarach et al., 2004) due to the loss of transcriptional 
co-repressor.   
Transgenic mice expressing Hr under the control of a keratin 14 promoter were 
recently created to rescue the hair growth in Hr null mice (Beaudoin et al., 2005).  Under 
the control of keratin 14 promoter, Hr is mainly expressed in the outer root sheath 
including bulge region. These mice displayed shorter hairs and, like Hrn, decreased 
proliferation of matrix cells, and thicker epidermis, suggesting delayed epidermal 
differentiation.  These authors concluded that Hr normally promotes differentiation 
toward hair cell fate and suppress the differentiation into epidermis(Beaudoin et al., 
2005), which is consistent with the apparent premature differentiation and increased 
keratinization reported in Hrn hair fibers. Unlike Hrn mice, K14-rHr transgenic mice did 
not lose hair although they have shorter hair. However, the expression pattern produced 
by driving Hr with the K14 promoter does not completely reproduce endogenous HR 
expression. Overexpression was primarily in the outer root sheath, while endogenous Hr 
is expressed in the inner and outer root sheath, and the matrix. Therefore, it is still 
possible that elevated Hr expression in its normal sites could produce the Hrn phenotype.  
The profile of KRTAP expression in Hrn mice resembles that seen in transgenic 
mice overexpressing Hoxc13, in which the Krtap16 family of genes was uniformly 
downregulated.  Hoxc13 binding sites have been reported in promoter regions of Krtaps 
from the 10, 12 and 16 families, suggesting that these genes are direct transcriptional 
targets of Hoxc13 (Awgulewitsch et al. 2004; Rogers 2004 JID).  Like many Krtaps, 
Hoxc13 expression was also significantly decreased in skin of Hrn mice.  In hair follicles, 
Hoxc13 is expressed in the rapidly dividing and differentiating keratinocytes directly 
apical to the dermal papilla, where it has been suggested to control proliferation and/or 
differentiation of matrix keratinocytes as they progress into formation of layers of the 
hair fiber (Godwin and Capecchi, 1998). This expression pattern overlaps the region of 
the initial morphological changes in Hrn follicles, and the putative function of Hoxc13 is 
consistent with the apparent disruption of the proliferation-differentiation transition in 
Hrn mutants. These collective findings place the Hrn gene upstream of Hoxc13.   
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The hair loss phenotype of Hrn mice appears to be due to a striking and premature 
increase in keratinocyte differentiation that occurs very early in hair fiber development.  
The early increase in differentiation is paralleled by decreased proliferation of matrix 
cells, suggesting that the underlying mutation alters the signaling mechanism that 
normally guides a gradual transition to differentiation and keratinization of the hair fiber. 
In this respect, hair of Hrn mutants resembles that of Dsg4 mutants (Kljuic et al., 2003).  
Loss of Dsg4 disrupted normal intercellular adhesion in the medulla and inner root sheath, 
leading to premature, abnormal and rapid keratinization of hair fibers (Kljuic et al., 2003).  
In addition, Dsg4 mutants also displayed downregulation of Hoxc13 and hHb2 and hHa4 
keratins. Dsg4 gene is upstream of Hoxc13. The expression of Dsg4 gene in Hrn/Hrn mice 
was examined with real time PCR and no difference was found between Hrn/Hrn and +/+ 
mice, suggesting no direct involvement of Dsg4 in Hrn mutant mice.  
Members of the TGF-β super family including BMP-2 and BMP-4 have been 
implicated in the induction and progression of various stages of the hair follicle cycle. 
BMP-2 and -4 are expressed in the hair shaft precursors, i.e. the precortical matrix, and 
dermal papilla, and regulate hair follicle cycling. Ectopic expression of BMP-4 in the 
outer root sheath of hair and whisker follicles inhibits hair matrix proliferation and 
accelerates the differentiation program in the outer root sheath (Blessing et al., 1993). 
Increased expression of BMP-4 in Hrn/Hrn mutants is consistent with the decreased 
proliferation in the precortex and matrix region shown in Ki-67 staining. The expression 
pattern of cytokeratins was also disturbed in some hair follicles (Blessing et al., 1993), 
which was also present in Hrn mutants. Increased expression of BMP-4 suggests its direct 
involvement in Hrn mutant mice. Recently it was found that Hr triggers reactivation of 
hair growth by repressing Wise, a modulator of Wnt signaling, and promoting Wnt 
signaling (Beaudoin et al., 2005). Accordingly, if Hrn is a pro-regulatory mutation in Hr, 
Wise expression should be repressed in Hrn/Hrn relative to +/+. However, we failed to 
detect changes of the expression of Wise in skin of 7-day old Hrn/Hrn mice by 
quantitative real time PCR.  
Mouse models are usually used to study human diseases and Hrn may be a novel 
model for a relative rare human hair syndrome. The only human hair syndrome (other 
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than those due to known mutations in Hr) that maps to the same genomic region as Hrn is 
Marie Unna hereditary hypotrichosis (MUHH) (Cichon et al., 2000; Green et al., 2003). 
MUHH is a rare disorder characterized by coarsely textured hair that is progressively lost 
with age, beginning in early adulthood, with no other obvious phenotypic consequences 
(Roberts et al., 1999).  SEM images of hair fibers from MUHH patients revealed a 
longitudinal groove and an irregular form (Kim et al., 2001), similar to that seen in 8-day 
Hrn/Hrn mice (figure 4-13).  For both models, mutations within the HR coding region 
have been excluded as the cause of the hair phenotype (Cichon et al., 2000; He et al., 
2004; Lefevre et al., 2000; van Steensel et al., 1999).  Recent studies even suggest that 
the phenotypes of MUHH are due to mutations in other or multiple loci in the human 
genome (Yan et al., 2004; Yang et al., 2005). This might be true with MUHH or due to 
the difficulties to distinguish MUHH patients from other similar diseases in clinics 
(Green et al., 2003). It is possible that mutations in a homologous gene underlie these two 
models, or that they are both due to a regulatory mutation in Hr. MUHH has been 
described as autosomal dominant (Argenziano et al., 1999), while Hrn is semi-dominant 
(Stelzner, 1983).  However, given the low incidence of MUHH and the relatively small 
number of affected individuals within the population, it is possible that this disorder is 
also semi-dominant and that individuals homozygous for the underlying mutation would 
display a much more severe phenotype.    
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   (A)                                                     (B) 
Figure 4-13 Longitudinal grooving in hairs of MUHH patients and 8-day Hrn/Hrn mice 
through scanning electron microscopy. (A) hair from MUHH patients (Kim et al., 2001); 
(B) hair from 8-day old Hrn/Hrn mice.  
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Chapter 5 Early molecular and histological alterations in Hrn mice 
 The data from mice at 0-5 days of age, included in this chapter, are being drafted 
into a manuscript that will focus on gene regulatory networks that are altered by Hrn.  
Introduction 
The Hrn mutation first manifests itself at postnatal day 6-7 as a sparse (Hrn/+) or 
virtually absent (Hrn/Hrn) coat of hair. In many cases, homozygous mice can be 
distinguished from the other two genotypes at 4-5 day by their shiny skin, smaller body 
size and reduced vibrissae. Therefore we are certain that Hrn has effects on the phenotype 
much earlier than postnatal day 7. In this chapter, we describe our efforts to identify the 
earliest phenotype of gene expression changes that result from the Hrn mutation. Without 
having identified the mutation, we did not have access to a strategy for genotyping mixed 
litters at early ages. On the BALB/C background, litter sizes are very small (~3-5) and 
mating between homozygous parents did not produce offspring. However, we outcrossed 
Hrn to FVB/N mice and litter sizes were large (up to 13). Mating of Hrn/Hrn parents 
produced offspring, although the females still had difficulty nursing the pups. We were 
able to cross-foster one of three such litters (n=10) onto a DBA/B6 mom, who cared for 
the offspring normally. From this litter we obtained mice that allowed us to examine the 
very early histological and gene expression changes at Hrn mutants. We present the 
results from postnatal days 0, 1, 3, and 7 in this chapter. 
Results 
Histological analysis of young mutant mice 
 Histological analysis plays an important role in characterizing the mouse mutant. 
Dorsal skins from 0-, 1-, and 3-day old +/+ and Hrn/Hrn mice were fixed in 10% neutral 
buffered formalin, embedded in paraffin, sectioned, and stained with hematoxylin & 
eosin (HE) (figure 5-1). Hair follicles in wild type mice at day 0 after birth appear normal 
with obvious inner root sheath, outer root sheath, dermal papilla, and cortex region. There 
is no hair shaft formed at this time (It would form and grow out from the piliary canal). 
Epidermis is normal with cornified layers. The keratinization zone in +/+ hair follicles is 
organized and located in the top of pre-cortex region. Hair follicles at 0-day Hrn/Hrn 
mutant mice are structurally normal with inner root sheath, outer root  
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Figure 5-1 Histology of 0-, 1-, and 3-day Hrn/Hrn and +/+ mice with HE staining. (A) 0 
day +/+ mice; (B) 0 day Hrn/Hrn mice; (C) 1 day +/+ mice skin; (D) 1 day Hrn/Hrn mice 
skin; (E) Histology of 3-day old +/+ mice; (F) Histology of 3-day old Hrn/Hrn mice. 
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sheath, and dermal papilla. Even at this early stage, hyperkeratosis is apparent in and 
apical to the pre-cortex, indicating that premature keratinization is one of (or the) earliest 
morphological change in Hrn follicle. The keratinization in hair follicles of 0-day Hrn/Hrn 
mice was not localized to the keratinization zone seen in 0-day +/+ mice; instead it occurs 
in a wider region and is disorganized. One day later, in +/+ mice, the keratinocytes in the 
pre-cortex region begin to differentiate and form a line of nuclei of keratinocytes, which 
will later form the hair shaft. However in 1-day old Hrn/Hrn mice, the hair follicle is 
increasingly disorganized. There is increased keratinization inside the hair follicles. There 
are no formations of lined nuclei of differentiated keratinocytes. Instead, this region is 
full of cornified materials. In addition, there are still subtle but noticeable cornified 
materials in the pre-cortex region. By the age of 3 days, the hair follicles in Hrn/Hrn mice 
are filled with more cornified materials in the region where a normal hair shaft forms in 
+/+ mice. The keratinization in the pre-cortex region becomes more significant. These 
findings indicate that hyperkeratosis begins immediately after birth (or perhaps even 
before birth) and becomes more severe with age. 
Microarray analysis with 0-day mutant mice 
 What causes hyperkeratosis in Hrn/Hrn mice is still unknown since the underlying 
genetic mutation remains unclear. However, the genes involved into the hyperkeratosis 
might be studied through genome-wide gene expression assays and provide a clue to the 
basis for the Hrn phenotype. Therefore, microarray analysis was applied to 0-day old 
Hrn/Hrn and +/+ mice to identify the earliest changes in gene expression due to the 
unknown Hrn mutation. About 60 genes were identified as differentially expressed in 
Hrn/Hrn mice, based on a 99% confidence level (table 5-1). Amongst these sixty genes, 
four genes are related with immunoglobin or T cell receptor, which means some sort of 
altered immunological function.  
The differentially expressed genes were uploaded to DAVID 2.1 (Database for 
Annotation, Visualization and Integrated Discovery) (http://david.abcc.ncifcrf.gov/) 
(Dennis et al., 2003) for functional annotation including Gene Ontology (GO) analysis. It 
was shown that several categories were enriched, including odorant binding, tryptase 
activity, extracellular space, transporter activity, phospholipid binding (table 5-2). It was 
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Table 5-1 Differentially expressed genes from the microarray analysis with 0-day 
Hrn/Hrn mice compared to wild type mice. The data was analyzed with ImaGene and 
GeneSight based on 99% confidence interval and fold change of 1.6 (20.7). 
Gene ID Gene Name 
Fold 
change
M16355 major urinary protein I (MUP I) -8.7 
M16356 major urinary protein II (MUP II) -8.3 
M16357 major urinary protein III (MUP III) -6.6 
AK020171 
12 days embryo male wolffian duct includes surrounding 
region cDNA -6.6 
NM_009947 copine 6 (Cpne6) -4.4 
M16360 major urinary protein V (MUP V) -4.1 
M29241 U5 small nuclear RNA, clone 1 -3.4 
J03299 liver transferring -3.2 
M17763 major urinary protein pseudogene (G2-4), exon 1 -3.1 
M27608 major urinary protein -3.0 
M23016 Transferring segment 4_ -2.8 
NM_007606 carbonic anhydrase 3 (Car3) -2.8 
NM_008648 major urinary protein 4 (Mup4) -2.7 
NM_026358 RIKEN cDNA 4930583H14 gene (4930583H14Rik) -2.6 
NM_020281 melanoma antigen, family A, 7 (Magea7) -2.5 
NM_016792 thioredoxin-like (32kD) (Txnl) -2.5 
AB037540 CYP4F14 mRNA for leukotriene B4 omega-hydroxylase -2.5 
AK006259 1700023A20Rik, RIKEN cDNA 1700023A20 gene -2.4 
AK020601 9530049O05Rik, RIKEN cDNA 9530049O05 gene -2.4 
M12449 cell adhesion molecule (CAM) uvomorulin -2.3 
NM_013805 claudin 5 (Cldn5) 2.3 
NM_009265 small proline-rich protein 1B (Sprr1b) 2.4 
BC004653 
SWI/SNF related, matrix associated, actin dependent regulator 
of chromatin, subfamily a, member 2 (Smarca2) 2.4 
AF375885 protein o-fucosyltransferase (Pofut1) 2.4 
AF108215 5_-AMP-activated protein kinase beta subunit 2.4 
AK019736 4930544I03Rik, RIKEN cDNA 4930544I03 gene 2.5 
NM_008476 Keratin complex 2, gene 6a (Krt2-6a) 2.5 
NM_013473 annexin A8 (Anxa8) 2.5 
AK021197 C330013E15Rik, RIKEN cDNA C330013E15 gene 2.6 
NM_013808 cysteine-rich protein 3 (Csrp3) 2.6 
NM_020591 RIKEN cDNA A030009H04 gene (A030009H04Rik) 2.6 
AK014850 
hypothetical Leucine-rich repeat/bZIP (Basic-leucine zipper) 
transcription factor family/Leucine-rich repeat, typical subtype 
containing protein 2.6 
AK004778 Transmembrane protein 43 (Tmem43) 2.6 
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Table 5-1 continued 
 
Gene ID Gene Name 
Fold 
change
AK004796 
weakly similar to pol polyprotein (fragment) [simian sarcoma-
associated virus, SSAV] 2.7 
NM_013545 hemopoietic cell phosphatase (Hcph) 2.8 
NM_011363 SH2-B PH domain containing signaling mediator 1 (Sh2bpsm1) 2.8 
NM_010789 myeloid ecotropic viral integration site 1 (Meis1) 2.9 
AK017885 Ras homolog gene family, member H (Rhoh) 3.0 
AK005497 1600019K03Rik, RIKEN cDNA 1600019K03 gene 3.2 
AK015086 spermidine/spermine N1-acetyl transferase-like 1 (Satl1) 3.3 
NM_011607 tenascin C (Tnc) 3.4 
AL136158 
dM538M10.5 (novel 7 transmembrane receptor (olfactory 
receptor like) protein similar to human HS6M1-28) 3.4 
L00653 mast cell protease-7 (Mcpt7) 3.6 
AK017047 4933433N18Rik, RIKEN cDNA 4933433N18 gene 4.2 
AK009746 Kaptin (actin-binding protein) 4.8 
NM_010781 mast cell protease 6 (Mcpt6) 4.9 
L04961 nuclear-localized inactive X-specific transcript (Xist) 5.8 
AK009793 2310043P16Rik, RIKEN cDNA 2310043P16 gene 19.7 
AF242214 38C2 immunoglobulin light chain variable domain -2.7 
V00808 
Part of the murine gene for kappa-immunoglobulin leader 
peptide and variable part (cell line MOPC41). -2.5 
AF318436 
clone 490.08 immunoglobulin heavy chain variable region 
gene 2.7 
Z12222 rearranged T-cell receptor beta chain Vbeta8 repertoire (VDJ). 3.0 
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Table 5-2 Functional annotation for the microarray data from 0-day Hrn/Hrn mice  
Enriched Categories Enriched Genes 
M16355 major urinary protein 1 
M16356 major urinary protein 2 
M16357,M27608 major urinary protein 3 
NM_008648 major urinary protein 4 
ODORANT 
BINDING 
 
 M16360 major urinary protein 5 
NM_010781 mast cell protease 6 TRYPTASE 
ACTIVITY L00653 mast cell protease 7 
NM_013805 claudin 5 
AB037540 
cytochrome P450, family 4, 
subfamily f, polypeptide 14 
NM_008648 major urinary protein 4 
M16360 major urinary protein 5 
NM_010781 mast cell protease 6 
L00653 mast cell protease 7 
AF375885 
protein O-fucosyltransferase 
1 
NM_011607 tenascin C 
EXTRACELLULAR 
SPACE 
 
 
 
 
 
 J03299,M23016 transferrin 
M16355 major urinary protein 1 
M16356 major urinary protein 2 
M16357,M27608 major urinary protein 3 
NM_008648 major urinary protein 4 
M16360 major urinary protein 5 
TRANSPORTER 
ACTIVITY 
 
 
 NM_016792 thioredoxin-like 1 
NM_013473 annexin A8 PHOSPHOLIPID 
BINDING NM_009947 copine VI 
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very surprised to notice that many proteins called major urinary proteins 1-5 were 
downregulated significantly. These proteins are related with odorant binding and 
transport of small molecules. 
 Microarray analysis with 7-day mice 
Seven-day old homozygous and heterozygous mutant mice were distinguished 
phenotypically from wild type mice. It was found in the previous chapter that premature 
keratinization occurred in the pre-cortex region of hair follicles in both Hrn/Hrn and Hrn/+ 
mice. As an additional step to catch the very early molecular changes in Hrn/Hrn mutant 
mice, microarray analysis was done in Hrn/Hrn and +/+ mice with slides containing about 
21,000 (22k) mouse genes and with slides containing about 15,000 (15k) mouse genes 
(15k is a subset of 22k). It was found that about 130 genes were differentially expressed 
in Hrn/Hrn mice compared to wild type mice (listed in table 5-3). Most of the 
differentially expressed genes in table 5-1 were downregulated and only 12 genes, 10% 
of the total genes were upregulated. Expression of Hr in 7-day old Hrn/Hrn mice was 
increased by 2-3 fold compared to wild type mice by real time PCR earlier. Since Hr has 
been shown to be a transcriptional co-repressor (Potter et al., 2001; Zarach et al., 2004), it 
would be expected that increased expression of Hr, even just 2-3 fold, would decrease 
expression of genes that are Hr targets. This might help to explain why most of the 
differentially expressed genes were upregulated. This might suggest that the Hrn mutation 
could be related to a regulatory mutation in Hr gene. 
It was noticed that many genes related with immune function were differentially 
expressed from the microarray analysis (table 5-4). Most of these genes are related with 
either immunoglobin or T cell receptor (including both α and β chain). All mice were 
maintained in a SPF (specific-pathogen-free) facility, so these changes are not due to 
dermal pathogens. Some forms of alopecia areata have been linked to autoimmune type 
changes. Therefore, it is possible that differential expression of these immune-related 
genes play some role in hair loss in Hrn.  
The differentially expressed genes were uploaded to DAVID 2.1 for functional 
annotation including GO analysis. One of the features of this program is that it can 
generate clusters of genes based on their cytobands in the genome. The program 
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Table 5-3 Differentially expressed genes from microarray analysis of 7-day old Hrn/Hrn 
mice compared with +/+ mice. The data was analyzed with ImaGene and GeneSight 
from BioDiscovery based on 99% confidence interval and fold change of 1.6. 
Gene ID Gene name Fold change 
NM_025602 DNA segment, Chr 10, ERATO Doi 718, expressed -4.2 
X75650 keratin, hair, acidic, 3B -4.1 
D89901 keratin associated protein 6-3 -4.1 
NM_011199 Parathyroid hormone receptor 2 -4.0 
NM_008124 gap junction membrane channel protein beta 1 -3.9 
NM_028333 angiopoietin-like 1 -3.7 
NM_008177 gastrin releasing peptide receptor -3.7 
BC006914 leucine zipper domain protein -3.6 
AK017244 trichohyalin-like 1 -3.6 
NM_019400 rabaptin, RAB GTPase binding effector protein 1 -3.4 
NM_023907 forkhead box I1 -3.4 
AK021201 protein kinase C binding protein 1 -3.4 
AK002671 protein phosphatase 1, regulatory (inhibitor) subunit 2 -3.3 
AK021005 AT rich interactive domain 1B (Swi1 like) -3.3 
AK013609 zinc finger, DHHC domain containing 4 -3.3 
AK021149 
potassium voltage-gated channel, subfamily H (eag-related), 
member 3 -3.3 
NM_025562 tetratricopeptide repeat domain 11 -3.2 
D86424 keratin associated protein 3-1 -3.2 
NM_008536 transmembrane 4 superfamily member 1 -3.1 
AK020505 early B-cell factor 2 -3.1 
AK017895 SET domain and mariner transposase fusion gene -3.1 
AK014721 ATPase, H+ transporting, V0 subunit D, isoform 2 -3.1 
NM_008237 hairy and enhancer of split 3 (Drosophila) -3.1 
AB031959 solute carrier organic anion transporter family, member 1b2 -3.1 
U46027 CREB transcription factor, novel spliced form -3.1 
NM_019960 heat shock protein 3 -3.0 
X99143 keratin, hair, basic, 6 (monilethrix) -3.0 
NM_009254 serine (or cysteine) proteinase inhibitor, clade B, member 6a -3.0 
NM_009294 syntaxin 4A (placental) -2.9 
AF345291 keratin associated protein 16-1 -2.9 
NM_008215 hyaluronan synthase1 -2.9 
NM_015756 Shroom -2.9 
AL021127 centrin 2 -2.9 
NM_018815 nucleoporin 210 -2.9 
M15525 laminin B1 subunit 1 -2.9 
AK019761 GLIS family zinc finger 1 -2.8 
BC013550 
TAF5-like RNA polymerase II, p300/CBP-associated factor 
(PCAF)-associated factor -2.8 
   
74 
Table 5-3 Continued 
 
Gene ID Gene name Fold change 
NM_010676 keratin associated protein 8-2 -2.8 
AK011693 ring finger protein 157 -2.8 
NM_010670 keratin associated protein 12-1 -2.8 
U50960 
clone TSAP2 p53-induced apoptosis differentially expressed 
mRNA sequence. -2.8 
NM_008891 Pinin -2.8 
NM_026402 APG3 autophagy 3-like (S. cerevisiae) -2.8 
NM_010561 interleukin enhancer binding factor 3 -2.8 
NM_009010 RAD23a homolog (S. cerevisiae) -2.8 
AK009447 vacuolar protein sorting 24 (yeast) -2.7 
NM_008412 Involucrin -2.7 
BC002226 hook homolog 2 (Drosophila) -2.7 
NM_008579 meiosis expressed gene 1 -2.7 
BC012520 pantothenate kinase 4 -2.7 
NM_026320 interleukin enhancer binding factor 2 -2.7 
D30748 protein tyrosine phosphatase, non-receptor type 15 -2.7 
NM_016716 cullin 3 -2.7 
AK005136 phosphatase and actin regulator 3 -2.7 
AK003884 protein phosphatase 1F (PP2C domain containing) -2.7 
AF340231 EGL nine homolog 2 (C. elegans) -2.7 
NM_009063 regulator of G-protein signaling 5 -2.7 
NM_008838 phosphatidylinositol glycan, class F -2.7 
NM_010885 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 -2.7 
AF357392 t-complex protein 1 -2.7 
NM_007478 ADP-ribosylation factor 3 -2.7 
AK011461 BTB (POZ) domain containing 4 -2.7 
AK007207 myosin, light polypeptide kinase -2.7 
NM_016857 exocyst complex component 7 -2.7 
AF418208 docking protein 5 -2.7 
L09600 nuclear factor, erythroid derived 2 -2.7 
BC005669 expressed sequence R74862 -2.6 
NM_008904 
peroxisome proliferative activated receptor, gamma, 
coactivator 1 alpha -2.6 
AK012212 Procollagen, type XVI, alpha 1 -2.6 
AY044153 histamine receptor H 3 -2.6 
NM_010807 MARCKS-like protein -2.6 
NM_007994 fructose bisphosphatase 2 -2.6 
AK017747 
SMC2 structural maintenance of chromosomes 2-like 1 
(yeast) -2.6 
NM_031872 taste receptor, type 1, member 3 (Tas1r3) -2.6 
BC011407 golgi autoantigen, golgin subfamily a, 2 -2.6 
NM_007520 BTB and CNC homology 1 -2.6 
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Gene ID Gene name Fold change 
AK018152 KH-type splicing regulatory protein -2.6 
M27134 MHC class I H-2K1-k pseudogene -2.6 
AF166265 glucagon-like peptide 2 receptor -2.6 
NM_011104 protein kinase C, epsilon -2.6 
S37491 Angiotensin receptor 1b -2.6 
S43865 
protein phosphatase 3, regulatory subunit B, alpha isoform 
(calcineurin B, type II) -2.6 
AF053628 D3Mm3e (D3Mm3e) -2.5 
NM_007526 BarH-like homeobox 1 -2.5 
AK004406 MAF1 homolog -2.5 
NM_021789 trafficking protein particle complex 4 -2.5 
NM_026924 zinc finger protein 339 -2.5 
AF357419 RNA, U68 small nucleolar -2.5 
NM_009446 Tubulin, alpha 7 -2.5 
NM_023136 thymidylate kinase (Tmk) -2.5 
AK018638 
diptheria toxin resistance protein required for diphthamide 
biosynthesis (Saccharomyces)-like 2 -2.5 
BC006661 debranching enzyme homolog 1 (S. cerevisiae) -2.5 
AK012914 Leucine rich repeat protein 1, neuronal -2.5 
NM_010919 NK2 transcription factor related, locus 2 (Drosophila) -2.5 
L10370 neurofibromatosis 1 -2.5 
NM_008762 olfactory receptor 15 -2.5 
NM_025681 limb expression 1 homolog (chicken) -2.5 
NM_007423 Alpha fetoprotein -2.5 
NM_010634 fatty acid binding protein 5, epidermal -2.5 
NM_009229 syntrophin, basic 2 -2.5 
BC004738 Similar to dual specificity phosphatase 9, clone MGC -2.5 
NM_015741 keratin associated protein 9-1 -2.5 
AK006697 methionine sulfoxide reductase A -2.5 
NM_009282 stromal antigen 1 -2.4 
AL133159 olfactory receptor 107 -2.4 
NM_011062 3-phosphoinositide dependent protein kinase-1 -2.4 
AB041350 procollagen, type IV, alpha 5 -2.4 
M18589 pseudo-kallikrein gene, exon 2, clone mGK-10._ -2.4 
NM_007654 CD72 antigen -2.4 
NM_009501 ventral anterior homeobox containing gene 1 -2.4 
NM_009396 tumor necrosis factor, alpha-induced protein 2 -2.4 
NM_010659 keratin complex 1, acidic, gene 1 -2.4 
NM_008553 achaete-scute complex homolog-like 1 (Drosophila) -2.4 
NM_015757 protocadherin 13 (Pcdh13) -2.4 
NM_007914 ets homologous factor -2.4 
AJ293592 Laminin, alpha 3 -2.4 
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Gene ID Gene name Fold change 
NM_013589 latent transforming growth factor beta binding protein 2 -2.4 
V00830 keratin complex 1, acidic, gene 10 2.2 
NM_008445 kinesin family member 3C 2.4 
NM_013459 adipsin 2.4 
AK006506 Enolase 3, beta muscle 2.5 
AK019689 Unc-84 homolog A (C. elegans) 2.5 
AK013576 brain-specific angiogenesis inhibitor 3 2.5 
NM_013541 Glutathione S-transferase, pi 1 2.8 
AB011019 EGF-like-domain, multiple 9 3.1 
AK010477 polymerase (DNA-directed), delta 4 3.4 
NM_019916 T-cell leukemia, homeobox 3 -2.4 
AL513354 
DNA segment, Chr 15, Brigham & Women's Genetics 0669 
expressed 3.5 
AK011423 glucosamine (N-acetyl)-6-sulfatase 5.1 
NM_025358 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 10.8 
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Table 5-4 Differentially expressed Ig- or TCR- related genes in 7-day Hrn/Hrn mice 
compared with +/+ mice. Microarray data was analyzed with ImaGene and GeneSight 
from BioDiscovery based on 99% confidence interval and fold change of 1.6. 
Gene ID Gene name Fold change 
M36743 immunoglobulin heavy chain 6 (heavy chain of IgM) -3.8 
U55578 
anti-DNA immunoglobulin light chain IgM mRNA, antibody 
363p.193 -3.5 
U07879 T cell receptor alpha chain AV10S10 precursor -3.4 
AF131134 immunoglobulin kappa light chain variable region gene -3.3 
S74556 Ig VH_rheumatoid factor RF1-7M _clone RF1-7M -3.1 
L41881 immunoglobulin kappa chain -3.1 
X03380 mRNA for GAT (HP9) anti-idiotypic Ab2 Ig heavy chain -3.0 
X66458 IG heavy chain V region (7F2). -2.9 
Z12199 rearranged T-cell receptor beta chain Vbeta8 repertoire -2.9 
U96685 immunoglobulin-like receptor PIRA4 (6M7) -2.8 
U26780 T cell receptor Va15/Ja35 alpha chain mRNA, isolate 726-1 -2.7 
U26799 T cell receptor Va8/Ja47 alpha chain mRNA, isolate 628-23 -2.7 
X55826 T-cell receptor alpha-chain (clone 14.12). -2.6 
AJ222596 similar to Ig heavy-chain V region precursor -2.5 
X06530 Ig active L-chain(k) V-region -2.4 
M20465 Ig rearranged kappa chain mRNA V-region (VH11-JK5) N4 -2.4 
AF012185 T-cell receptor alpha chain (TCRA) -2.4 
AF041952 infected mouse A seq 4, day 14, T cell receptor beta chain 2.9 
AF041922 infected mouse A seq 6, day 10, T cell receptor beta chain 3.1 
AF041935 infected mouse B seq 8, day 10, T cell receptor beta chain 3.3 
AF041918 infected mouse A seq 2, day 10, T cell receptor beta chain 3.4 
AF041950 infected mouse A seq 2, day 14, T cell receptor beta chain 3.6 
AF041969 infected mouse C seq 4, day 14, T cell receptor beta chain 3.6 
AF041962 infected mouse B seq 5, day 14, T cell receptor beta chain 3.9 
AF041971 infected mouse C seq 6, day 14, T cell receptor beta chain 4.0 
AF041923 infected mouse A seq 7, day 10, T cell receptor beta chain 4.6 
U86728 T-cell receptor alpha V region t1g5 8.8 
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generated five gene clusters according to their positions in mouse genome (table 5-5). 
These five significant cytobands are on 5 different chromosomes, 2H4, 5G1, 11D, 16A1, 
and 17A3.1. Each cluster contains at least 2 different genes with differential expression.  
Cytoband clusters of 16A1 and 11D consist of a few keratins and/or keratin-associated 
proteins. These gene clusters might suggest that the expressions of the genes in each 
cluster are regulated in the same or similar pattern, or by the same transcriptional factors, 
in Hrn/Hrn mutant mice. 
 Functional annotation analysis suggests that there are several categories 
significantly enriched in Hrn/Hrn mutant mice compared to +/+ mice at 7-day after birth 
(table 5-6). These enriched categories include coiled coil, cytoskeleton, keratins, 
extracellular matrix structural constituents, calcium signaling pathway, calcium binding, 
transcription regulation, basement membrane, protein phosphatase inhibitor, and basic-
leucine zipper transcription factor. Most of these enriched categories are closely related 
with hair follicle development and hair cycles. For example, categories of coiled coil, 
cytoskeleton, keratins, and extracellular matrix structural constituents are directly related 
with hair growth. Calcium binding and calcium signaling pathway are very critical to 
regulate the basic events such as regulation of transcription and keratinocyte 
differentiation. The enriched categories of transcription regulation and basic-leucine 
zipper transcription factor suggest that the transcriptional regulation in Hrn/Hrn mutant 
mice was systematically regulated by many different transcriptional factors. The 
functional annotation of microarray data suggests the possible effects of Hrn mutation and 
the possible functions of unknown mutated gene for Hrn.  
Pathway and network analysis  
  Network analysis of these differentially expressed genes was done with the trial 
version of Ingenuity pathway analysis (Ingenuity Systems Inc, Mountain View, CA). The 
list of differentially expressed genes as well as their expression changes was uploaded to 
the online database of Ingenuity. The program generates all the possible networks from 
the uploaded genes plus the annotated genes in the online database. Figure 5-2 just shows 
one gene network generated from the microarray analysis by Ingenuity. Genes with red 
color indicate those genes downregulated in microarray analysis and those with green 
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Table 5-5 Clusters of differentially expressed genes in cytobands of mouse chromosomes 
in 7-day Hrn/Hrn mice. Microarray analysis was done with ImaGene and GeneSight. The 
cytoband analysis was through DAVID 2.1 from NIH. 
Cytoband Gene ID Gene Name 
NM_007520 BTB and CNC homology 1 
U50960 RIKEN cDNA 1190017O12 gene 
AF345291 keratin associated protein 16-1 
NM_010676 keratin associated protein 8-2 
BC006914 leucine zipper domain protein 
AK007207 myosin, light polypeptide kinase 
NM_008762 olfactory receptor 15 
16 A1 
 
 
 
 
 AK003884 
protein phosphatase 1F (PP2C domain 
containing) 
NM_025562 tetratricopeptide repeat domain 11 
5 G1 AK019689 unc-84 homolog A (C. elegans) 
NM_008215 hyaluronan synthase1 
17 A3.1 NM_025681 limb expression 1 homolog (chicken) 
AK011461 BTB (POZ) domain containing 4 
AY044153 histamine receptor H 3 2 H4 
 AK005136 phosphatase and actin regulator 3 
D86424 keratin associated protein 3-1 
NM_015741 keratin associated protein 9-1 
NM_010659 keratin complex 1, acidic, gene 1 
V00830 keratin complex 1, acidic, gene 10 
11 D  
  
  
  X75650 keratin complex 1, acidic, gene 3 
 
80 
Table 5-6 Functional annotation of the microarray data from 7-day Hrn/Hrn mice through 
DAVID 2.1 from NIH. 
Enriched Categories Enriched Genes 
AK017747 SMC2 structural maintenance of chromosomes 2-like 1 
NM_028333 angiopoietin-like 1 
NM_016857 exocyst complex component 7 
BC011407 golgi autoantigen, golgin subfamily a, 2 
BC002226 hook homolog 2 (Drosophila) 
NM_010659 keratin complex 1, acidic, gene 1 
V00830 keratin complex 1, acidic, gene 10 
X75650 keratin complex 1, acidic, gene 3 
X99143 keratin complex 2, basic, gene 10 
NM_008445 kinesin family member 3C 
M15525 laminin B1 subunit 1 
AJ293592 laminin, alpha 3 
AK005136 phosphatase and actin regulator 3 
NM_019400 rabaptin, RAB GTPase binding effector protein 1 
NM_009294 syntaxin 4A (placental) 
COILED COIL 
 
 
 
 
 
 
 
 AK019689 unc-84 homolog A (C. elegans) 
AL021127 centrin 2 
BC002226 hook homolog 2 (Drosophila) 
NM_010670 keratin associated protein 12-1 
D89901 keratin associated protein 6-3 
NM_015741 keratin associated protein 9-1 
NM_010659 keratin complex 1, acidic, gene 1 
NM_008445 kinesin family member 3C 
AK007207 myosin, light polypeptide kinase 
NM_015756 Shroom 
NM_009229 syntrophin, basic 2 
AF357392 t-complex protein 1 
CYTOSKELETON 
 
 
 
 
 
 
 NM_009446 tubulin, alpha 7 
NM_010670 keratin associated protein 12-1 
D86424 keratin associated protein 3-1 
D89901 keratin associated protein 6-3 
NM_015741 keratin associated protein 9-1 
NM_010659 keratin complex 1, acidic, gene 1 
V00830 keratin complex 1, acidic, gene 10 
X75650 keratin complex 1, acidic, gene 3 
KERATIN 
 
 
 
 X99143 keratin complex 2, basic, gene 10 
M15525 laminin B1 subunit 1 
AJ293592 laminin, alpha 3 BASEMENT 
MEMBRANE AB041350 procollagen, type IV, alpha 5 
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Table 5-6 Continued 
 
Enriched Categories Enriched Genes 
M15525 laminin B1 subunit 1 
AJ293592 laminin, alpha 3 
AB041350 procollagen, type IV, alpha 5 
EXTRACELLULAR 
MATRIX 
STRUCTURAL 
CONSTITUENT AK012212 procollagen, type XVI, alpha 1 
S37491 angiotensin receptor 1b 
U46027 cAMP responsive element binding protein 1 
NM_008177 gastrin releasing peptide receptor 
AK007207 myosin, light polypeptide kinase 
CALCIUM 
SIGNALING 
PATHWAY 
 S43865 
protein phosphatase 3, regulatory subunit B, alpha 
isoform (calcineurin B, type II) 
AB011019 EGF-like-domain, multiple 9 
AL513354 RIKEN cDNA 4931407K02 gene 
AL021127 centrin 2 
M15525 laminin B1 subunit 1 
NM_013589 
latent transforming growth factor beta binding protein 
2 
S43865 
protein phosphatase 3, regulatory subunit B, alpha 
isoform (calcineurin B, type II) 
NM_009229 syntrophin, basic 2 CALCIUM ION 
BINDING AK017244 trichohyalin-like 1 
AK011461 BTB (POZ) domain containing 4 
NM_007520 BTB and CNC homology 1 
NM_007526 BarH-like homeobox 1 
AK019761 GLIS family zinc finger 1 
AK004406 MAF1 homolog 
NM_010919 NK2 transcription factor related, locus 2 (Drosophila) 
BC013550 
TAF5-like RNA polymerase II, p300/CBP-associated 
factor (PCAF)-associated factor 
U46027 cAMP responsive element binding protein 1 
AK020505 early B-cell factor 2 
NM_008237 hairy and enhancer of split 3 (Drosophila) 
NM_010561 interleukin enhancer binding factor 3 
L09600 nuclear factor, erythroid derived 2 
NM_008904 
peroxisome proliferative activated receptor, gamma, 
coactivator 1 alpha 
TRANSCRIPTION 
REGULATION 
 
 
 
 
 
 
 
 AK021201 protein kinase C binding protein 1 
NM_007520 BTB and CNC homology 1 
U46027 cAMP responsive element binding protein 1 
BASIC-LEUCINE 
ZIPPER (BZIP) 
TRANSCRIPTION 
FACTOR L09600 nuclear factor, erythroid derived 2 
M15525 laminin B1 subunit 1 PROTEIN 
PHOSPHATASE 
INHIBITOR AJ293592 laminin, alpha 3 
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Figure 5-2 One network generated from the differentially expressed genes in microarray 
analysis at 7 days of age with trial version of Ingenuity. Red: downregulated expression; 
Green: upregulated expression. 
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color are for the genes with upregulation. The program is able to identify the signaling 
pathways connected through the networks. For example, the network shown in figure 5-2 
indicated that three signaling pathways, ERK/MAPK signaling, G-protein-coupled 
receptor signaling, and Wnt/β-catenin signaling pathways are affected by Hrn mutation. 
Altogether, there are more than 10 different networks generated by network analysis 
using Ingenuity. Totally there are seven different signaling pathways affected in Hrn/Hrn 
mutant mice: Wnt/β-catenin signaling, ERK/MAPK signaling, apoptosis signaling, TGF-
β signaling, NF-κB signaling, P38 MAPK signaling, G protein coupled receptor signaling. 
All these pathways play important roles in cell cycle and growth. Wnt/β-catenin (Fuchs, 
1998; Jamora et al., 2003; Lowry et al., 2005) and TGF-β (Peters et al., 2005) signaling 
pathways are critically involved in hair follicle development and hair cycle. The analysis 
of signal pathways suggests the possible roles of Hrn mutation due to either the over-
expression of Hr gene or another unknown gene mutation. 
At the same time, PathwayAssist software from Stratagene was also used to 
analyze the differentially expressed genes at 7 days of age (figure 5-3). Instead of 
deriving many separate networks in Ingenuity, PathwayAssist generates a large network 
based on the gene lists by extracting biological interactions from the scientific literature. 
The uncharacterized genes within the uploaded gene list were listed as separate nodes 
outside of the network. The cellular processes affected in the networks include focal 
contact, motility, differentiation, proliferation, assembly, secretion, oxidative 
phosphorylation, and apoptosis. The functional classes affected include protein kinase C, 
SAP kinase, antisense RNA, porin, caspase, ubiquitin, hydrolase, and protein 
serine/threonine kinase. The cell objects affected in the network include plasma 
membrane, cytoskeleton, intermediate filament, adhesion junctions, and chromatin. The 
network also lists the small molecules working in the network, such as glucose and 
dexamethasome. Compared to the analysis with Ingenuity, the information generated 
from the network is less reliable since the interactions extracted from literature text 
mining while the interactions in Ingenuity is curated and updated very often in its online 
database. Altogether, the analyses with both softwares suggest the alteration of 
proliferation, differentiation, and apoptosis as well as the related signaling pathways. 
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Figure 5-3 Pathway analysis with the differentially expressed genes at 7 days of age 
through the trial version of PathwayAssist from Stratagene. 
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Discussion 
Histological analysis with mutant mice from 0 to 4 days after birth suggests that 
there is abnormal pre-mature keratinization occurring in the cortex region of hair follicles 
that begins right after or even before birth. It is not known what occurred during the 
embryogenesis stages since it is still very difficult to get a homozygous litter and we have 
not performed timed matings. Premature keratinization may be the initial event that leads 
to hair loss in Hrn mice. The premature keratinization in the hair follicle of 0 to 4 days 
old mutant mice validates the previous finding in older mice of abnormal hyperkeratosis 
in the hair follicles and the formation of mineralized dermal cysts. This histological 
change is due to either a regulatory mutation in Hrn in Hr or an unknown mutation in 
another gene. 
Microarray analysis with 0 day mutant mice provides more explanation about the 
phenotypes in Hrn mutants. Two thirds of the genes with altered expression are 
upregulated in the mutants and others are downregulated. Among the list, one interesting 
gene is keratin 2-6a with more than 2 fold increased expression. As reported in the 
previous chapter, numerous keratins and keratin-associated proteins are dysregulated in 
older Hrn mice. Krt2-6a is the first of this class of genes to show altered expression. Krt2-
6a usually forms a heterodimer with keratin 1-16 or keratin 1-17. Krt2-6a is 
constitutively expressed in the various stratified epithelia, including the companion cell 
layer of the hair follicle, tongue, footpad, nail bed, oral mucosa t (Mahony et al., 2000; 
Rothnagel et al., 1999). In addition, the expression of keratin 2-6a is inducible in 
response to different stimulus, for example, wounding, diseases states including skin 
tumors and psoriasis (Stoler et al., 1988), phorbol esters and all trans-retinoic acid 
(Rothnagel et al., 1999). The induction results in its expression in the outer root sheath of 
hair follicle and throughout the epidermis, including the basal layer. The increased 
expression of keratin 2-6a in Hrn/Hrn mice might be directly or indirectly due to the Hrn 
mutation. A mutation that caused loss of mouse keratin 2-6a results in the collapse of 
keratin filaments, the destruction of hair follicles and eventually alopecia, indicating that 
the innermost outer root sheath cells are uniquely sensitive to even slightly altered keratin 
2-6a proteins (Baker et al., 1997; Wojcik et al., 1999). Therefore, the increased 
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expression of mouse keratin 2-6a might cause abnormal keratinization in outer root 
sheath of hair follicle in Hrn/Hrn mice, which results into the destruction of hair follicle 
and eventual formation of alopecia.  
 Another gene called Sprr1b (small proline-rich protein 1B) was upregulated with 
more than 2 fold in Hrn/Hrn than +/+ mice. Sprr proteins are the primary constituents of 
the cornified envelope (Martin et al., 2004). Sprr1b locates in a region called epidermal 
differentiation complex in chromosome 1 consisting of S100A10, trichohyalin, 
profilaggrin, involucrin, SPRR3, SPRR1B, SPRR2A, loricrin, S100A9, S100A9, S100A8, 
S100A6, which are related with the terminal differentiation of epidermis (Mischke et al., 
1996). The increase expression of Sprr1b indicates the increased cornified materials, 
which suggests hyperkeratosis occurrence in Hrn/Hrn mice.  
 Another one interesting differentially expressed gene is called Smarca2, 
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, 
member 2. It was shown that Smarca2 homologs in human are transcriptional 
coactivators cooperating with the estrogen receptor, the retinoic acid receptor (Chiba et 
al., 1994), and the glucocorticoid receptor (Muchardt and Yaniv, 1993). Its expression 
was upregulated by 2-fold in Hrn/Hrn mice compared to +/+ mice. This gene has been 
identified as a gene correlated with an anti-hair growth pattern, with sharp expression 
rising at catagen (Lin et al., 2004). Increased expression of Smarca2 might underlie 
reduced hair growth in Hrn/Hrn mice.  
Major urinary proteins (MUPs) are members of lipocalin family proteins mainly 
produced by the liver. They are secreted into the urine and bind to small-molecular-
weight volatile pheromones. In rodents, they play important roles in individual 
recognition, territorial marking, social behavior, and transport of small molecules 
(Beynon and Hurst, 2003). Increased expression at 0-day Hrn/Hrn mice might be due to 
the unbalanced ratio of male and female mice between +/+ and Hrn/Hrn mice as we did 
not establish the gender of pups used at this age. Another possible explanation is that the 
increased expression of these major urinary proteins is due to Hrn mutation or part of the 
Hrn phenotype. Recently, an increased expression (5-fold) of major urinary protein 1 was 
reported in Hr-/- mice compared to wild type mice through the microarray analysis, which 
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was also verified by the northern blot (7-fold) (Zarach et al., 2004). In addition, it was 
also reported that this group of proteins was upregulated in our HrrhR/HrrhR mice through 
microarray analysis (mentioned in Chapter 6). MUPs have been shown to be expressed in 
skin, and their function there has been linked to transport of small molecules (Held et al., 
1989). The transgenic mice with a fusion of ~2.5 kb of 5’ flanking region from the MUP 
BL6-11 gene with SV40 T antigen coding sequence expressed the transgene in the skin 
sebaceous glands and the preputial gland, a modified sebaceous gland, which is 
consistent with the presence of MUP mRNA in the skin and a putative role for MUPs in 
the transport and excretion of small molecules (Held et al., 1989). This validates our 
microarray experiments in terms of the expression of MUP gene in the skin and suggests 
a possible function related with skin and hair growth. It was also found that the 
expression of major urinary protein 2 (MUP2) was suppressed by 3-methylcholanthrene 
(MC) through aryl hydrocarbon receptor (AhR)-mediated disruption of the growth 
hormone (GH) receptor signaling pathway (Nukaya et al., 2004). The function of AhR is 
known to interact with Hr. All of these suggest that the down-regulation of major urinary 
proteins in Hrn/Hrn mice might be related with the over-expression of Hr gene or another 
unknown gene mutation. 
Another gene, SH2-B PH domain containing signaling mediator 1 (Sh2bpsm1 or 
Sh2-B) was differentially expressed at 0-day mutant mice with increased expression. The 
isoforms of Sh2-B form a family of signaling proteins with other proteins including APS 
and LNK. The functions of Sh2-B have been described as activators, mediators, or 
inhibitors of cytokine and growth factor signaling. Sh2-B is an endogenous enhancer of 
leptin sensitivity and required for maintaining normal energy metabolism and body 
weight in mice (Ren et al., 2005). Sh2-B homozygous null mice were severely 
hyperphagic and obese while the overexpression of Sh2-B counteracted PTP1B-mediated 
inhibition of leptin signaling in cultured cells (Ren et al., 2005). The expression of Sh2-B 
was significantly increased by almost 3 fold in Hrn/Hrn mutant mice compared to +/+ 
mice, which might be related with the retarded body growth in Hrn mutant mice. Sh2-B 
also regulates the activity of a variety of transporters under normal and pathological 
conditions (Jiang et al., 2005), which might play important roles in skin or hair growth. 
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Sh2-B also specifically activates JAK2 and it may serve as adapter proteins for all three 
JAKs (JAK1-3) independent of any role they have in JAK activity (O'Brien et al., 2002). 
The adapter protein Sh2-B in human was found to interact with FGFR3 (fibroblast 
growth factor receptor 3) to mediate FGFR3-dependent signaling. The increased 
expression of human Sh2-B in 293T cells activates FGFR3, which causes the 
phosphorylation and nuclear translocation of STAT5 (Kong et al., 2002b).  Sh2-B was 
shown having roles in mast cell development (Kubo-Akashi et al., 2004). Here we 
observed two mast cell proteases with differential expression in Hrn mutants, which 
might suggest the possible involvement of Sh2-B in the mutants. 
One gene called tenascin C (Tnc) was upregulated in 0-day mutants. It is an 
extracellular matrix protein with a spatially and temporally restricted tissue distribution. 
In the embryo it is present in dense mesenchyme surrounding developing epithelia, in 
tendon anlagen, and in developing cartilage and bone. In the adult tenascin remains 
present in tendons and myotendinous junctions in the perichondrium and periosteum, as 
well as in smooth muscle. It was shown that this gene is enriched in the outer root sheath 
(ORS), as one of the molecular signatures of ORS (Rendl et al., 2005). Tnc induces the 
expression of Mmp-9 (matrix metalloproteinase 9) in the collaboration of TGFβ 1 in 
breast cancer cells (Ilunga et al., 2004; Kalembeyi et al., 2003), suggesting that the 
increased expression might directly involve into the phenotype development of the Hrn 
mutants. 
Claudin 5 (Cldn5), also called transmembrane protein deleted in velocardiofacial 
syndrome (TMVCF), was also upregulated in Hrn mutants at 0 day of age. Claudins are 
components of tight junction strands. Tight junctions constitute continuous seals around 
cells that serve as a physical barrier preventing solutes and water from passing freely 
through the paracellular space. Other members of claudin family, Cldn1 and Cldn3 
decreased solute permeability in overexpressing cells, while Cldn5 increased 
permeability (Coyne et al., 2003). Cldn5 exists predominantly in pentameric and 
hexameric configurations and forms specific heterophilic interactions with Cldn1 and 
Cldn3 (Coyne et al., 2003). Cldn1, Cldn4, and Cldn10 are found to be the signature genes 
of the matrix in hair follicles (Rendl et al., 2005) and skin lacking Cldn1 displays 
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abnormally short hairs and wrinkled skin (Furuse et al., 2002). The increased expression 
of Cldn5 might abolish the heterophilic protein complex with Cldn1 and Cldn3 and 
contribute to the phenotype development of Hrn mutants.  
It was very interesting to notice that several genes in the 0-day list, including 
hemopoietic cell phosphatase (Hcph), mast cell proteases (Mcpt6 and Mcpt7), and 
cysteine-rich protein 3 (Csrp3), are upregulated. These genes were recently found to have 
an expression pattern inversely correlated with hair growth, with decreased expression in 
anagen and increased expression in catagen phase of normal hair cycles (Lin et al., 2004). 
Increased expression of these genes might be related to the reduced hair growth. Another 
gene called carbonic anhydrase 3 (Car3) was downregulated in 0-day mutants. The 
expression of Car3 drops at catagen in normal hair follicle cycles (Lin et al., 2004). The 
decreased expression of Car3 suggests abnormal hair growth in the mutants.  
Microarray analysis with mice at 7 days of age identified a larger set of 
differentially expressed genes, including many keratins and keratin-associated proteins 
that are directly related to hair growth. The down-regulation of hair keratins and keratin-
associated proteins is consistent with the loss of hair in mutant animals. Most of these 
genes are significantly downregulated in Hrn mutants, suggesting that the overexpression 
of Hr as a transcriptional co-repressor might be a cause of the Hrn phenotype. Several 
cytobands on different mouse chromosomes, including 2H4, 5G1, 11D, 16A1, and 
17A3.1, were enriched with many differentially expressed genes, suggesting the genes in 
each cytoband might be regulated by a common promoter or a similar mechanism. 
Cytobands 16A1 and 11D contain many structural proteins including many keratins and 
keratin-associated proteins. It is possible that the expression of these genes might be the 
immediate downstream events of Hrn mutation.  
Functional annotation of the microarray results suggests that many categories 
were significantly enriched, indicating the importance of these categories in hair growth, 
including keratins, extracellular matrix structural constituent, calcium signaling pathway, 
and transcription regulation. Several of the genes with differential expression were 
suggested previously as molecular signatures of hair matrix (Krt1-1 and krt2-10), outer 
root sheath (Col4a5), and dermal papilla (Lama3, Pdgfra) (Rendl et al., 2005). The 
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expression of all these signature genes was downregulated in Hrn mutants, possibly 
suggesting reduced proliferation in hair matrix, outer root sheath, and dermal papilla, 
consistent with our histological findings.  
Network analysis of the microarray data suggests that the Hrn mutation affects 
Wnt/β-catenin, apoptosis, and TGF-β signaling pathways in skin of Hrn/Hrn mutants. It 
has been shown that these signaling pathways plays very important roles in hair follicle 
morphogenesis, hair growth and hair follicle cycles (Fuchs, 1998; Paus and Foitzik, 2004; 
Rogers, 2004; Shimizu and Morgan, 2004; Stenn and Paus, 2001). Genes related with 
Wnt/β-catenin signaling pathways are downregulated, suggesting repressed Wnt 
signaling. Recently it was found that Hr triggers reactivation of hair growth by repressing 
Wise, a modulator of Wnt signaling, and promoting Wnt signaling (Beaudoin et al., 
2005). Hr overexpression in 7-day Hrn/Hrn mice should promote Wnt/β-catenin signaling 
pathway. However, we were unable to detect the expression changes of Wise in 7-day 
Hrn/Hrn mice. One reason for this is that the location of Hr expression is different 
between the transgenic Hr mice generated for reactivating hair growth (Beaudoin et al., 
2005) and our Hrn/Hrn mutants. Hr expression in the transgenic mice is in the outer root 
sheath and hair bulb as the follicles enter catagen and is under the control of keratin 14 
promoter (Beaudoin et al., 2005). However, in Hrn/Hrn mutant mice, Hr is expressed in 
the outer root sheath, inner root sheath, matrix cells, and fibroblasts in the sinus. Thus, it 
is very difficult to compare these two mouse models.  
Pathway and network analysis from the microarray data also suggests that many 
cellular processes including focal adhesion, differentiation, proliferation, assembly, and 
apoptosis are altered in skin of Hrn/Hrn mutants. Focal adhesion is critical for outer root 
sheath to adhere to, synthesize, and remodel its adjacent basement membranes. The 
alteration of focal adhesion in skin suggests the change in outer root sheath. Dsg4 null 
mice are an example of how loss of an adhesion molecule in hair follicles lead to hair loss, 
and in fact these mice display a phenotype very similar to that of Hrn. Changes of 
proliferation and differentiation in skin are consistent with the histological analysis, 
which indicates reduced proliferation and abnormal switch from proliferation to 
differentiation in hair follicle precortical region. The alteration of assembly might suggest 
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the abnormal assembly of hair keratins and keratin-associated proteins, leading to the 
premature keratinization in the precortex region and aberrant hair shaft formation. 
Changes of apoptosis in skin might reflect the change of cell proliferation and the failure 
of hair shaft formation. The affected cellular objects from pathway analysis including 
cytoskeleton, intermediate filament, adhesion junctions, and chromatin, are consistent 
with the functional annotation of the microarray data, which suggests the similar 
categories are enriched and altered due to the Hrn mutation. 
It is very surprising to notice that so many genes responsible for immune function 
are differentially expressed at both 0 and 7 day-old mice. Hair follicle has a very complex 
immunologic profile with matrix cells in its base and perifollicular macrophages, mast 
cells, Langerhan’s cells, and other immunocytes. It is possible that the alteration of 
immune profiling might be secondary to the hair follicle phenotype. However, it is also 
possible that the immune changes observed with microarray analysis are due to the Hrn 
mutation. It has been shown recently that hairless could trigger reactivation of hair 
growth in hair follicle by promoting Wnt signaling (Beaudoin et al., 2005) and it was 
found that Wnt/β-catenin signaling pathway was altered in the mutants. If the Hrn 
phenotype is related with the overexpression of Hr gene, then Wnt signaling pathway 
should be affected. Tcf1 (T-cell factor 1) and Lef1 (lymphoid enhancing factor-1) are 
critical for the development of T cells (Verbeek et al., 1995). Homologs of Tcf1/Lef1 has 
been shown to interact with Wnt effector β-catenin to mediate axis formation in Xenopus 
(Molenaar et al., 1996). It was shown that interaction of Tcf1 with β-catenin was required 
for thymocyte differentiation, and that this interaction was shown to be mediated by Wnt1 
and Wnt4 (Staal et al., 2001). Based on this, many genes related with T-cell 
differentiation and development could be differentially expressed due to Hrn mutation 
and not secondary to the phenotype.  
In summary, the Hrn mutation was characterized with the histological analysis of 
young animals and microarray analysis of mice at different ages. Although the genetic 
mutation has not been identified, we have studied the signaling pathways affected by this 
mutation. The microarray analysis might provide useful clues to explore the molecular 
targets of HR and help to finally identify the underlying genetic mutation.  
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Chapter 6 Molecular and physiological basis for hair loss  
in mice carrying a novel nonsense mutation in Hr 
The results presented in this chapter are being prepared as a manuscript that will 
be submitted to Journal of Investigative Dermatology. 
Introduction  
 The first description of rhino mice was reported by Gaskoin in 1856 (Gaskoin, 
1856) as “rhinoceros” with hair loss and wrinkled skin. Later, the mouse called hairless 
arose spontaneously in 1939 at McGill University in Montreal, Canada (Sundberg, 1994). 
Shortly thereafter it was shown that rhino and hairless were allelic (Howard, 1940). The 
phenotype in rhino mice (Hrrh) is more severe than that of hairless mice (Hrhr), and this is 
thought to be due to more severe effects of the mutation on Hr protein levels. The 
classical mutation Hrhr is caused by the insertion of a provirus into intron 6 of Hr, 
resulting in aberrant splicing and significantly reduced expression (Jones et al., 1993). All 
cloned Hrrh mutations are nonsense mutations that cause nonsense-mediated decay of Hr 
mRNA (Panteleyev et al., 1998b) and virtually complete loss of mRNA.  
Rhino alleles of Hr are so named because of the excessive skin wrinkling of Hrrh 
mutants. The wrinkling is due to large utricles and dermal cysts filled with keratins that  
form in the dermis from the remnants of hair follicle (Mann, 1971; Panteleyev et al., 
1998b; Sundberg, 1994; Sundberg and Boggess, 1998). Dermal cysts originate from 
undifferentiated epithelial cells of the deepest part of the hair follicle with the peripheral 
cells developing into sebocyte-like cells and outer root sheath cells (Bernerd et al., 1996). 
The cysts are filled with keratins 5, 14, 6, and 17, and lipids including cholesterol esters, 
wax esters, and very small amounts of triglycerides, cholesterol and ceramides (Bernerd 
et al., 1996). As for Hrhr, hair loss coincides with onset of the first postnatal anagen. 
Nonsense mutations in Hr have also been described in human patients with APL, but the 
excessive skin wrinkling is not present in affected human patients.  
HrrhR arose spontaneously downstream of a translocation experiment, but was not 
due to a translocation. The male parent was a treated JH male and the female parent was 
an SB female. SB refers to the F1 hybrid made from SEC/E x C57BL/E. The mutant was 
outcrossed to BLH F1's for stock maintenance. BLH refers to C3Hf x C57BL10a. 
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Homozygous mutant mice are normal at birth and display a typical coat until 2-3 weeks 
after birth, the time at which the first hair cycle initiates. At this point they fail to initiate 
the first hair cycle and begin to lose their hair. By 5-weeks of age the mice are hairless 
and have wrinkled skin. Because the phenotype of this mutant is so similar to the known 
rhino (Hrrh) mice (Howard, 1940; Panteleyev et al., 1998b), we sequenced the Hr 
genomic DNA and found a novel nonsense mutation in exon 12, leading to a premature 
stop codon. Here we report the cloning of this rhino allele of Hr, detailed histological and 
molecular characterization of the phenotype. 
Results 
Phenotype 
The HrrhR mutant mice arose spontaneously in Oak Ridge National Lab. It was 
maintained in the ORNL mouse facility by mating HrrhR/HrrhR male with HrrhR/+ female 
with an inbred mixed strain background. Both genders of mutant mice appear to be fertile 
and viable, but the females have difficulty in nursing pups, likely due to skin lesions that 
develop due to thin skin. HrrhR/HrrhR mice were distinguishable from HrrhR/+ or +/+ as 
early as 2 weeks of age due to hair loss. HrrhR/+ mice are phenotypically normal. As the 
HrrhR/HrrhR mice age, they become almost completely nude and their skin becomes 
excessively wrinkled in a fashion similar to other Hrrh alleles (Ahmad et al., 1998c; 
Ahmad et al., 1998d; Brancaz et al., 2004; Garcia-Atares et al., 1998; Panteleyev et al., 
1998a; San Jose et al., 2001; Sundberg and Boggess, 1998) (Figure 6-1 A). One 
difference is that hair loss in HrrhR/HrrhR mice begins in a random manner across the body, 
while other Hr mutants lose hair in a head-to-tail manner (Panteleyev et al., 1998b). The 
hair on the snout, head, and both ears is the last to be lost (Figure 6-1 B), likely due to the 
slower cycling of follicles in these areas. The HrrhR/HrrhR mutant mice still have the 
vibrissae even after they are hairless. The homozygotes have longer nails compared to the 
heterozygotes by 4 weeks of age and become more significant with age (data not shown). 
Thymuses in the homozygotes are much smaller compared to those in the heterozygotes, 
suggesting thymic abnormalities related to the mutation.  
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Figure 6-1 Photos of HrrhR/HrrhR mice. (A) 6-month old HrrhR/HrrhR; (B) 5-week old 
HrrhR/HrrhR. 
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Novel nonsense mutation 
 The phenotype of HrrhR/HrrhR mutant mice is extremely similar to other rhino 
mice (Hrrh/Hrrh). Therefore, we began by sequencing the genomic region of Hr using  
direct sequencing of PCR products amplified using primer pairs that spanned the genomic 
DNA (Table 3-1). Genomic DNA was extracted from tail snips. Primers were designed to 
amplify overlapping fragments of about 700-900 bp in length. PCR products were 
separated through 1% agarose gel electrophoresis and purified with GFX columns. 
Sequences were extracted from raw chromatograms using Chromas software and 
compared to the published Hr sequence using BLAST (NCBI). Using this strategy, we 
found a base pair change from C to T in position 3134 of Hr mRNA (NM_021877) in the 
homozygous mutant mice (Figure 6-2). This change occurred in exon 12 of Hr gene 
leading to the formation of a premature stop codon from arginine 814 (R814X). As 
expected, heterozygotes showed a mixture of C and T at position 3134. Samples from a 
total of 100 animals were sequenced to confirm the mutations. Due to its distance from 
the terminal exon, this mutation is predicted to be degraded through nonsense-mediated 
decay. The mutation also abolishes a digestion site of restriction enzyme Cac8I, which 
can be used to genotype mice prior to the development of hair loss. A new pair of primers 
was specially designed to amplify the segment containing the mutation as well as the 
restriction digestion site of Cac8I.  The amplified PCR product from wild type mouse 
was fully digested by Cac8I (figure 6-3). It showed two bands with smaller size around 
200 bp in the gel electrophoresis. The PCR product from the DNA of the heterozygous 
mice was partially digested by Cac8I and three bands were seen in the gel electrophoresis. 
Among the three bands, the very top one is the DNA without restriction digestion by 
Cac8I. The two bands in the bottom are digested DNA fragments. The PCR product from 
the DNA of HrrhR/HrrhR mice was not digested by Cac8I due to the mutation and only one 
band was seen at the top of the agarose gel. The results of Cac8I restriction digestion 
were confirmed with DNA sequencing.  
Significant reduction of Hr expression 
 Northern blotting was used to determine if the mutant HrrhR mRNA was degraded 
due to nonsense-mediated decay. Two different probes were designed, one covering the  
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Figure 6-2 Genotyping of wild type (+/+), heterozygous (HrrhR/+), homozygous 
(HrrhR/HrrhR) mice in exon 12 of Hr. Arrows indicate the position of mutation (3134C to 
T of NM_021877). Wild type mice have a C at position 3134. Heterozygous mice have 
T/C at this position. Homozygous mice have a T at this position. 
C C A G G C C T G C/T G A G G A
C C A G G C C T G C G A G G A
C C A G G C C T G T G A G G A
+/+
HrrhR/+ 
HrrhR/HrrhR 
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Figure 6-3 The digestion pattern of PCR products from the genomic DNA of HrrhR/HrrhR, 
HrrhR/+, and +/+ mice. The PCR products were amplified with primers called gRHF and 
gRHR.  
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exon 12 and containing the mutation site, and the other covering exons 5 to 11. Both 
probes were amplified through PCR, separated on gel, and purified through GFX 
columns. Total RNA from dorsal skin of 1, 7, 14, and 35-day old mice was extracted,  
separated on gels using electrophoresis, transferred overnight to the membranes using 
capillary effect, and crosslinked to the membranes using UV-light. Probes were randomly 
labeled with α-32P-CTP and hybridized to membranes at 42°C overnight. Results are 
shown in figures 6-4 and 6-5. Results with each probe suggest that there is significant 
loss of Hr mRNA in HrrhR/HrrhR mutant mice compared to either wild type or HrrhR/+ 
mice. This significant loss of Hr expression was found in homozygous mice at all ages 
including 1-, 7-, 14-, and 35-day after birth. There is only one major band in each 
Northern blot, matching to the size of full-length Hr mRNA transcript. No other 
transcripts were found, indicating that no alternatively spliced transcripts correspond to 
these two probes. Splicing might occur in other regions of Hr gene not represented by 
these probes, such as 3’ end. There is a very strong signal of Hr expression in 14 days 
after birth, consistent with its known expression pattern. HrrhR/HrrhR mutant mice exhibit 
much more prominent wrinkling phenotype than hairless mice (Hrhr/Hrhr) or rhino mice 
(Hrrh/Hrrh). The phenotype is very similar to the one in rhino-Yurlovo (HrrhY/HrrhY) 
(Panteleyev et al., 1998a) and the null mutant (Hrtm1Cct/Hrtm1Cct) (Zarach et al., 2004). 
This might suggest that the severe skin-wrinkling phenotype in HrrhR/HrrhR mutant mice 
is due to significant or complete loss of Hr expression.  
Utricle and dermal cysts formation 
 It was reported previously that formation of utricles at postnatal day 12 was the 
first morphological change in Hr-/- mice (Zarach et al., 2004). A detailed histological 
analysis with a series of different ages of mice from postnatal day 1 to 35 was performed 
to identify the first recognizable change in HrrhR/HrrhR mutants. The development of hair 
follicles in HrrhR/HrrhR mice is normal compared to wild type at postnatal days 1 and day 
7 (Figure 6-6) and overall follicle structure is normal. There is no difference in the 
thickness of epidermis or the number of hair follicles in the skin between HrrhR/HrrhR and 
HrrhR/+ mice. By postnatal day 10, however, the infundibulum near the top of the piliary 
canal become wider and contains increased keratinized material (Figure 6-7), ultimately  
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Figure 6-4 Significant reduction of Hr expression in the dorsal skin of HrrhR/HrrhR mice 
(1). The total RNA was extracted from the dorsal skin of each genotype at different ages 
(1, 7, 14, 35 days after birth). 20 μg of the total RNA was loaded on each lane. The probe 
was amplified with PCR covering exon 12 containing the mutation.  The probe was 
randomly labeled with α-32P-CTP and blot to the membrane overnight at 42°C. The red 
block arrow indicates the position for full-length hairless mRNA. The bottom panel 
shows the intensity of 28S band from the gel.  
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Figure 6-5 Significant reduction of Hr expression in the dorsal skin of HrrhR/HrrhR mice 
(2). The total RNA was extracted from the dorsal skin of each genotype at different ages 
(1, 7, 14, and 35 days after birth). Twenty μg of the total RNA was loaded on each lane. 
The probe was amplified with PCR covering exon 5 to exon 11.  The probe was 
randomly labeled with α-32P-CTP and blot to the membrane overnight at 42°C. The red 
block arrow indicates the position for full-length hairless mRNA. The bottom panel 
shows the intensity of 28S band from the gel.  
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Figure 6-6 Histology of the dorsal skin from HrrhR/+ and HrrhR/HrrhR mice at 1 and 7 days 
of age. (A) Histology of the dorsal skin of 1-day old HrrhR/+ mouse; (B) Histology of the 
dorsal skin of 1-day old HrrhR/HrrhR mouse; (C) Histology of the dorsal skin of 7-day old 
HrrhR/+ mouse; (D) Histology of the dorsal skin of 7-day old HrrhR/HrrhR mouse.  
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Figure 6-7 Utricle formation in the dorsal skin of 10-day old HrrhR/+ and HrrhR/HrrhR 
mice. (A) Histology of the dorsal skin of 10-day old HrrhR/+ mice; (B) Histology of the 
dorsal skin of 10-day old HrrhR/HrrhR mice; (C) Higher magnification of a local area from 
panel B. 
 
(A) (B) 
(C) 
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leading to utricle formation in the HrrhR/HrrhR mutants. Other parts of the hair follicles in 
mutant mice are relatively normal compared to the heterozygous mice. These changes 
become more prominent by postnatal day 14 (figure 6-8) with the increase widening of 
the infundibulum in HrrhR/HrrhR mice. Cross sections also showed the formation of 
utricles. At postnatal day 18 (figure 6-9), the utricle formation is present in all the hair 
follicles in HrrhR/HrrhR mice, but none in HrrhR/+ mice. The amount of keratinized 
materials filling in the utricles increases progressively. The utricle formation 
encompasses the entire area distal to the sebaceous glands. By 3 weeks of age, the entire 
hair follicle becomes keratinized (figure 6-10 B). Hair follicles in HrrhR/HrrhR mice lose 
their connections with the dermal papilla, but no such change is seen in HrrhR/+ mice. 
Dermal cysts begin to form at this stage. By the age of 5-weeks, several layers of huge 
dermal cysts are formed and all hair follicles are disintegrated (figure 6-10 D). The 
dermal cysts are filled with a large amount of cornified materials. During the preparation 
of histological slides, a lot of white materials, which are cornified materials, fell out from 
the tissue. The size of the dermal cysts increases as the mice age, which causes 
progressive wrinkling of the skin. 
Microarray analysis  
 Little is known about the molecular basis of the morphological changes in 
HrrhR/HrrhR mutant mice. To identify the genes with altered expression in skin of 
HrrhR/HrrhR mutant mice, we used microarray experiments to profile expression in the 
skin of 7-day, 10-day, and 5-week old mice. We used these early ages to precede (7-day) 
and coincide with (10-day) the appearance of the phenotype. Gene expression changes in 
7-day old mice might suggest the earliest initial molecular events due to the HrrhR 
mutation. Differential expression at 10 days might provide the molecular basis related to 
formation of utricles, while the analysis with 5-week old mice might provide the 
molecular basis related with hair loss and the formation of dermal cysts. 
 Totally 10 mice (5 HrrhR/+ and 5 HrrhR/HrrhR) from one litter and 3 mice (1 
HrrhR/+ and 2 HrrhR/HrrhR) from another litter were used for the microarray analyses at 7 
days of age. Microarray analysis was done with ImaGene and GeneSight from 
Biodiscovery. No genes showed statistically significant alterations in gene expression. 
104 
 
 
 
 
Figure 6-8 Utricle formations in the dorsal skin of 14-day old mice. (A) Histology of the 
dorsal skin of 14-day old HrrhR/+ mice; (B) Histology of the dorsal skin of 14-day old 
HrrhR/HrrhR mice; (C) Higher magnification of formed utricle in the skin of HrrhR/HrrhR 
mice; (D) the cross sections of the dorsal skin of 14-day old HrrhR/HrrhR mice.
(A)
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(D)
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Figure 6-9. Utricle formation in the dorsal skin from 18-day old HrrhR/+ and HrrhR/HrrhR 
mice. (A) and (B) Histology of the dorsal skin from 18-day old HrrhR/+ mice; (C) 
Histology of the dorsal skin from 18-day old HrrhR/HrrhR mice; (D) Histology of the cross 
sections of the dorsal skin from 18-day old HrrhR/HrrhR mice. 
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Figure 6-10 Dermal cyst formation in 21- and 35-day old HrrhR/HrrhR mice. (A) Histology 
of the dorsal skin from 21-day old HrrhR/+ mice; (B) Histology of the dorsal skin from 
21-day old HrrhR/HrrhR mice; (C) Histology of the dorsal skin from 35-day old HrrhR/+ 
mice; (D) Histology of the dorsal skin from 35-day old HrrhR/HrrhR mice.  
(A) 
(B) 
(D) 
(C) 
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by using 95% confidence interval and a minimum fold change of 2. This might be due to 
the limit of the oligolibrary spotted on the array because this oligolibrary does not cover 
the whole mouse genome. Since there are no significant morphological changes in the 
skin of 7-day HrrhR/HrrhR animals, this reinstates that the phenotype develops between 7 
and 10 days of age.  
 Unlike 7 days, significant changes in gene expression were found at 10 days, the 
earliest point at which the phenotypic changes were found histologically. These 
hybridizations used an oligo array format representing ~ 15,000 mouse genes. Six mice 
containing three HrrhR/+ and three HrrhR/HrrhR mice from one litter were used, and 
hybridizations with each pair of samples were done with dye swaps. All 6 slides 
generated high quality images. Data were analyzed with ImaGene and GeneSight from 
BioDiscovery to derive the list of genes with differential expression, using 99% 
confidence interval and a minimum fold change of 2. Differentially expressed genes were 
defined as those that were significant in analysis of all 6 hybridizations together and that 
showed a response in two of three biological replicates. Results are listed in table 6-1.  
 It is very intriguing to notice that most of the differentially expressed genes in 
table 6-1 are upregulated at 10-day after birth, which is consistent with the loss of Hr 
function as a transcriptional co-repressor (Zarach et al., 2004). This list of genes was 
uploaded to DAVID (Dennis et al., 2003) for functional annotation.  Several categories 
were enriched based on the functional annotation as shown in table 6-2. These categories 
include cell organization and biogenesis, intermediate filament, non-membrane-bound 
organelle, and coiled coil. The genes in each enriched category were listed in table 6-2. 
Among the differentially expressed genes, two of them are keratins, Krt2-1 and Krt1-10, 
both of which show increased expression in HrrhR/HrrhR mutants. Krt 1-10 and Krt 2-1 are 
coexpressed in terminally differentiated epidermis and heterodimerize to form 
intermediate filaments. Their co-upregulation indicates a disturbance of normal 
keratinocyte differentiation in HrrhR/HrrhR mice. 
 It was also found that a large number of genes related with either immunoglobulin 
or T cell receptor β chain are upregulated in the skin of 10-day old HrrhR/HrrhR mutants 
comparing to HrrhR/+ mice. These genes are listed in table 6-3. The increased expression 
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Table 6-1 List of differentially expressed genes from 10-day old HrrhR/HrrhR mice. Data 
was analyzed with ImaGene and GeneSight from BioDiscovery based on the 99% 
confidence interval and the fold change of 1.5 (20.6).  
Gene ID Gene name Symbol 
fold 
change
L04961 Xist (X inactive specific transcript) Xist -2.9 
AK013594 RIKEN cDNA 2900024O10 gene  -2.6 
NM_010702 Leukocyte cell-derived chemotaxin 2 Lect2 -2.4 
NM_007740 Procollagen, type IX, alpha 1 Col9a1 -2.1 
NM_016875 Y box protein 2 (Ybx2) Ybx2 1.9 
NM_011043 protocadherin 10 Pcdh10 1.9 
NM_019402 Poly(A) binding protein, nuclear 1 Pabpn1 1.9 
NM_013510 Erythrocyte protein band 4.1-like 1 Epb4.1l1 1.9 
AK011423 Glucosamine (N-acetyl)-6-sulfatase Gns 1.9 
AK011425 
Solute carrier family 25 (mitochondrial carrier, 
phosphate carrier), member 24 Slc25a24 1.9 
L38249 LIM homeobox protein 3 Lhx3 1.9 
NM_011957 cAMP responsive element binding protein 3-like 1 Creb3l1 2.1 
V00830 Keratin complex 1, acidic, gene 10 Krt1-10 2.1 
AK005108 RIKEN cDNA 1500002C15 gene  2.1 
AK020189 Zinc finger protein 59 (Zfp59) Zfp59 2.2 
AK003656 lipocalin-interacting membrane receptor Limr 2.3 
U94828 Regulator of G-protein signaling 16 Rgs16 2.3 
NM_008473 Keratin complex 2, basic, gene 1 Krt2-1 2.3 
L04678 Integrin beta 4 Itgb4 2.4 
AY036887 myeloid/lymphoid or mixed-lineage leukemia 3 Mll3 2.4 
NM_008952 Pipecolic acid oxidase, mRNA Pipox 2.4 
NM_008564
Minichromosome maintenance deficient 2 mitotin 
(S. cerevisiae) Mcm2 2.6 
L76157 proline rich protein with ubiquitin-like domain Bat-3 2.7 
NM_021883 Tropomodulin 1 (Tmod1) Tmod1 2.8 
NM_018874 Pancreatic lipase related protein 1 Pnliprp1 2.9 
NM_010552 Interleukin 17 Il-17 3.0 
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Table 6-2 Functional annotations of the differentially expressed genes in 10-day old 
HrrhR/HrrhR mice compared with HrrhR/+ mice. Enriched categories including the genes in 
each category was shown below.  The analysis was done with DAVID from NIH.  
 
Enriched Category Name Enriched Genes 
Cell organization and 
biogenesis 
 
Krt1-10, Krt2-1, Mcm2, 
Tmod1, Mll3, Pipox, Epb4.1l1 
Structural molecular 
activity 
Krt1-10, Krt2-1, Epb4.1l1, 
Col9a1 
Non-membrane-bound 
organelle 
Krt1-10, Krt2-1, Mcm2, 
Tmod1, Xist, Epb4.1l1 
Coiled-coil Krt1-10, Krt2-1, Mll3, Pabpn1 
mRNA binding Pabpn1, Ybx2 
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Table 6-3 List of differentially expressed genes related with immune functions in 10-day 
HrrhR/HrrhR mice compared with HrrhR/+ mice. Microarray analysis was done with 
ImaGene and GeneSight softwares from BioDiscovery based on the 99% confidence 
interval and the fold change of 1.5 (20.6). 
Gene ID Gene name 
fold 
change 
Z12394 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ) 2.5 
Z12416 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ) 2.2 
Z12426 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ) 1.9 
Z12446 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ) 2.5 
Z12457 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ) 2.1 
Z12461 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ) 2.4 
Z12497 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ) 2.4 
Z12498 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ) 2.7 
Z12499 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ) 1.9 
Z12545 rearranged T-cell receptor beta chain Vbeta8 repertoire (VDJ) 2.1 
Z12571 rearranged T-cell receptor beta chain Vbeta8 repertoire (VDJ) 1.9 
Z12184 T-cell receptor beta, variable 13 2.1 
Z12273 T-cell receptor beta, variable 13 2.5 
Z12280 T-cell receptor beta, variable 13 2.7 
U55582 IgG light chain gene, V region 3.8 
U21569 
Immunoglobulin A heavy chain variable region (IGHV gene), 
clone WJ17 2.2 
U55699 Immunoglobulin kappa light variable region (IgKV gene) 2.1 
Y11589 Immunoglobulin lambda chain, mAb 667 3.5 
AF041957 infected mouse A seq 9, day 14, T cell receptor beta chain 1.9 
AF041896 infected mouse B seq 5, day 7, T cell receptor beta chain 2.2 
AF041910 infected mouse C seq 13, day 7, T cell receptor beta chain 2.1 
AF041882 Uninfected mouse B seq 9, T cell receptor beta chain 1.9 
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of these genes is directly or indirectly due to the loss of Hr function. It suggests that there 
might be some significant immunological reactions occurring in the mutant mice. These 
immune responses might be related with the phenotypes in HrrhR/HrrhR mice although the 
exact functions of these genes in immune system of the skin are still not very clear.  
 Microarray experiments and data analysis were also applied to the 5-week old 
HrrhR/HrrhR and HrrhR/+ mice. Data were analyzed with ImaGene and GeneSight from 
BioDiscovery and shown in table 6-4. Most genes were upregulated due to the loss of Hr 
function since Hr is suggested to be a transcription co-repressor (Potter et al., 2001). 
There are four different keratins with differential expressions, including keratin 2-1, 
keratin 1-15, keratin 2-6a, and type I epidermal keratin. The expression of keratin 1-15 
was downregulated while the expression of the other three was upregulated due to the 
loss of Hr function. It was also found that many genes related to immunoglobin and T-
cell receptor were differentially expressed in 5-week HrrhR/HrrhR mice, which is listed in 
table 6-5.  
 The GenBank accession numbers of the differentially expressed genes were 
uploaded to DAVID 2.1 (http://apps1.niaid.nih.gov/david/) for functional annotation. 
Among the 138 differentially expressed genes, 119 genes were annotated in DAVID and 
used for further analysis.  About ten different categories were found to be enriched based 
on the level 5 of gene ontology, including molecular function, biological process, and 
cellular component (table 6-6). These enriched categories are cytoskeleton, myofibril, 
intermediate filament cytoskeleton, actin cytoskeleton, cytoskeleton organization and 
biogenesis, anion transport, angiogenesis, cellular macromolecule catabolism, cysteine-
type endopeptidase activity, and striated muscle thin filament. Most of these categories 
are related with cytoskeleton, which suggests that the loss of Hr function directly or 
indirectly affects the cytoskeleton. 
 The differentially expressed genes in 5-week old HrrhR/HrrhR mice as well as 
their expression alterations were uploaded to Ingenuity for pathway and network analysis. 
Figure 6-11 shows one network created from this analysis. Most of the genes in figure 6-
11 from our microarray analysis were upregulated. This analysis revealed signaling 
pathways that are affected in HrrhR, based on differential expression. Altogether, it was 
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Table 6-4 List of the differentially expressed genes in 5-week old HrrhR/HrrhR mice 
compared with HrrhR/+ mice. Microarray analysis was done with ImaGene and 
GeneSight from BioDiscovery based on 99% confidence interval and fold change of 1.6 
(20.7). 
Gene ID Gene Name 
Fold 
change 
AK002589 0610012D17Rik, RIKEN cDNA 0610012D17 gene 2.5 
BC004797 0610040J01Rik, RIKEN cDNA 0610040J01 gene -2.8 
AK005108 1500002C15Rik, RIKEN cDNA 1500002C15 gene 2.5 
AK005145 1500004F05Rik, RIKEN cDNA 1500004F05 gene -2.5 
AK006506 1700029K24Rik, RIKEN cDNA 1700029K24 gene 2.5 
AK006707 1700047G03Rik, RIKEN cDNA 1700047G03 gene 2.6 
AK006816 1700056N10Rik, RIKEN cDNA 1700056N10 gene 2.4 
AK018881 1700066C05Rik, RIKEN cDNA 1700066C05 gene 2.4 
AK007829 1810048J11Rik, RIKEN cDNA 1810048J11 gene 2.5 
AK007938 1810062O18Rik, RIKEN cDNA 1810062O18 gene -2.3 
AK009423 2310020J12Rik, RIKEN cDNA 2310020J12 gene -2.7 
U01139 2610020N02Rik, RIKEN cDNA 2610020N02 gene 2.4 
AK019584 4930425K24Rik, RIKEN cDNA 4930425K24 gene 3.2 
AK015453 4930453J04Rik, RIKEN cDNA 4930453J04 gene -2.6 
AK016542 4932432N11Rik, RIKEN cDNA 4932432N11 gene 2.7 
AK017060 4933434M16Rik, RIKEN cDNA 4933434M16 gene 2.4 
AK017381 5430432M24Rik, RIKEN cDNA 5430432M24 gene 2.3 
AK020414 9430013L17Rik, RIKEN cDNA 9430013L17 gene 2.6 
AK020947 A930040O22Rik, RIKEN cDNA A930040O22 gene 4.0 
NM_011062 3-phosphoinositide dependent protein kinase-1 (Pdpk1) -2.3 
NM_020561 acid sphingomyelinase-like phosphodiesterase 3a (ASML3) 2.7 
NM_009672 acidic nuclear phosphoprotein 32 (Anp32) -2.8 
AK014322 AF4/FMR2 family, member 3 (Aff3) 2.7 
NM_007504 
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 
(Atp2a1) -2.2 
Z83816 axonemal dynein heavy chain (partial, ID mdhc8). 3.3 
NM_026602 Breast carcinoma amplified sequence 2 (Bcas2) 3.8 
U80888 CAG trinucleotide repeat mRNA -2.4 
NM_020036 calmodulin 4 (Calm4) 3.4 
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Table 6-4 Continued 
 
Gene ID Gene Name 
Fold 
change 
AK014694 camello-like 3 (Cml3) -3.2 
AB070894 clipin E/coronin 6 type A -2.6 
NM_007779 colony stimulating factor 1 receptor (Csf1r) -2.2 
NM_007710 creatine kinase, muscle (Ckmm) -2.2 
NM_007793 cystatin B (Cstb) 2.9 
AK003744 Cystatin E/M (Cst6) 4.4 
NM_007830 diazepam binding inhibitor (Dbi) 2.2 
AK004912 dual specificity phosphatase 23 (Dusp23) 2.3 
AK021364 E130101E03Rik, RIKEN cDNA E130101E03 gene 2.4 
AF277093 Elovl4 mRNA, complete cds. 4.2 
M14721 epidermal profilaggrin 3 
NM_010634 fatty acid binding protein 5, epidermal (Fabp5) 8.3 
NM_010211 four and a half LIM domains 1 (Fhl1) 2.4 
NM_019516 galectin-related inhibitor of proliferation (Grip1) -2.3 
NM_010354 gelsolin (Gsn) -2.2 
NM_008130 GLI-Kruppel family member GLI3 (Gli3) 3.1 
NM_008131 glutamine synthetase (Glns) 2.2 
AK012496 Hsdl1, hydroxysteroid dehydrogenase like 1 2.5 
AK004007 
hypothetical Aspartyl protease, retroviral-type family 
profile/Peptidase aspartic, active site containing protein 3 
U96693 immunoglobulin-like receptor PIRB5 (6M1) -2.2 
NM_010552 interleukin 17 (Il17) 4.1 
NM_008469 keratin complex 1, acidic, gene 15 (Krt1-15) -2.8 
NM_008473 Keratin complex 2, basic, gene 1 (Krt2-1) 4.8 
NM_008476 keratin complex 2, gene 6a (Krt2-6a) 2.3 
NM_010715 ligase I, DNA, ATP-dependent (Lig1) -2.3 
AK003656 Limb region 1 like (Lmbr1l) 3.8 
AF251268 Low affinity sodium-glucose cotransporter (Slc5a4b) -2.5 
NM_025349 
LSM7 homolog, U6 small nuclear RNA associated (S. 
cerevisiae) -2.3 
M16355 major urinary protein I (MUP I) -2.7 
M16360 major urinary protein V (MUP V) -2.2 
NM_011847 mammalian relative of DnaJ (Dnajb6) 2.4 
 
 
  
114 
Table 6-4 Continued 
 
Gene ID Gene Name 
Fold 
change 
NM_008613 meiosis-specific nuclear structural protein 1 (Mns1) 2.5 
NM_008564 
minichromosome maintenance deficient 2 (S. cerevisiae) 
(Mcm2) 4.6 
BC013625 NOL1/NOP2/Sun domain family 2 (Nsun2) 3.1 
AF332077 Parathyroid hormone receptor 2 (Pthr2) 2.2 
NM_008987 pentaxin related gene (Ptx3) 2.4 
M12289 Perinatal skeletal myosin heavy chain mRNA, 3' end. -2.5 
NM_008952 peroxisomal sarcosine oxidase (Pso) 3.8 
NM_011078 PHD finger protein 2 (Phf2) -2.4 
NM_011182 pleckstrin homology, Sec7 and coiled/coil domains 3 (Pscd3) 2.9 
AK011193 Plexin A1 (plxna1) 2.6 
NM_019402 poly(A) binding protein, nuclear 1 (Pabpn1) 3.3 
NM_007552 Polycomb group ring finger 4 (Pcgf4) 2.2 
NM_007743 procollagen, type I, alpha 2 (Cola2) -2.3 
NM_031163 procollagen, type II, alpha 1 (Col2a1) -2.2 
D17546 Procollagen, type XVIII, alpha 1 (Col18a1) 3.6 
AF316872 PTEN induced putative kinase 1 (Pink1) 2.3 
AK003705 putative weakly similar to skin-specific protein 3.1 
U94828 regulator of G-protein signaling 16 (Rgs16) 4.5 
NM_011289 ribosomal protein L27 (Rpl27) 2.5 
NM_026811 RIKEN cDNA 1110031B11 gene (1110031B11Rik) 7.5 
NM_026394 RIKEN cDNA 1110055J05 gene (1110055J05Rik) 4.6 
NM_027205 RIKEN cDNA 1600015I10 gene (1600015I10Rik) 2.2 
NM_027137 RIKEN cDNA 2310037L11 gene (2310037L11Rik) 3.7 
NM_029667 RIKEN cDNA 2310069N01 gene (2310069N01Rik) 4.9 
NM_027622 RIKEN cDNA 4921530G04 gene (4921530G04Rik) -2.5 
AK011583 RIKEN clone 2610028E01 -2.2 
AK006757 ring finger and FYVE like domain containing protein (Rffl) -2.3 
AK020481 RNA binding motif protein 12 (Rbm12) 3.5 
X03766 sceletal muscle alpha-actin (pAM 91; AA 40-375) -3.2 
NM_011408 schlafen 2 (Slfn2), mRNA. -3.2 
AK017710 Similar to basic proline-rich protein 2.9 
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Table 6-4 Continued 
 
Gene ID Gene Name 
Fold 
change 
AK002609 
sirtuin 5 (silent mating type information regulation 2 
homolog) (S. cerevisiae), 3.4 
NM_013670 small nuclear ribonucleoprotein N (Snrpn) 2.9 
NM_028625 Small proline rich-like 2 (Sprrl2) 4.7 
NM_025984 Small proline rich-like 3 (Sprrl3) 2.7 
NM_026822 Small proline rich-like 5 (Sprrl5) 2.4 
AK011425 
solute carrier family 25 (mitochondrial carrier, phosphate 
carrier), member 24 (Slc25a24) 7.6 
AY032863 solute carrier family 26, member 6 2.3 
NM_009216 somatostatin receptor 1 (Smstr1) 3.6 
AF407332 sperm ion channel -2.3 
NM_009261 spermatid perinuclear RNA-binding protein (Spnr) 3.1 
M92417 Stefin A1 (Stfa1) 7.8 
M92419 stefin A3 (Stfa3) 22.1 
AF124299 Stratum corneum chymotryptic enzyme 2.7 
NM_009359 testis expressed gene 9 (Tex9) 3.9 
AK003152 Titin (Ttn) -2.3 
NM_009369 transforming growth factor, beta induced, 68 kDa (Tgfbi) -2.5 
BC013497 transmembrane protein 66 (Tmem66) 2.3 
NM_009394 troponin C, fast skeletal (Tncs) -2.6 
NM_011620 troponin T3, skeletal, fast (Tnnt3) -2.7 
J02644 type I epidermal keratin 2.9 
AK013783 Ubiquitin specific protease homolog [Homo sapiens] -2.6 
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Table 6-5 List of differentially expressed genes related with immune functions in 5-week 
HrrhR/HrrhR mice compared with HrrhR/+ mice. Microarray analysis was done with 
ImaGene and GeneSight softwares from BioDiscovery. 
 
Gene ID Gene Name 
Fold 
change 
AF151729 clone 7 T-cell receptor alpha chain 2.3 
M59956 Ig active kappa chain mRNA V-J region, partial cds. 2.8 
AF041927 infected mouse A seq 11, day 10, T cell receptor beta chain 2.8 
AF041896 infected mouse B seq 5, day 7, T cell receptor beta chain 2.5 
AF041907 infected mouse C seq 10, day 7, T cell receptor beta chain. 2.8 
AF041910 infected mouse C seq 13, day 7, T cell receptor beta chain 4.0 
Y11589 mRNA for antibody light chain, clone library pYBM-AL6. 2.8 
Z12528 Rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ) 3.5 
Z12473 Rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ). 4.3 
Z12427 Rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ). 3.3 
Z12472 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ). 2.7 
Z12498 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ). 2.5 
Z12184 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ). 2.9 
Z12497 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ). 2.8 
Z12416 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ). 2.7 
Z12416 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ). 2.7 
Z12461 rearranged T-cell receptor beta chain Vbeta5 repertoire (VDJ). 2.5 
Z12555 Rearranged T-cell receptor beta chain Vbeta8 repertoire (VDJ) 3.6 
Z12581 rearranged T-cell receptor beta chain Vbeta8 repertoire (VDJ) 3.0 
Z12580 Rearranged T-cell receptor beta chain Vbeta8 repertoire (VDJ). 3.1 
Z12545 rearranged T-cell receptor beta chain Vbeta8 repertoire (VDJ). 2.4 
Z12254 rearranged T-cell receptor beta chain Vbeta8 repertoire (VDJ). 2.2 
X61756 Rearranged T-cell receptor beta variable region (Vb17a). -2.2 
AE008686 
T-cell receptor alpha/delta locus section 4 of 4 of the complete 
region 2.2 
M16120 T-cell receptor insulin B-chain reactive beta chain VNDNJC -2.6 
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Table 6-6 Enriched categories and the genes in each enriched categories in 5-week old 
HrrhR/HrrhR mice compared with HrrhR/+ mice. The microarray analysis was done with 
ImaGene and GeneSight from BioDiscovery. The differentially expressed genes were 
applied to DAVID 2.1 for functional annotation based on gene ontology. 
 
Enriched Categories Enriched Genes 
J02644 Type I epidermal keratin 
X03766 actin, alpha 1, skeletal muscle 
AK003744 cystatin E/M 
Z83816 dynein, axonemal, heavy chain 3 
NM_008469 keratin complex 1, acidic, gene 15 
NM_008473 keratin complex 2, basic, gene 1 
NM_008476 keratin complex 2, basic, gene 6a 
NM_008613 meiosis-specific nuclear structural protein 1 
M12289 
Myosin, heavy polypeptide 8, skeletal muscle, 
perinatal 
NM_009261 spermatid perinuclear RNA binding protein 
AK003152, 
X64700 Titin 
NM_009394 troponin C2, fast 
CYTOSKELETON 
 
 
 
 
 
 
 
 
 
 NM_011620 troponin T3, skeletal, fast 
M12289 
Myosin, heavy polypeptide 8, skeletal muscle, 
perinatal 
AK003152, 
X64700 Titin 
NM_009394 troponin C2, fast 
MYOFIBRIL 
 
 NM_011620 troponin T3, skeletal, fast 
J02644 Type I epidermal keratin 
NM_008469 keratin complex 1, acidic, gene 15 
NM_008473 keratin complex 2, basic, gene 1 
NM_008476 keratin complex 2, basic, gene 6a 
INTERMEDIATE 
FILAMENT 
CYTOSKELETON 
 
 NM_008613 meiosis-specific nuclear structural protein 1 
X03766 actin, alpha 1, skeletal muscle 
M12289 
Myosin, heavy polypeptide 8, skeletal muscle, 
perinatal 
AK003152, 
X64700 Titin 
NM_009394 troponin C2, fast 
ACTIN 
CYTOSKELETON 
 
 NM_011620 troponin T3, skeletal, fast 
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Table 6-6 Continued  
 
Enriched Categories Enriched Genes 
X03766 actin, alpha 1, skeletal muscle 
Z83816 dynein, axonemal, heavy chain 3 
NM_008469 keratin complex 1, acidic, gene 15 
NM_008473 keratin complex 2, basic, gene 1 
NM_008476 keratin complex 2, basic, gene 6a 
CYTOSKELETON 
ORGANIZATION 
AND BIOGENESIS 
 
 
 M12289 
myosin, heavy polypeptide 8, skeletal muscle, 
perinatal 
NM_007743 procollagen, type I, alpha 2 
NM_031163 procollagen, type II, alpha 1 
D17546 procollagen, type XVIII, alpha 1 
ANION 
TRANSPORT 
 
 AY032863 solute carrier family 26, member 6 
U80888 Angiomotin 
AK011583 integrin alpha V 
ANGIOGENESIS 
 
 D17546 procollagen, type XVIII, alpha 1 
NM_025349 
LSM7 homolog, U6 small nuclear RNA 
associated (S. cerevisiae) 
Z12184, 
Z12254 RIKEN cDNA 1810049H19 gene 
AK004007 RIKEN cDNA 2300003P22 gene 
AK012496 RIKEN cDNA 2700067E09 gene 
AK006506 enolase 3, beta muscle 
AF124299 kallikrein 7 (chymotryptic, stratum corneum) 
AK003152, 
X64700 Titin 
CELLULAR 
MACROMOLECULE 
CATABOLISM 
 
 
 
 
 AK013783 Ubiquitin specific protease 32 
AK012496 RIKEN cDNA 2700067E09 gene 
AK003152, 
X64700 Titin 
CYSTEINE-TYPE 
ENDOPEPTIDASE 
ACTIVITY AK013783 Ubiquitin specific protease 32 
NM_009394 troponin C2, fast STRIATED MUSCLE THIN 
FILAMENT NM_011620 troponin T3, skeletal, fast 
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Figure 6-11 Gene networks of the differentially expressed genes from 5-week old 
HrrhR/HrrhR vs. HrrhR/+ mice analyzed with Ingenuity. The microarray analysis was done 
with ImaGene and GeneSight from BioDiscovery. Red: genes with downregulated 
expression. Green: genes with upregulated expression.  
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found that three signaling pathways were affected, including Wnt/β-catenin, apoptosis, 
and ERK/MAPK signaling pathways. All of these pathways play significant roles in hair 
follicle development and growth. The alteration of these pathways suggests that the 
function of Hr gene is directly or indirectly related with these signaling pathways. 
Discussion 
 A novel nonsense mutation R814X in exon 12 of Hr was successfully identified 
in rhino-like mice that originated at Oak Ridge National Laboratory. This mutation has 
been designated as HrrhR in MGI (Mouse Genome Informatics) (Blake et al., 2003). The 
mutation has been used to genotype the mutant mice in relation to the rhino-like 
phenotype, across more than one hundred mice. Homozygous mice always contain the 
mutation in both chromosomes. Heterozygous mice are always heterozygous for the 
nonsense mutation, meaning a mixture of a mutated allele and a wild type allele. Wild 
type mice do not contain any mutations in the same region. Thus, it is confirmed that the 
HrrhR mutation is a disease-causing mutation that is responsible for the typical rhino 
phenotype of rhino-like mutant mice and that HrrhR is an allele of Hr. There are sixteen 
pathogenic Hr mutations (including this mutation) reported to cause the phenotype of 
hairless or rhino in mice (table 2-2). It indicates that there is a wide spectrum of different 
Hr mutations including nonsense mutations, insertion of a provirus in the introns, and 
deletions in the exons.  
 The mutation of HrrhR is a change of C to T in position of 3134 based on the 
sequence of Hr mRNA (NM_021877), resulting in a nonsense mutation in Hr, which 
should lead to nonsense-mediated mRNA decay (Maquat, 2005). The expression of Hr 
was examined in dorsal skin of mice aged from 1 day to 7, 14, and 35 days by Northern 
blotting with two probes covering different portions of Hr mRNA. Hr expression in the 
dorsal skin of HrrhR/HrrhR mice was significantly reduced compared to those in either +/+ 
or HrrhR/+ mice at all ages (day 1, 7, 14, and 35). Lack of expression of Hr due to Hr 
mutations leads to the complete loss of hair in mice (Cserhalmi-Friedman et al., 2004; 
Panteleyev et al., 1998b). Decreased expression of Hr has been directly linked to the 
hairless phenotype by topically applying Hr-specific catalytic oligonucleotides designed 
to cleave the mouse Hr mRNA to recapitulate the hair phenotype (Cserhalmi-Friedman et 
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al., 2004). Significantly reduced Hr expression in HrrhR/HrrhR mice validates the nonsense 
mutation in Hr responsible for the rhino-like phenotype. This novel nonsense mutation 
was confirmed in more than one hundred mutant mice by direct sequencing of the region 
containing the mutation. It has been successfully used as a basic tool to genotype the 
mice before they develop the phenotype of hair loss.  
 The phenotypic change was seen at as early as 10 days of age with widening of 
the infundibulum and formation of utricles in the hair follicles, which becomes more 
severe with age. Dermal cysts were formed by 4 weeks of age and no normal hair follicle 
structures were observed. The phenotype is very similar to that of Hr-/- mice, which 
develop utricles at as early as postnatal day 12 (Zarach et al., 2004). The earlier formation 
of utricles in our mutants suggests a similar severity of the phenotype, including the 
wrinkling skin. Aged HrrhR/HrrhR mutants have skin wrinkling similar in severity to Hr-/- 
mice, consistent with the extremely low level of Hr mRNA in HrrhR/HrrhR mutants. 
However, the pattern of hair loss is random in HrrhR/HrrhR mutants, which is different 
with the pattern in Hr knockout mice starting from head.  
 In order to identify the downstream events of HrrhR mutation, we applied 
microarray analysis to study the genes with altered expressions prior to (7-day), 
coinciding with (10-day), and after (5-week) phenotype development. We did not find 
genes with statistically significant alteration in expression at 7 days of age. However, 
many genes were found with statistically significant increased expressions in HrrhR/HrrhR 
mutants, which are consistent with the loss of Hr as a transcriptional co-repressor.  
Many of these differentially expressed genes are linked to hair follicle cycling, including 
IL-17, Rgs16, Krt1-10, Krt2-1, Lipocalin2 (interacting with Limr), Itgb4, Mcm2, Mll, and 
Crebl1 (Lin et al., 2004). Functional annotation indicates that cell organization, structural 
molecules, and coiled-coil interactions are significantly altered in skin of 10-day old 
mutants. 
 IL-17, a proinflammatory cytokine produced by T cells, plays an important role in 
activating T cells in allergen-specific T cell-mediated immune responses (Nakae et al., 
2002). Its expression characterizes a unique T helper linage that regulates tissue 
inflammation and the overexpression of IL-17 in lung causes inflammation (Park et al., 
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2005). It is known that many inflammatory cytokines, including TNF-α, IL-1α, induce 
drastic morphologic changes and growth arrest of hair follicles in vitro as well as in vivo 
(Groves et al., 1995; Mahe et al., 1996). This might suggest the involvement of the 
increased expression of IL-17 in the development of dermal cysts and hair loss. 
 Among the differentially expressed genes, Itgb4 (integrin β4) was upregulated in 
10-day mutant mice. Itgb4 is a glycoprotein associating with α6 integrin to form the 
α6/β4 complex as a receptor for laminin and plays a critical structural role in the 
hemidesmosome of epithelial cells. Defects in Itgb4 cause epidermolysis bullosa letails 
characterized by mucocutaneous fragility and gastrointestinal atresia (Iacovacci et al., 
2003), and long blistering of the skin associated with hair and tooth abnormalities (van 
der Neut et al., 1999). Itgb4 was shown to be a signature gene of outer root sheath (Rendl 
et al., 2005) a region where Hr is also expressed (figure 4-11) (Panteleyev et al., 1999). It 
was shown that hairless phenotype in Hrhr/Hrhr mutant mice is due to the dyscoordination 
of cell proliferation in distinct hair follicle compartments, malpositioning of the proximal 
inner root sheath, striking atrophy of outer root sheath and failure of trichilemmal 
keratinization in the developing club hair (Panteleyev et al., 1999). In catagen stage, the 
hair bulb and central outer root sheath disintegrate into separate cell clusters in Hrhr/Hrhr 
mutants, thus disrupting all epithelial contact with the dermal papilla. The altered 
expression of Itgb4 might alter the adhesion between center outer root sheath and hair 
bulb and lead to the formation of utricles and the failure to initiate the first hair cycle in 
HrrhR/HrrhR mutant mice. Therefore, the loss of Hr expression in the outer root sheath 
might induce the expression of Itgb4 directly and lead to the phenotype of rhino mice, 
suggesting that Itgb4 might be a direct target of Hr function, which needs to be validated 
in the future. 
 Krt2-1 and Krt1-10, which are coexpressed in suprabasal terminally 
differentiating epithelia cells, are both upregulated by about 3 fold in 10-day old 
HrrhR/HrrhR mutant mice. Krt2-1 and Krt1-10 are also expressed in the inner root sheath 
of hair follicles (Botchkarev and Paus, 2003). Mutations in Krt2-1 or krt1-10 lead to 
epidermolytic hyperkeratosis, epidermolysis bullosa simplex, and epidermolytic 
palmoplantar keratoderma in human patients (Porter et al., 1996). Increased expression of 
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Krt2-1 and Krt1-10 suggests increased terminal differentiation in the inner root sheath 
and might lead to the altered keratinization pattern in skin of HrrhR/HrrhR mutants.  
 Limr, lipocalin-interacting membrane receptor, was upregulated in 10-day old 
HrrhR/HrrhR mutants. Lipocalins are transporters for small hydrophobic molecules, such as 
lipids, steroid hormones, bilins, and retinoids. The ablation of RXR (retinoid X receptor)-
α leads to a progressive alopecia after the first pelage and the destruction of hair follicle 
architecture and the formation of utricles and dermal cysts in adult mice, suggesting that 
RXRα plays a key role in anagen initiation during the hair follicle cycle (Li et al., 2001). 
In addition, RXRα ablation results in epidermal interfollicular hyperplasia with 
keratinocyte hyperproliferation and aberrant terminal differentiation, accompanied by an 
inflammatory reaction of the skin (Li et al., 2001). This suggests that the transportation of 
retinoids might play important roles in hair growth and hair follicle cycles. The increased 
expression of Limr might affect the function of Lipocalin, the transportation of retinoids, 
thus the hair follicle cycles.  
 Hr has been found to trigger reactivation of hair growth by repressing a modulator 
of Wnt signaling, Wise, to promote Wnt signaling pathway in Hr knockout mice during 
the initiation of first hair follicle cycle(Beaudoin et al., 2005). In 10-day old mice, loss of 
Hr function did not lead to alteration of Wise expression change examined by quantitative 
real time PCR, suggesting that hair loss in HrrhR/HrrhR mutant mice may not be directly 
due to the expression change of Wise, at least in terms of utricle formation. We did find 
that Wnt signaling pathway was affected in 5-week mutant mice, supporting the possible 
relationship between Hr and Wnt pathway. Regulation of Wise gene expression is just 
one part of Hr functions in hair follicle growth and cycles. The relationship between Hr 
and Wise signaling may be specific to the stage of the hair cycle, and Hr is differentially 
regulated from anagen to catagen (Beaudoin et al., 2005). 
 Microarray analysis with 5-week old mutant mice is consistent with the 
phenotype of hair loss. We found that many genes encoding procollagens, keratins, 
transcription factors, proteinase, and kinases, were enriched with differential expressions, 
suggesting their involvement in the HrrhR/HrrhR phenotype. Functional annotation of 
microarray data indicated that categories of cytoskeleton and anion transport are enriched 
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in 5-week HrrhR/HrrhR mutant mice, suggesting that Hr is related to the regulation of the 
genes in these categories. Network analysis suggests that signaling through Wnt/β-
catenin, ERK/MAPK, and apoptosis pathways, is altered in HrrhR/HrrhR, based on 
differential expression. Alteration of apoptosis has been confirmed previously in the 
catagen of hair follicles (Panteleyev et al., 1999) as increased apoptosis in dermal papilla 
of Hrhr/Hrhr mutant mice. This confirmation strengthens the reliability of our microarray 
analysis. 
 We also noticed that many immune-related genes display differential expression 
in HrrhR/HrrhR mutants at both 10 days and 5 weeks of age. We also found that the thymus 
in HrrhR/HrrhR mutants was significantly smaller compared to HrrhR/+ mice at 4-weeks 
and the difference is more significant as the mice age. Accelerated atrophy of the thymus 
with age has been reported in both Hrrh-J/Hrrh-J and Hrrhsl/Hrrhsl mutants (San Jose et al., 
2001; Zhang et al., 2005). Detailed immunohistochemistry analysis of the thymus in  
Hrrh-J/Hrrh-J mutant mice shows relative cortical atrophy, enlargement of blood vessels, 
proliferation of perivascular connective tissue, and the appearance of cysts (San Jose et 
al., 2001). Hr has been reported to be expressed in thymus, suggesting the possible 
involvement of Hr in T cell development and functions (Cachon-Gonzalez et al., 1994). 
Skin also contains many macrophages, mast cells, and Langerhan’s cells, which are 
related with immune systems. Atrophy of the thymus in Hrrh/Hrrh mutants may also cause 
immune changes in skin including hair follicles. Thus, the differential expression of 
immune-related genes in skin is associated with the loss of Hr function.  
 In summary, we have identified a novel nonsense mutation in murine Hr gene, 
leading to significantly reduced expression of Hr probably through nonsense-mediated 
decay. The phenotype of HrrhR/HrrhR mutants is very similar with Hr-/- mice, including 
extremely low levels of Hr expression. Microarray analysis highlighted a gene expression 
profile that is consistent with the development of hair loss phenotype. In particular, 
several candidate genes (e.g., Itgb4) were highlighted as potential initial downstream 
events due to the HrrhR mutation.  
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Chapter 7 Conclusions and future directions for elucidating the role of Hr  
in hair follicle development and maintenance 
Molecular and physiological basis for hair loss in Hrn mutant mice  
 Near naked hairless mice (Hrn) arose spontaneously at Oak Ridge National 
Laboratory in the 1980s. The mutation was first reported in 1983 by Stelzner (Stelzner, 
1983) as an autosomal, semi-dominant allele of the mouse hairless gene. Semi-
dominance means that the heterozygous mutants have a less severe phenotype compared 
to the homozygotes. The homozygotes never develop a normal pelage, and heterozygotes 
have a sparse coat that is severe with age. Since then, no other studies have examined this 
mutant.  
Both the phenotype and the molecular mechanisms involved with the phenotype 
were characterized systematically. It was found that Hrn/Hrn mutants have delayed body 
growth in terms of both body weight and body length. Vibrissae in Hrn/Hrn mutants are 
much shorter and curly. There are few hairs in Hrn/Hrn mutants. Of these few hairs, they 
have normal overlapping cuticles on the surface of hair shaft, with blunt and irregular 
ends. Pili multigemini, which means more than two hair shafts coming out of one piliary 
canal in skin, was found in 5-week and 5-month old Hrn/+ mutants, but not in Hrn/Hrn 
mutants. Histological analysis suggests two alternative mechanisms for this: 1) during 
early anagen, more than two hair follicles were associated with each other and they 
shared one piliary canal on the surface of the skin; 2) during early anagen, more than two 
regions in distinct parts of hair follicles were initiated for keratinocytes proliferation and 
differentiation to produce hair shafts so that more than one hair shaft grows from one hair 
follicle.  
Histological analysis with dorsal skin suggests that the premature keratinization 
occurs in the matrix and precortical region of hair follicle in Hrn/Hrn mutants after birth. 
Hyperkeratosis in hair follicles became more severe as the mice age. Hair follicles were 
completely filled with keratinized materials and the normal structure of hair follicles was 
totally devastated due to the pre-mature keratinization. Dermal cysts were formed and 
mineralized in Hrn/Hrn mutants. Ki-67 antigen staining suggested an abrupt change 
around the line of Auber from proliferation to differentiation in the pre-cortex region of 
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hair follicles in Hrn/Hrn mutants. There are also fewer proliferating cells in the matrix and 
pre-cortical region of hair follicles in Hrn/Hrn mutants. Instead of forming a normal hair 
shaft, a disorganized premature keratinization occurred in the precortex region.  
Although the previous research suggested that Hrn is an allele of Hr, no mutations 
were found within the murine Hr locus by genomic sequencing. Hr was differentially 
expressed in Hrn/Hrn mutants with increased expression at an early age and reduced 
expression in adult animals. This might suggest a regulatory mutation in Hr. At the same 
time, many other candidate genes near Hr locus and with either high expression in skin or 
hair follicle/cycle-related functions were sequenced to identify potential mutations. No 
mutations were found in these candidates. Some microRNAs in the region close to Hr 
locus were also considered for the effort of identifying the mutation although no 
mutations were found.  
 The gene expression profile in Hrn/Hrn mutants was surveyed with mouse 
microarray experiments. Microarray analysis was done with 0-, 7-, and 35-day old mice. 
A set of keratins (Krt) and keratin-associated proteins (Krtap) was found with differential 
expression in Hrn/Hrn mutants compared to +/+ mice. Most of the keratins and keratin-
associated proteins, many of which are related with hair shaft formation and growth, were 
downregulated in Hrn/Hrn mutants, which is consistent with the phenotype of hair loss. 
Keratinization is a time- and space-controlled event in hair follicles. Any disturbance in 
the expression of Krt and Krtap might interfere with the balance of keratinization control 
and hair shaft formation. However, the working forces behind the differential expression 
of Krt and Krtap were not identified since the genetic mutation was not identified. Some 
other genes were also identified at day 0 after birth from microarray analysis. These 
genes include Krt2-6a, Sh2-B, Smarac2, Sprr1b, and several members of major urinary 
proteins (MUP), and some may play important roles in the development of the near naked 
phenotype. Microarray analysis showed that many genes normally with low expression in 
anagen phase displayed increased expression, which is consistent with the hair loss. 
Microarray analysis with 7-day old mice suggests that members of cytoskeleton, keratin, 
and extracellular matrix structural components displayed altered expression in the 
127 
mutants. Calcium signaling pathway and transcriptional regulation were also significantly 
altered in the mutant mice due to the mutation.  
 However, the genetic change of the Hrn mutation has not been identified although 
a great effort of this dissertation research was to sequence DNA and cDNA in search for 
potential mutations. It suggests that either a regulatory mutation that increases Hr 
expression or an unknown gene mutation regulates the expression of BMP-4 and affects 
the expression of down-stream effectors including Foxn1, β-catenin, Hes1, distinct 
keratins and keratin-associated proteins. These alterations disturb the balance of 
proliferation and differentiation in the matrix and precortical region of hair follicle, 
leading to premature keratinization in these regions and finally the formation of 
mineralized dermal cyst.  
The Hrn mutation could be used as a model to study human diseases. Marie Unna 
hereditary hypotrichosis (MUHH) maps to the same genomic region as Hrn (Cichon et al., 
2000; Green et al., 2003). Patients with MUHH manifest a similar phenotype as Hrn 
mutant mice. For both models, mutations within the HR coding region have been 
excluded as the cause of the hair phenotype (Cichon et al., 2000; He et al., 2004; Lefevre 
et al., 2000; van Steensel et al., 1999). It is possible that mutations in a homologous gene 
underlie these two models, or that they are both due to a regulatory mutation in Hr. 
MUHH has been described as autosomal dominant (Argenziano et al., 1999), while Hrn is 
semi-dominant (Stelzner, 1983).  However, given the low incidence of MUHH and the 
relatively small number of affected individuals within the population, it is possible that 
this disorder is also semi-dominant and that individuals homozygous for the underlying 
mutation would display a much more severe phenotype. Characterization of Hrn mutation 
might help to identify the mutation in MUHH patients and to find new ways to improve 
or cure the hair loss in these patients. Microarray analysis with Hrn mutation provides the 
molecular clues of the phenotype development and helps to improve the understanding of 
hair growth and hair follicle cycle.  
Molecular mechanisms underlying hair loss in HrrhR mutant mice 
 The mutation in HrrhR mutant mice also arose spontaneously in Oak Ridge 
National Laboratory, several generations downstream of a translocation experiment. The 
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mutation is autosomal recessive, and only homozygous mutants have the phenotype of 
hair loss. Mutants have normal hair follicle morphogenesis, but fail to initiate the first 
hair cycle. Utricles begin to form at 10 days after birth and the infundibulum becomes 
wider. The hair follicles are filled with keratinized materials so that the structure of hair 
follicles is destroyed and dermal cysts are formed. The skin becomes wrinkled and severe 
with age. The mutation was successfully identified as a nonsense mutation, leading to 
dramatically reduced expression of Hr in the homozygotes, as evidenced by Northern 
blotting.  
 Microarray analysis was used to identify the downstream molecular events of this 
nonsense mutation. Mice at an age prior to the formation of utricles (7 days) and an age 
that coincided with the formation of utricles (10 days) were used in the microarray 
analysis to identify the earliest changes in gene expression due to the HrrhR mutation. 
Differentially expressed genes, including IL-17, Krt1-10, Krt2-1, Limr, and Itgb4, were 
identified in mutant mice at 10 days, but not at 7 days. These differentially expressed 
genes might provide useful information for the potential molecular target of Hr in hair 
follicles. IL-17, as a pro-inflammatory cytokine, may play important roles in hair growth 
and hair follicle cycles. Krt1-10 and Krt2-1 are important for the terminal differentiation 
of keratinocytes in skin. Itgb4, as a signature gene of outer root sheath, manifests 
increased expression, coinciding with the disintegration of hair bulb and the outer root 
sheath and loss of Hr expression in the outer root sheath. It suggests that Hr might 
regulate the expression of Itgb4 in the outer root sheath to help initiate the first hair cycle. 
Microarray analysis with mice at both 10 days and 5 weeks of age suggests the alteration 
of immune function in skin, indicating the involvement of Hr in immune system, which is 
consistent with the accelerated atrophy of the thymus in homozygous mutants. The 
network and pathway analysis of the microarray data shows that signaling through 
Wnt/β-catenin, ERK/MAPK, and apoptosis pathway is altered in HrrhR/HrrhR mice, 
suggesting the possible function of Hr to regulate these pathways.  
Hypothesis for the distinct roles of Hr in both Hrn and HrrhR mutant mice 
 Hr protein is reported to translocate to the nucleus (Djabali et al., 2001), to 
associate with nuclear matrix, and to form a repressor complex with other nuclear 
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receptors, including thyroid hormone receptors (Potter et al., 2002), vitamin D receptors 
(Hsieh et al., 2003), ROR-α (Moraitis et al., 2002). Hr is also associated with histone 
deacetylases (HDACs), indicating its potential roles in chromatin remodeling (Beaudoin 
et al., 2005; Potter et al., 2002). It is reported recently that Hr promotes the Wnt signaling 
pathway to initiate the first hair cycle, by repressing the expression of gene WISE, an 
inhibitor of Wnt signaling (Beaudoin et al., 2005). The distinct roles of Hr in our two 
mutant mice are summarized in figure 7-1. Briefly, the loss of Hr in HrrhR/HrrhR mutant 
mice significantly alters Wnt/β-catenin, apoptosis, and ERK/MAPK signaling pathways, 
leads to increased expression of many genes including Itgb4, IL-17, Krt2-1, and Krt1-10, 
which might be associated with widening of infundibulum of hair follicle and formation 
of utricles. The normal structures of hair follicles were completely destroyed in 
HrrhR/HrrhR mutants by 5 weeks of age, associated with the decreased expression of hair 
keratins and keratin-associated proteins and hair loss. However, the roles of Hr in Hrn 
mutants are different compared to those in HrrhR mutants, which are shown in figure 7-1. 
Hr expression is upregulated at early days in homozygous mutants either due to a 
regulatory mutation in Hr or an unknown gene mutation, which directly or indirectly 
leads to the increased expression of BMP-4 and the reduced proliferation in hair matrix. 
The increased expression of BMP-4 results in the decreased expression of Foxn1, Hoxc13, 
hair keratins, and keratin-associated proteins, and premature keratinization, which leads 
to abnormal hair shaft differentiation, finally the formation of dermal cysts, destruction of 
hair follicles, and hair loss.  
Future directions 
 To identify the Hrn mutation, transgenic mice need to be generated with the 
overexpression of Hr in the inner and outer root sheath and the matrix of hair follicles as 
well as the fibroblasts in the sinus, if possible. The overexpression of Hr in these regions 
matches with the Hrn mutant mice and can be used to validate if the Hrn mutation is due 
to Hr overexpression. The problem for this is to find the correct promoter to express Hr 
in these regions. Otherwise, it is not very useful for the validation of Hrn mutation. 
Another way to characterize the Hrn mutation is through fine genetic mapping by 
crossing to re-map the locus for Hrn mutation on the chromosome. This task is not 
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Figure 7-1 Schematic illustration of the hypothesized roles of Hr in Hrn and HrrhR mutant 
mice. Red color indicates increased expression and blue indicates decreased expression. 
The question mark (?) indicates unknown mechanisms. 
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challenging, but very labor-intensive. The outcome of this approach is also not 
guaranteed to identify the mutation. There is a good chance to find the mutation if the 
mutation maps to a different region. This work seems too risky to do in the future. Both 
of the approaches are based on the assumption that Hrn is a single gene mutation in either 
the regulatory sequence or the coding region. If the Hrn mutation is a nonsense mutation 
in the coding region of a single gene, microarray covering the whole mouse genome, at 
least all the genes on mouse chromosome 14 could be done to check expression levels of 
all the genes around Hr. The assumed nonsense mutation should lead to the degradation 
of mutated mRNA through nonsense-mediated decay. A gene or transcript with 
significant reduction of expression in Hrn/Hrn mutants might carry the mutation. This 
strategy has been used with our microarray analysis though our microarray just covers 
about 50% of genes in mouse genome. 
 To characterize the molecular functions of Hr, the HrrhR/HrrhR mutant mice need 
to be studied with more details. We have identified a set of genes with differential 
expression in skin of 10-day old mutants. The alterations in expression need to be 
validated with either real time PCR or in situ hybridization on the tissue dissections. If 
the expression changes of IL-17, Itgb4, Krt2-1, and Krt1-10 could be confirmed with in 
situ hybridization, then the expression of these genes could be examined by reporter 
assay with the overexpression of Hr. These reporter assays help to identify the genetic 
interactions of Hr and possibly the interacting proteins. 
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1. Detailed protocols for aminoallyl labeling of RNA in microarray experiments 
 
1. Purpose  
This protocol describes the labeling of eukaryotic RNA with aminoallyl labeled 
nucleotides via first strand cDNA synthesis followed by a coupling of the 
aminoallyl groups to either Cyanine 3 or 5 (Cy3/Cy5) fluorescent molecules.  
2. Materials  
2.1 5-(3-aminoallyl)-2’deoxyuridine-5’-triphosphate (AA-dUTP) (Sigma; Cat # 
A0410)  
2.2 100 mM dNTP Set PCR grade (Life Technologies; Cat # 10297-018)  
2.3 Anchored T primer (2mg/mL)  
2.4 SuperScript II RT (200U/µL) (Life Technologies; Cat # 18064-014)  
2.5 Cy-3 ester (AmershamPharmacia; Cat # RPN5661)  
2.6 Cy-5 ester (AmershamPharmacia; Cat # RPN5661)  
2.7 QIAquick PCR Purification Kit (Qiagen; Cat # 28106)  
2.8 RNeasy® Mini Kit (Qiagen; Cat # 74106)  
3. Reagent preparation  
3.1 Phosphate Buffers  
3.1.1 Prepare 2 solutions: 1M K2HPO4 and 1M KH2PO4  
3.1.2 To make a 1M Phosphate buffer (KPO4, pH 8.5-8.7) combine:  
 1M K2HPO4……..9.5 mL  
 1M KH2PO4……..0.5 mL 
3.1.3 For 100 mL Phosphate wash buffer (5 mM KPO4, pH 8.0, 80% 
EtOH) mix:  
1 M KPO4 pH 8.5…. 0.5 mL  
MilliQ water………... 15.25 mL  
95% ethanol………... 84.25 mL  
Note: Wash buffer will be slightly cloudy.  
3.1.4 Phosphate elution buffer is made by diluting 1 M KPO4, pH 8.5 to 4 
mM with MilliQ water.  
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3.2 Aminoallyl dUTP  
3.2.1 For a final concentration of 100mM add 19.1 µL of 0.1 M KPO4 
buffer (pH 7.5) to a stock vial containing 1 mg of aa-dUTP. Gently vortex 
to mix and transfer the aa-dUTP solution into a new microtube. Store at –
20ºC.  
3.2.2 Measure the concentration of the aa-dUTP solution by diluting an 
aliquot 1:5000 in 0.1 M KPO4 (pH 7.5) and measuring the OD289. (Stock 
concentration in mM = OD289 x 704)  
3.3 Labeling Mix (50X) with 2:3 aa-dUTP: dTTP ratio  
3.3.1 Mix the following reagents:  
Final concentration  
dATP (100 mM)………5µL…... (25 mM)  
dCTP (100 mM)………5µL…... (25 mM)  
dGTP (100 mM)………5µL…... (25 mM)  
dTTP (100 mM)………3µL……(15 mM)  
aa-dUTP (100 mM)…...2µL……(10 mM)  
Total: 20µL  
3.3.1 Store unused solution at –20°C.  
3.4 Sodium Carbonate Buffer (Na2CO3): 1M, pH 9.0  
4.4.1 Dissolve 10.8 g Na2CO3 in 80 mL of MilliQ water and adjust pH to 
9.0 with 12 N HCl; bring volume up to 100 mL with MilliQ water. Aliquot 
and store at -80°C. 
4.4.2 To make a 0.1 M solution for the dye coupling reaction dilute 1:10 
with water.  
Note: Carbonate buffer changes composition over time; make it fresh 
every couple of weeks to a month.  
3.5 Cy-dye esters 
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4. Procedure  
4.1 Aminoallyl Labeling  
4.1.1 To 10-15 µg of total RNA which has been DNase I-treated and 
Qiagen RNeasy purified, add 2.5 µL Anchored T primers (2 
mg/mL) and bring the final volume up to 18.5 µL with RNase-free 
water.  
4.1.2 Mix well and incubate at 65-70°C for 10 minutes.  
4.1.3 Snap-freeze in ice for 2-3 minutes, centrifuge briefly at >10,000 rpm 
and continue at room temperature.  
4.1.4 Add:  
5X First Strand buffer………….. 6 µL  
0.1 M DTT…………………….. 3 µL  
50X aminoallyl-dNTP mix…….. 0.6 µL  
SuperScript II RT (200U/µL)….. 2 µL  
4.1.5 Mix and incubate at 42°C for 3 hours to overnight (usually 
overnight). 
4.1.6 To hydrolyze RNA, add:  
1 M NaOH 10 µL  
0.5 M EDTA 10 µL  
mix and incubate at 65°C for 15 minutes.  
4.1.7 Add 10 µL of 1 M HCl to neutralize pH.  
4.2 Reaction Purification I: Removal of unincorporated aa-dUTP and free amines 
(use the Qiagen method)  
Note: This purification protocol is modified from the Qiagen QIAquick 
PCR purification kit protocol. The phosphate wash and elution 
buffers (prepared in 3.1.3 & 3.1.4) are substituted for the Qiagen 
supplied buffers because the Qiagen buffers contain free amines 
which compete with the Cy dye coupling reaction.  
4.2.1 Mix cDNA reaction with 300 µL (5X reaction volume) buffer PB 
(Qiagen supplied) and transfer to QIAquick column.  
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4.2.2 Place the column in a 2 ml collection tube (Qiagen supplied) and 
centrifuge at ~13,000 rpm for 1 minute. Empty collection tube.  
4.2.3 To wash, add 750 µL phosphate wash buffer to the column and 
centrifuge at ~13,000 rpm for 1 minute.  
4.2.4 Empty the collection tube and repeat the wash and centrifugation 
step.  
4.2.5 Empty the collection tube and centrifuge column an additional 1 
minute at maximum speed.  
4.2.6 Transfer column to a new 1.5 mL microtube and carefully add 40 µL 
phosphate elution buffer to the center of the column membrane.  
4.2.7 Incubate for 5 minute at room temperature.  
4.2.8 Elute by centrifugation at ~13,000 rpm for 1 minute.  
4.2.9 Elute a second time into the same tube by repeating steps 4.2.6- 4.2.8. 
The final elution volume should be ~80 µL.  
4.2.10 Measure the concentration of cDNA.  
4.2.11 Dry sample in a speed-vac.  
* Here the dried sample could be stored in –20 or –80 °C for a couple of 
weeks 
4.3 Coupling aa-cDNA to Cy Dye Ester.  
4.3.1 Resuspend aminoallyl-labeled cDNA in 10 µL 0.05 M sodium 
carbonate buffer (Na2CO3), pH 9.0; incubate at 37°C for 10-15 
minutes. 
Note: Carbonate buffer changes composition over time so make sure you 
make it fresh every couple of weeks to a month.  
4.3.2 Add 10 ul of labeled cDNA to the appropriate tube of NHS-ester Cy 
dye (dry pellet) 
Note: To prevent photobleaching of the Cy dyes wrap all reaction tubes in 
foil and keep them sequestered from light as much as possible.  
4.3.3 Incubate the reaction for 1 hour in the dark at room temperature.  
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4.4 Reaction Purification II: Removal of uncoupled dye (Qiagen PCR Purification 
Kit)  
4.4.1 To the reaction add 35 µL 100 mM NaOAc pH 5.2.  
4.4.2 Add 250 µL (5X reaction volume) Buffer PB (Qiagen supplied).  
4.4.3 Place a QIAquick spin column in a 2 mL collection tube (Qiagen 
supplied), apply the sample to the column, and centrifuge at ~13,000 for 1 
minute. Empty the collection tube.  
4.4.4 To wash, add 0.75 mL Buffer PE (Qiagen supplied) to the column 
and centrifuge at ~13,000 for 1 minute.  
Note: Make sure Buffer PE has added ethanol before using (see label for 
correct volume).  
4.4.5 Empty collection tube and centrifuge column for an additional 1 
minute at maximum speed.  
4.4.6 Place column in a clean 1.5 mL microtube and carefully add 40 µL 
Buffer EB (Qiagen supplied) to the center of the column 
membrane.  
4.4.7 Incubate for 5 minutes at room temperature.  
4.4.8 Elute by centrifugation at ~13,000 rpm for 1 minute.  
4.4.9 Elute a second time into the same tube by repeating steps 4.4.6- 4.4.8. 
The final elution volume should be ~80 µL.  
4.4.10 Measure the efficiency of dye coupling and dry the sample in the 
speed-vac for about 40-45 min. 
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2. Detailed protocols for microarray hybridizations 
 
1. Purpose 
This protocol describes how to perform microarray hybridization after the 
successful coupling of dyes with cDNA.  
2. Materials and solutions 
2.1 Formamide 
2.2 20X SSC 
2.3 10% BSA 
2.4 10% SDS  
2.5 Mouse cot1 DNA (1 mg/ml) 
3. Reagents preparation 
3.1 1X pre-hybridization buffer 
Formamide                                 7.5 ml  
20X SSC                                    7.5 ml 
10% BSA                                   3.0 ml 
10% SDS                                   300 ul  
dH2O                                        11.7 ml  
Total                                          30 ml 
It can be reused for a few times and store at 4oC. Preheat at 42oC before 
use. 
3.2 1X hybridization buffer 
Formamide                       250 ul 
20X SSC                          250 ul  
10% SDS                           10 ul 
Cot1 DNA(1ug/ul)           100 ul 
dH2O                                390 ul 
Total                               1000 ul 
Store at -20oC. 
3.3 wash buffer 1 
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    20X SSC                      50 ml 
    10% SDS                      10 ml 
    dH2O                           940 ml 
Total                          1000 ml 
Microwave 1 min and 30 sec till the temperature is ~ 42oC. Stir to mix 
temperature. 
3.4 wash buffer 2 
20X SSC                        10 ml  
dH2O                               990 ml 
                        Total                              1000 ml 
3.5 Wash buffer 3 
20X SSC                                       10 ml  
dH2O                                          1990 ml 
Total                                           2000 ml 
4. Procedures 
4.1 Prewarm the pre-hybridization buffer at 42 oC for 10 min. 
4.2 Place printed slides in a slide container containing prehybridization buffer and 
incubate at 42oC water bath for 45 minutes. 
4.3 Wash the prehybridized slides twice (using a forceps to hold the slides) in 
distilled water in two 50ml tubes. 
4.4 Very carefully blow dry slides completely. Hold the slide near the bar code 
end with a forceps and blow-dry first at the barcode away from the array end 
towards the forceps. Then dry the array by blowing down the slides away from 
the forceps. Next dry the back of the slide. Do not wait too long following 
prehybridization to hybridize. Get the slides ready in the hybridization chamber 
(filled with 5X SSC to keep humidity). 
4.5 Prewarm the 1X hyb buffer at 42 oC for 10-15 minutes. Add 35 ul 1X hyb 
buffer to each tube with dried down coupled pellet. Let it sit at room temperature 
for 5 minutes then pipet up and down to dissolve the pellet. The total 
hybridization volume is 70 ul for one mouse 22k slide. Mix for dye swap (Cy3+ 
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Cy5) the appropriate samples, spin briefly and incubate at 95oCfor 5 minutes and 
spin for 30 seconds. 
Note: Never try to put the hyb buffer on ice due to SDS in the buffer! 
4.6 Load the probes to the slides with M-series Lifterslips. The lifterslips should 
not be washed or cleaned by any means before hybridization. The hybridization 
buffer should be loaded from the end of slides without labeling to get samples 
loaded evenly. 
4.7 Wrap the hybridization chamber in aluminum foil and incubate in a 42oC 
water bath overnight. 
4.8 Take the slides out carefully and wash the slides in the rack with wash buffer 
1 at 42oC for 5 minutes with strong stirring. Then the slides were washed with 
buffer 2 at room temperature for 3 minutes twice. The slides were finally washed 
with buffer 3 at room temperature for 1 minutes four times.  
Notes: All the slides should face out of the stirring in the container. Try to keep 
the slides merged in the washing solutions all the time to reduce the chance of 
unwashed dyes to dry. 
4.9 The slides were blowed dry and ready to scan. 
Notes: The light should be turned off during the loading of samples to the slides 
and during the slide washing after hybridization. 
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3. Generation of the antiserum against murine Hr  
  
The Hr-specific antiserum was generated based on the report from Thompson’s 
group in John Hopkins University (Potter et al., 2001). Briefly, the amino acids 450-730 
of mouse Hr were expressed as a GST (glutathione S-transferase) fusion protein and 
purified with GST beads. The fusion protein was used to immunize rabbits (Covance).  
The region of Hr corresponding to amino acids 450-730 is 1728-2567 base pairs 
in NM_021877. A pair of primers was designed to amplify the segment: Hr-F5: 5’-
CAACGGATCCATATAGGAAGCAAGGCGGAG-3’; Hr-R5: 5’-
CGCCGAATTCCTC- TTCTTTGATGTCCTTGGTC-3’. PCR with Hr-F5/R5 was used 
to generate the fragments 1728-2567 bp in NM_021877. There are BamH1 digestion site 
in Hr-F5 primer and EcoRI digestion site in Hr-R5 primer. The PCR products from Hr-
F5/R5 were digested with BamH1 and EcoRI at 37ºC. The pGEX-3X vector (a gift from 
Dr. Yisong Wang in Oak Ridge National Lab) was digested with BamH1 and EcoRI at 
37ºC at the same time. The digested PCR products and pGEX-3X vector were separated 
by agarose gel and purified by GFX column from Amersham. The PCR products were 
ligated with digested pGEX-3X vector, and transfected into JA226 cells by 
electroporation with 1700 Volts for 5 milli-seconds. The transfected clones were 
validated with digestion of BamH1 and EcoRI. The expression of Hr peptide was induced 
by adding 1mM of IPTG (isopropyl-β-D-thiogalactopyranoside). GST-Hr protein was 
purified with GST agarose beads. The purification was validated by SDS-PAGE (sodium 
dodecyl sulfate polyacrylamide gel electrophoresis) with Comassie Blue staining. Totally 
one milligram of GST-Hr fusion protein was sent to Covance to immunize two rabbits to 
generate the Hr antiserum.  
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4. Regulation of human HR gene expression by thyroid hormone and vitamin D3 in 
human keratinocyte HaCaT cell line 
 
 It has been reported that vitamin D receptor physically interacts with HR (Hsieh 
et al., 2003). Hr also acts as transcriptional co-repression of both thyroid hormone 
receptor (TR) and the orphan nuclear receptor, RORα (Moraitis et al., 2002; Potter et al., 
2001). However, it is still unknown whether the expression of Hr inside the cells is 
ligand-dependent. Therefore, we used human keratinocyte HaCaT cell line (gift from Dr. 
G. Timothy Bowden in the University of Arizona, Tucson, Arizona) to study the effects 
of thyroid hormone (T3) and vitamin D3 (VD3) on the expression of HR. The final 
concentration of both TH and VD3 was 50 nM for the treatment according to the 
literatures. The cells were treated for 24 and 48 hours with TH or VD3. The cells from 0 
hours of both treatments were used as time series control and the cells from either 24 or 
48 hours group without either treatment were also used for treatment controls. Each 
group of treatment or the control contains at least 3 dishes of HaCaT cells for design. The 
total RNA was extracted from HaCaT cells after the proper treatments with RNeasy kit 
from Qiagen. The complimentary DNA (cDNA) was generated by RT-PCR with 
oligo(dT) primers and 1 ug of total RNA. A pair of primers for real time PCR was 
designed to amply the human hairless from the cell lines: HrQF5: 5’-
CACCAGGTCTGGGTCAAGTT-3’ and HrQR5: 5’-GGGCGTTTTCTGTGTTGATT-3’. 
It was found that the HR expression in HaCaT cells are not affected by either thyroid 
hormone or vitamin D3, suggesting the regulation of HR is ligand-independent of thyroid 
hormone and vitamin D3. Our results are consistent with the finding from Dr. 
Christiano’s groups (Engelhard and Christiano, 2004), which is that the regulation of Hr 
expression in keratinocytes is T3 independent.  
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